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ABSTRACT 
Experimental meningitis was induced in pigmented guinea pigs by subarachnoid inoculation 
of 1 x Escherichia coli K-12 or 3 x CFU Streptococcus pneumoniae serotype 2 
D39 (NCTC 7466) or PLN-A, or defined isogenic derivatives of D39 
deficient in pneumolysin, neuraminidase or hyaluronidase respectively. All animals 
developed a meningeal inflammatory response and a labyrinthitis. Hearing loss in 
pneumococcal meningitis was measured by recording the evoked auditory nerve compound 
action potential from the round window membrane. Animals infected with PLN-A sustained 
significantly less hearing loss than those infected with wild-type D39 (12 dB vs. 50 dB 12 h 
post inoculation; P<0.0001), Neuraminidase deficiency did not alter the course of the 
meningeal inflammatory response nor affect hearing loss. The mutant survived 
poorly in the cerebrospinal fluid and blood but still caused hearing loss. Both pneumococcal 
and E. coli meningitis induced specific ultrastructural lesions in the organ of Corti as judged 
by high-resolution scanning and transmission electron microscopy, and these lesions were 
most severe with pneumolysin-sufficient pneumococcal infection. 
Microperfusion of CFU S. pneumoniae D39 directly into the scala tympani of guinea 
pigs also resulted in electrophysiological and ultrastructural damage to the organ of Corti 
that could be diminished by pretreatment with antibiotics. 
The data confirm the cochlea as the site of meningogenic deafness. They suggest that 
pneumolysin expression is chiefly responsible for meningogenic deafness and that if 
pneumococci invade the inner ear during bacterial meningitis, cochlear deafhess will rapidly 
ensue. 
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1. INTRODUCTION 
1.1. Bacterial meningitis. 
Acute bacterial meningitis is a common and much-feared disease with a significant 
mortality. In spite of dramatic improvements in antibiotic therapy and supportive care over 
the last fifty years, not everyone who survives bacterial meningitis can expect to make a full 
recovery. Around 10% of survivors will have some kind of neurological deficit, ranging 
from sensorineural deafness to hemiplegia or worse. Patients in developing countries fare 
especially badly, and pneumococcal meningitis in particular carries a grim prognosis. 
This thesis is chiefly concerned with pneumococcal meningitis and the deafness which it 
causes. Data from a newly developed model of hearing loss in experimental meningitis in the 
guinea pig are presented. The findings show that experimental meningitis damages the 
physiological function and ultrastructure of the inner ear. Evidence for the importance of 
pneumococcal toxin pneumolysin in this process will be discussed. Some of the first in vivo 
data obtained from experimental infections with pneumococci deficient in neuraminidase or 
hyaluronidase will also be presented. 
This introduction will review: 
• clinical aspects of bacterial meningitis; 
• the pathogenesis of pneumococcal disease; 
the structure and function of the inner ear; 
• the pathogenesis of meningitis with reference to experimental infection models; 
• 
The final section discusses shortcomings in the current paradigm used to explain why 
deafness occurs in meningitis and outlines the experimental data to be presented in 
subsequent chapters. 
evidence from clinical and experimental studies of deafness in meningitis. 
1.1.1. Epidemiology and causative agents. 
The annual mean incidence of bacterial meningitis in the USA was between 1.9 per 100,000 
and 4.0 per 100,000 in a recent survey (Wenger et al 1990) and is probably similar in the 
UK. In developing countries, attack rates may be ten times higher (Bryan et al 1990). Three 
organisms are responsible for the majority of cases of bacterial meningitis: Neisseria 
meningtidis, Streptococcus pneumoniae and Haemophilus influenzae with case fatality 
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rates in the USA in the early 1980s of 10.3%, 26.3% and 6.0% respectively (Schlech et al 
1985). All are exclusive human pathogens and are commonly carried in the nasopharynx of 
healthy people (Austrian, 1986). Streptococcus pneumoniae will be considered in detail in 
section 1.2; we will briefly consider here the other major pathogens. 
Haemophilus influenzae is a small (0.3-0.5 x 1-2 non-motile non-sporing fastidious 
Gram-negative cocco-bacillus. Haemophili are facultative anaerobes which grow best in 
enriched media. Almost all clinically significant disease is caused by the encapsulated 
Haemophilus influenzae type B (Hib). Penicillin resistance is common. Until the recent 
introduction of the Hib conjugate vaccine in most developed countries, Hib was the 
commonest cause of bacterial meningitis in children under five and was an important cause 
of invasive bacteremia in infants. The incidence declines in older children, who acquire 
specific neutralising antibody. Because of the rapid fall in the incidence of invasive Hib 
infection, clinical studies of meningitis conducted at a time of high Hib prevalence must be 
interpreted carefully today. There has been a suggestion that the incidence of pneumococcal 
infection has increased to fill the niche left by eradication of Hib (Baer et al 1995). Globally, 
invasive Hib infections remain an extremely serious problem because Hib conjugate 
vaccination has not been made available to the deprived children in the developing world 
that need it most (Dagan 1996). 
Neisseria meningitidis (meningococcus) is a delicate non-sporing non-motile Gram negative 
oval diplococcus (0.8 in diameter) which also requires enriched media (such as Mueller- 
Hinton medium) for isolation. There are eight main serogroups which vary in their 
pathogenicity and geographical distribution. Group B serotypes are mainly responsible for 
outbreaks in the UK, but groups A and C are common in the sub-Saharan epidemics. 
Invasive meningococcal disease can progress at frightening speed and can kill within 12 h of 
initial symptoms. There is an important distinction between meningococcal meningitis, in 
which the infection is limited to the cerebrospinal fluid (CSF) space, and the severe systemic 
illness of meningococcal septicaemia. Meningococci are exquisitely sensitive to penicillin 
and there is as yet little problem with resistance. 
Escherichia coli is a common cause of neonata1 meningitis. Eighty per cent of isolates bear 
the K1 capsular subtype (Mulder et al 1984). E. coli are Gram-negative, motile, non- 
sporing bacilli (0.5 x 1-2 Colonies grown on Macconkey medium are smooth, glossy 
and tinged rose-pink due to lactose fermentation. Three kinds of surface antigens are 
demonstrable: the O (somatic), K (capsular) and H (flagellar) antigens. Between serogroups 
there is great diversity in antibiotic sensitivity, virulence and production of enterotoxins. 
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Other causes of acute bacterial meningitis include Citrobacter spp and Group B 
Streptococci (GB S) in neonates, and Listeria monocytogenes, Pseudomonas and 
Staphylococcus in adults. Mycobacterium tuberculosis can present as an acute meningitis 
but will not be further considered here. 
1.1.2. Clinical presentation and treatment 
The initial symptoms of bacterial meningitis resemble the onset of 'flu. Babies may refuse 
feeds, vomit, become difficult to wake and feverish. Adults and children commonly develop 
headache, neck stiffness and drowsiness. They may be unable to tolerate bright lights 
(photophobia) and become confused. In meningococcal septicaemia, a purplish blotchy rash 
can develop. A recent retrospective survey of 305 cases of bacterial meningitis occurring in 
the UK during 1989 and 1990 showed that two-thirds of patients had been unwell for at 
least 12 h prior to admission. Less than 18% of patients had received antibiotic therapy 
before admission as is currently recommended (British Society for the Study of Infection 
1995). Signs found on examination include fever, neck stiffness, impaired consciousness or 
coma, and a purpuric rash (usually but not invariably associated with meningococcal 
disease). The occurrence of seizures and coma are poor prognostic factors. The most 
important investigation is examination of the cerebrospinal fluid (CSF) by Gram stain, 
culture and cell count. A definitive diagnosis rests on CSF culture or detection of 
pneumococcal antigen. Contrary to popular belief organisms can be isolated from the 
majority of cases given antibiotics before admission. Classically the CSF in acute bacterial 
meningitis is turbid, with a predominant neutrophil leukocytosis in excess of 5-10 
sometimes over 10,000 a raised CSF protein concentration (>0.5 g/l) and a reduced 
CSF:plasma glucose ratio (<2/3). However, in 18% of the cases in the BSSI series the CSF 
was clear even though it contained viable organisms. Blood cultures are positive in around 
60% of cases. 
Treatment of acute bacterial meningitis requires hospital admission, prompt intravenous 
antimicrobial therapy and good supportive care. The choice of antibiotic is dictated by local 
epidemiology and resistance patterns. In the UK, the combination of benzylpenicillin and 
chloramphenicol remains popular (British Society for the Study of Infection, 1995). 
Penicillin-resistant pneumococci (PRSP) probably originated in Spain and are now 
distributed widely around the world, being a particular problem in the USA and South 
Africa (Klugman, 1994b). In these areas, first line therapy consists of a third-generation 
cephalosporin such as cefotaxime. Because PRSP often exhibit intermediate resistance to 
third-generation cephalosporins (Klugman, 1994a), some authors now recommend adding 
vancomycin to the initial blind therapy in such areas (McCracken, Jr., 1996). The prevalence 
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of PRSP isolates in England and Wales rose from 1.5% in 1990 to 3.9% in 1995 (Johnson, 
1996), indicating a serious problem ahead. 
1.2. Streptococcus pneumoniae. 
1.2.1. Introduction. 
Streptococcus pneumoniae (the pneumococcus) is an important human pathogen. It is a 
major cause of community-acquired pneumonia, otitis media, meningitis, and bacteremia, 
particularly attacking people at extremes of age, those with underlying disease such as HIV 
infection, and hyposplenic individuals. Common predisposing factors for pneumococcal 
meningitis include pneumonia, sinusitis, middle ear pathology and CSF leak following head 
injury. In the UK during the period 1982-1992 there were 22 567 reports of pneumococcal 
bacteraemia and 3 500 reports of pneumococcal meningitis, representing about 18% of the 
total meningitis reports received by the Public Health Laboratory Service (PHLS). The 
annual mean incidence of pneumococcal meningitis in the UK during the period 1989-92 
was 8.7 episodes per 100,000 population (Askenasy et al 1995). In the US the reported 
incidence is about 1.1 per 100,000 population but rises to 30 per 100,000 in infants under 5 
months of age (Schlech, 1985). Globally, S. pneumoniae causes over 1 million deaths a year 
in children under the age of 5 years (Obaro, 1996). Pneumococcal meningitis occurs in 
epidemics across sub-Saharan Africa and is the most common form of meningitis in some 
areas (Dagan, 1996). 
Study of the pneumococcus has yielded much information, including the discovery of DNA 
as the transforming factor and the recognition of capsular polysaccharide as an immunogen, 
leading to the manufacture of the first bacterial polysaccharide vaccine (Avery and Dubos, 
193 1; Austrian, 198 1 ; Tuomanen et al 1995; Watson et al 1993). 
1.2.2. Pneumococcal structure. 
Pneumococci are Gram-positive cocci about 1 in diameter which grow in pairs or short 
chains. They are non-motile and non sporing. Three layers make up the surface: the plasma 
membrane, the cell wall, and the polysaccharide capsule. The capsule is some 200-400 nm 
thick and conceals the underlying layers during exponential growth. Differences in capsular 
structure provide immunogical diversity and form the basis for serotyping organisms. The 
cell wall has a triple-layered peptidoglycan backbone consisting of alternating N- 
acetylglucosamine and N-acetylmuramic acid residues cross-linked through peptide chains. 
It is a dynamic macromolecule with components being continuously inserted into and 
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released from the structure (Tuomanen et al 1995). Cell wall polysaccharide, a complex 
teichoic acid, is linked to the peptidoglycan backbone by N-acetylmuramic acid. A specific 
enzyme, autolysin (N-acetylmuramic acid-L-alanine amidase), cleaves this linkage. The 
Forsmann antigen, which is an inhibitor of autolysin, is a lipoteichoic acid embedded in the 
plasma membrane. Cells in the stationary phase of growth liberate Forsmann antigen, so 
deregulating local autolysin and inducing cell lysis. Both peptidoglycan and teichoic acid are 
powerful stimulators of the immune response (Tuomanen et al 1985a). Little is known 
about the function of the various surface proteins that have recently been identified 
(Tuomanen et al 1995). Pneumococcal surface protein A (PspA) is an antigenically variable 
surface protein which is firmly anchored in the cell wall and appears to be essential for full 
virulence. It might act by inhibiting complement activation (AlonsoDeVelasco et al 1995). 
Other surface proteins are probably involved in pneumococcal adherence to epithelial cells 
(Paton et al 1993a) and degradation of complement component C3 (Angel et al 1994). 
Pneumococci are aerobic and facultatively anaerobic and grow well in most laboratory 
media such as Todd Hewitt medium, or Brain Heart Infusion broth. In broth culture, 
pneumococci tend to autolyse once stationary phase is reached. Colonies of encapsulated 
organisms on blood agar are small, smooth and transparent and surrounded by a greenish 
area of a-haemolysis. Unencapsulated pneumococci form rough colonies. The presence of 
capsule can be confirmed with the Quellung test which is serotype specific (Frasch, 1995). 
At least three interchangeable variants can be defined on colonial morphology: opaque, 
semi-transparent and transparent. 
1.2.3. Colonisation of the host. 
Pneumococci generally reside in the human nasopharynx and probably the entire human 
population is colonised at some time(Austrian, 1986). Some of these people go on to 
develop invasive disease. This seems to be associated with recent colonisation and is more 
likely with certain serotypes (Boulnois, 1992). The main route of infection is by aerosol 
inhalation of pneumcocci which colonise the upper and then the lower respiratory tract. The 
lower respiratory tract is protected by several non-specific mechanisms, such as the cough 
reflex, mucociliary transport and IgA secretions, and by the presence of resident alveolar 
macrophages. Pneumococci secrete an IgAl -specific protease, which would inhibit mucosal 
immunity provided by IgA. Colonisation and invasion is aided by a specific interaction with 
disaccharide molecules such as N-acetyl glucosamine ß 1-3 galactose (GlcNAcß 1 -3Gal) 
found on oral epithelial cells. Pneumococcal phase variation contributes to the colonisation 
as the transparent phenotype binds up to times more efficiently to GlcNAcßl-3Gal than 
the opaque phenotype (Cundell et al 1995). Resting pneumocytes express two classes of 
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receptors to which pneumococci of any phase can bind: N-acetyl-D-galactosamine linked 
ßl-3 or ß 1 4  to galactose (GalNAcßl-3Gal or GalNAcß 1-4Gal). Transparent-phase 
pneumococci also bind to a platelet-activating factor (PAF) receptor expressed on activated 
pneumocytes (Cundell e? al 1995), which may explain increased susceptibility to 
pneumococcal disease after respiratory viral infections. It has also been suggested that 
neuraminidase derived from pneumococci or during co-infection with the influenza virus 
exposes target receptors on the host cells by cleaving sialic acid from glycolipids (Krivan et 
al 1988). In isolated organ cultures of human respiratory epithelium, pneumococci are 
found to adhere only to mucus and to damaged ciliated mucosa, where they attach to the 
gaps between cells (Rayner et al 1995). 
Once established in the alveoli, intra-alveolar replication gives rise to the classic lobar 
pneumonia. A bacteraemia can ensue, either by invasion from the pneumonic lung or 
perhaps directly by invasion from the upper respiratory tract. Pneumococci are cleared from 
the blood stream by the liver and spleen. An acute phase protein, C-reactive protein (CRP), 
binds to pneumococcal cell wall and activates the classical complement pathway, so acting 
as a primitive antibody. Pneumococci probably reach the meninges by haematogenous 
spread but the exact mechanisms of entry into the subarachnoid space remain a mystery. As 
discussed below, various pneumococcal components elicit a vigorous local immune 
response. Host tissue damage results both from an excessive local immune reaction and 
from pneumococcal products which are directly cytotoxic. 
1.2.4. Capsule. 
The possession of a polysaccharide capsule is essential for invasive pneumococcal disease to 
occur. At least 84 capsular types are recognised (Collee e? al 1989). The capsule acts to 
resist opsonophagocytosis (Wood, Jr. and Smith, 1949). Encapsulated strains are some 
times more virulent then unencapsulated strains in experimental models in vivo and all 
strains isolated from clinically invasive disease are encapsulated (Avery and Dubos, 193 1; 
Austrian, 198 1). Capsule is not however necessary for pneumococcal replication in the CSF 
space (Tuomanen e? al 1985b). Although capsule is an essential virulence factor, capsular 
polysaccharides are in general poor stimulators of the inflammatory reaction which is held 
to be responsible for so much autologous tissue damage. In spite of this, purified capsular 
polysaccharides can stimulate production and secretion of tumour necrosis factor-alpha 
(TNFa) by murine macrophages (Simpson et al 1994). Certain serotypes are frequently 
isolated from cases but rarely found in carriers, suggesting these serotypes are more virulent 
for invasive disease. Variation of the capsule itself is at least partly responsible for the 
difference in virulence between serotypes. For example, replacing the capsule of a highly 
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virulent type 5 strain with type 3 capsule by genetic manipulation renders the otherwise 
isogenic derivative avirulent for mouse bacteremia. But switching the capsule of a relatively 
apathogenic type 6B strain to the same type 3 capsule enhances virulence (Kelly et al 1994). 
These data demonstrate that there is a complex interaction between capsular type and other 
virulence mechanisms such as differences in exposure of the cell wall components. There is 
also serotype variation in the activation of the alternate complement pathway, one of the 
immune system's first line defences (Fine, 1975). 
The current 23-valent polysaccharide vaccine contains types 1, 2, 3, 4, 6B, 7F, 8, 9N, 9V, 
10A, 11A, 12F, 14, 15B, 17F, 18C, 19F, 19A, 20, 22F, 23F and 33F. The prevalence of 
invasive pneumococcal serotypes varies geographically and with age, so the expected level 
of protection afforded by the vaccine varies between patient groups. In the UK at least, of 
750 pneumococcal blood isolates and 130 CSF isolates serotyped in the UK by the PHLS in 
1993, over 95% belonged to serotypes present in the 23-valent vaccine (George, 1995). In 
spite of this apparently good coverage capsular polysaccharides are poorly immunogenic in 
those most at risk of infection (Lee and Wang, 1994). Thus over recent years attention has 
focused on other pneumococcal consituents which may induce inflammation or enhance 
virulence. This work aims firstly to improve upon current immunisation techniques by 
finding more immunogenic targets for at-risk populations and provide cross-serotype 
immunity (Alexander et al 1994; Lock et al 1992). Conjugate vaccines help promote a T- 
helper cell response, and so induce better immunity in young infants. Polysaccharide-protein 
conjugate vaccines containing a biologically inactive toxoid such as a derivative of the 
pneumococcal protein pneumolysin are showing great promise (Lee and Wang, 1994; 
Mitchell et al 1992). Unfortunately for the majority of those at risk, conjugate vaccines 
undergoing trials at present omit serotypes 1, 5 and 7 which are common causes of invasive 
pneumococcal disease in children in developing countries (Dagan, 1996). Study of such 
accessory virulence factors also helps to elucidate the mechanism of pneumococcal disease. 
Table 1.1 (derived from AlonsoDeVelasco, 1995) lists some characteristics of the major 
proposed pneumococcal virulence factors. 
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Virulence factor Proposed mechanism of virulence Selected References 
Capsule Resists phagocytosis Wood, Jr. and Smith, 1949 
Poorly immunogenic 
Fails to activate alternative 
complement pathway 
Avery and Dubos, 193 1 
Fine, 1975 
Cell wall products Induces inflammation and Chemotaxis Tuomanen et al 1985a 
Tanaka et al 1994 
Heumann et al 1994 
Geelen et al 1993 
Kim et al 1995 
Attaches to endothelial cells and is 
Directly cytotoxic for astrocytes 
cytotoxic 
Pneumoly sin see table 1.2 
Neuraminidase Exposes cell surface receptors for Krivan et al 1988 
pneumococcal adherence 
Damage to glycolipids, glycoproteins Paton et al 1993a 
and oligosaccharides 
Promotes neutrophil adherence Marin et al 1995 
the blood brain barrier 
Survival in the blood stream and CSF 
?Nutritional (this thesis) 
Release of pneumolysin and cell wall 
material during spontaneous lysis 
Hyaluronidase Bacterial dissemination and breaching Kostyukova et al 1995 
Hill et al 1996 
Lock et al 1992 
Berry et al 1992 
Canvin et al 1995 
Autolysin 
Hydrogen Cytotoxic for alveolar epithelial cells Duane et al 1993 
peroxide 
PspA Inhibits complement activation AlonsoDeVelasco et al 1995 
IgAl protease Inhibits mucosal defence Kornfield and Plaut, 198 1 
C3 degrading Resists opsonophagocytosis Angel et al 1994 
proteinase 
Adhesins Binding to epithelial cells Paton et al 1993a 
Oxidative Prevents neutrophil killing due to Perry et al 1994 
response inhibitor reactive oxygen intermediates 
Table 1.1: Possible pneumococcal virulence factors. 
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1.2.5. Cell wall. 
Tuomanen and colleagues (1995) emphasise the role of cell wall products in the 
pathogenesis of pneumococcal infection. Pneumococcal cell wall (PCW) material liberated 
during exponential growth in the alveolar space binds to epithelial and endothelial cells 
(Geelen et al 1993). PCW causes contiguous endothelial cells to separate from each other, 
resulting in tissue oedema and probably aiding pneumococcal invasion. Activation of the 
procoagulant cascade causes fibrin deposition. Liberated PCW also binds to leukocyte 
CD 14 receptors, eliciting the production of cytokines, particularly interleukin- 1 (IL- 1) in 
vitro. However, Heumann et al (1994) found that in the presence of 10% pooled plasma, 
various intact Gram-positive cell walls could also induce TNF-a and interleukin-6 (IL-6) 
expression by monocytes. In vivo, therefore, all three of these proinflammatory cytokines 
are likely to be expressed. Leukocytes are recruited both by the selectin-integrin (CD18) 
pathway commonly activated by many infections, and in the lung by a CD18-independent 
but PAF-dependent pathway unique to pneumococcal infection. Leukocyte recruitment into 
the subarachnoid space in response to challenge with pneumococci (but not with 
Haemophilus influenzae) is reduced by a specific PAF-receptor antagonist (Cabellos et al 
1992). Local activation of complement amplifies the immune response. As leukocytes begin 
to control the infection by phagocytosing organisms, the dying bacteria release more PCW 
and soluble factors such as pneumolysin, which serve to increase autologous tissue damage. 
Rapid destruction of bacteria by cell wall active antibiotics will, according to this model, 
cause a transient rise in local inflammation due to the excess PCW released. Pneumococcal 
cell wall products at a similar concentration to that which provokes meningeal inflammation 
in vivo induce TNFa and nitric oxide production by cultured rat glial cells. This is inhibited 
by dexamethasone (Freyer et al 1996). Heat-killed pneumococci and PCW are cytotoxic for 
both human microglia and astrocytes in cell culture, but there is no evidence that 
pneumococcal cell products are directly toxic for neuronal cell lines (Kim et al 1995). 
Different components of PCW have different activities in vivo. Meningeal inflammation 
provoked by the teichoic acid component of PCW peaks at 5 h whereas that due to the 
peptidoglycan component peaks at 24 h (Tuomanen et al 1985a). 
Although the role of cell wall in inducing inflammation is undisputed, Boulnois (1 992) and 
Paton (1993) have emphasised the role of pneumococcal proteins in pathogenesis. 
Pneumolysin, neuraminidase, and hyaluronidase are of particular relevance to this thesis and 
will be considered below in more detail. 
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1.2.6. Pneumolysin. 
The production of a haemolysin by the pneumococcus was first reported by Libman (1 905), 
and the factor responsible was purified to homogeneity by Shumway et al (1971). The gene 
has been isolated, cloned and expressed in E. coli by two independent groups (Paton et al 
1986; Walker et al 1987). 
Structure and function of pneumolysin 
Pneumolysin consists of single 53 kD polypeptide chain. It is one of a family of cholesterol- 
binding cytolysins (previously known as thiol-activated cytolysins) produced by Gram- 
positive organisms which share certain characteristics, including similar molecular weight, 
reversible loss of activity upon oxidation of crude preparation or exposure to cholesterol, 
and immunological cross-reactivity (Mitchell et al 1992). The most important difference 
between pneumolysin and other similar toxins is that pneumolysin is located in the 
cytoplasm, and the predicted amino acid sequence lacks a typical N-terminal signal peptide 
(Walker et al 1987). Cytolysins bind to cholesterol in plasma membranes, oligomerise, and 
form large (40-50 nm) transmembrane pores which cause cell lysis. Pneumolysin possesses a 
structural motif of an 11 amino acid sequence surrounding a single cysteine residue which is 
common to other pore-forming toxins. This is thought to form an amphiphilic helix spanning 
the cell membrane. Evidence from site directed and random mutagenesis studies have shown 
that mutations within this motif can abolish haemolytic activity. The altered proteins 
resulting from such mutagenesis studies are referred to as pneumolysoids or simply toxoids. 
Thiol-activation is in fact only necessary for the crude preparations of the toxin as oxidation 
does not affect the haemolytic activity of the purified protein. Consistent with this, the 
single cysteine residue itself is not necessary for full haemolytic activity as this property was 
not affected by a substitution (Saunders et al 1989). The greatest reduction 
in haemolytic activity achieved by a single substitution is for (a 99% fall) 
(Hill et al 1994) but the combination of and reduces 
haemolytic activity to 0.0001% of wild type (Berry et al 1995). A 
substitution prevents the toxin forming oligomers in the cell membrane and also reduces 
haemolytic activity by 99% (Mitchell et al 1992). 
Cell binding appears to be mediated by the C-terminus of the peptide, with deletion of as 
few as six terminal residues decreasing cell binding by 98% (Owen et al 1994). The ability 
of pneumolysin to activate complement is critically dependent upon yet another part of the 
molecule, being abolished by a substitution, which reduces but does not 
completely abolish binding to Fc (Mitchell et al 1991). Blocking studies with monoclonal 
antibodies confirm that haemolytic activity is independent of cell binding and complement 
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activation. Two of these monoclonals also cross-react with the clostridial toxin, 
perfringolysin O (deLosToyos et al 1996). 
The exact structure of the pore-forming mechanism remains unclear but recent 
ultrastructural studies by Morgan et al (1 994, 1995) confirm that oligomerisation occurs 
and that the four domains of pneumolysin pack into a square planar arrangement. In lipid 
bilayers, pneumolysin forms multiple-sized channels with varying cation:anion selectivity. 
The small, more cation-selective channels become voltage sensitive in the presence of 
divalent cations (Korchev et al 1992). 
Role in pathogenesis 
Evidence for the role of pneumolysin in pathogenesis has come from three main areas of 
research: 
• Study of the direct cytotoxic and immunomodulatory activity of the toxin itself using 
native or recombinant protein; 
• Modification of the course of pneumococcal infection in animals previously immunised 
with pneumolysin or toxoided pneumolysin; 
• Comparison of the course of experimental infection induced by wild type pneumococcal 
infection with that due to isogenic mutants deficient in pneumolysin or expressing 
toxoided pneumolysin. 
Activities of pneumolysin 
Pneumolysin has a wide range of cytotoxic and immunomodulatory effects, some of which 
are detailed in table 1.2 (see also Paton 1996) . The potential contribution of pneumolysin 
to the pathogenesis of infection is large. Toxicity has usually been assessed using cultured 
cell lines. There are data available about the in vivo toxicity of purified pneumolysin in rat 
lung, guinea pig inner ear and rabbit cornea. Toxoided pneumolysin has also been tested in 
all of these systems (although the data for intracochlear perfusion is unpublished). In a 
model of rabbit meningitis, recombinant pneumolysin (0.1 to 1 administered by 
cisterna1 injection induces a CSF leukocytosis (maximal at 4 h) and a rise in CSF 
concentrations of TNFa (maximal at 2 h), lactate and protein (Friedland et al 1995). This 
inflammatory response is unaffected by a substitution (Asp-3 which renders the 
toxoid unable to activate complement. However, a toxoid deficient in haemolytic activity 
induces less meningeal infiammation. Both of these toxoids also exhibit less 
ability than intact pneumolysin to induce pneurnonic change when administered into rat lung 
(Feldman et al 199 1). A non-haemolytic toxoid still causes ultrastructural 
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damage to the organ of Corti characteristic of pneumolysin when perfused into scala 
tympani of guinea pigs (SD Comis, MP Osborne and A Cohen, unpublished findings). 
Protection by immunity to pneumolysin. 
Immunisation of BALB/c mice with highly purified native pneumolysin (Paton et al 1983) 
or a toxoided derivative (Paton et al 1993b) provides significant protection 
from intraperitoneal challenge with virulent serotype 2 S. pneumoniae strain D39. More 
interestingly, concurrent immunisation with autolysin does not enhance survival. Immunity 
to autolysin alone does not alter the course of infection with a pneumolysin-deficient strain 
(PLN-A) although it does provide partial protection from wild type infection. This suggests 
that the main contribution of autolysin in vivo is to release pneumolysin. Immunity against 
pneumolysin should provide protection across serotypes. Immunisation of mice with the 
pneumolysoid (Trp-433 provides partial or complete protection against at least nine 
different pneumococcal serotypes except for one clinical isolate (strain GB05; serotype 3) 
when administered intranasally (Alexander et al 1994). In general, pneumolysoid 
immunisation is more effective in countering intranasal challenge than preventing 
bacteraemia after intraperitoneal challenge. 
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Activity Reference 
Cytotoxicity: 
Cytolytic for RBCs at high concentrations Boulnois, 1992 
Inhibits ciliary beating in human nasal turbinate organ 
culture (1-50 
Toxic to cultured bovine pulmonary artery endothelial 
cells 
Toxic to cultured pulmonary alveolar epithelial cells (30 
ng/ml). Increases alveolar permeability in isolated 
perfused rat lung (200 ng/ml) 
Steinfort et al 1989 
Rubins et al 1992 
Rubins et al 1993 
Immunornodulatory functions: 
Irreversibly inhibits human lymphocyte proliferation and 
antibody production in vitro (1 O ng/ml) 
Activates complement ( 1 - 1 O 
Binds Fc fragment of antibody (1-10 
Ferrante et al 1984 
Paton et al 1984 
Mitchell et al 1991 
Inhibits respiratory burst of neutrophils 
Induces IL- 1 ß and TNFa in human mononuclear 
phagocytes (1 ng/ml) 
Activates PLA2 in cultured pulmonary endothelial cells 
(10 ng/ml to 1 
Perry et al 1993 
Houldsworth et al 1994 
Rubins et al 1994 
In vivo effects: 
Induces salient features of pneumonia in rat lung 
Intracisternal injection induces a CSF leukocytosis and 
TNF response in rabbits 
Feldman et al 199 1 
Friedland et al 1995 
Intracochlear perfusion causes electrophysiological and 
ultrastructural damage to the organ of Corti of guinea pigs 
Comis et al 1993 
(1-10 
Approximate concentration of pneumolysin needed is given where clear from the literature. Typical specific 
activity for recombinant pneumolysin is about haemoiytic units per mg protein. Thus 1 ca. 
500 HU/ml 
Table 1.2: Activities of purified pneumolysin possibly related to pathogenesis of infection 
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Investigations with pneu molysin-deficient organisms. 
The different course of an experimental infection induced by pneumococci deficient in 
pneumolysin compared to that induced by wild-type infection might provide significant 
clues about the actual functions of pneumolysin in vivo. The isolation of the pneumolysin 
gene (pin) allowed the construction by insertion-duplication mutagenesis of defined isogenic 
mutant strains deficient in pneumolysin or containing modified pneumolysin. One of the key 
difficulties encountered was that encapsulated pneumococci proved difficult to transform 
with the vector DNA, so a two-stage process proved necessary (see appendix A) (Berry et 
al 1989). The resulting pneumolysin-deficient mutant, PLN-A, has been studied in several 
different infection models including that described in the current work. 
In the first description, Berry et al (1989) reported that the LD50 of PLN-A for 
intraperitoneal injection in the mouse is about 100 times higher than the LD50 of the parent 
strain D39. Similar results were obtained in the unusual species of Quackenbrush mice when 
the work was repeated with another defined pneumolysin-deficient strain of a serotype 3 
pneumococcus (Berry et al 1992). The absence of pneumolysin therefore modifies the 
infection but does not prevent death. Benton et al (1995) looked more carefully at the 
kinetics of in vivo growth after intraperitoneal inoculation of D39 or PLN-A in CBA/N 
mice. Animals inoculated with wild-type D39 sustain an exponential bacteraemia (doubling 
time ca. 1.4 h) which continues until death ensues. Those inoculated with PLN-A initially 
develop a similar exponential bacteraemia which then plateaus at around CFU/ml. Co- 
infection with D39 restores the ability of PLN-A to grow exponentially beyond the plateau 
level, suggesting strongly that pneumolysin production is required for exponential growth to 
occur in the bloodstream. Pre-infection with PLN-A prevents D39 from growing beyond the 
plateau level, perhaps because of the induction of tolerant immunity. 
What about the earlier steps of infection? PLN-A when inoculated intranasally in mice 
induces a less severe pneumonia and a delayed bacteraemia compared to wild type infection, 
even though cell wall products are released. But an autolysin-negative mutant (AL,-2) 
causes neither pneumonia nor bacteraemia (Canvin et al 1995). This suggests there may be 
an interaction between the cellular products released by autolysin, perhaps between cell wall 
and pneumolysin or an as yet unidentified toxin. When PLN-A is applied to an isolated 
human nasal turbinate preparation, the onset of a decline in ciliary beat frequency is 
significantly delayed compared to wild type. Only with wild-type organisms is there 
significant damage to the cell surfaces, with blebbing of the ciliated cell surface and 
breakdown of the intercellular tight junctions (Rayner et al 1995). One of the possible 
mechanisms of action of pneumolysin therefore is to promote breakdown of the respiratory 
epithelium and augment invasion. This is of great relevance to the findings in the inner ear 
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to be described later. In isolated rat lung, Rubin et al (1 995) reported that PLN-A induces 
less injury to the capillary barrier and is unable to replicate as well as wild type. The 
addition of exogenous pneumolysin corrects these defects. 
The contribution of the various activities of pneumolysin to pathogenesis has been assessed 
by manufacturing isogenic mutants which express toxoided pneumolysin genes. In a mouse 
bacteraemia model, median survival is prolonged by intraperitoneal challenge with either of 
two pneumococcal mutants which express toxoids deficient in haemolytic activity 
and plus Mice infected with a complement- 
activation deficient mutant have the same median survival as mice infected 
with the parent strain (Berry e? al 1995). Both types of mutant have impaired virulence for 
mouse pneumonia, although pneumolysin-related haemolytic activity accounts for much of 
the acute lung injury and early intra-alveolar replication, while pneumoly sin-related 
complement activation augments bacteraemia (Rubins et al 1996). 
Not all the experimental data support a significant role for pneumolysin. Friedland et al 
(1995) induced meningitis in rabbits by intracistemal inoculation of 3x103 CFU log-phase 
D39 or PLN-A. There were no differences in the course of CSF leukocytosis or CSF 
concentrations of TNFa, lactate and protein. Both organisms grew exponentially at the 
same rate with no lag phase (a phenomenon sometimes observed with other pneumococcal 
strains and also with the pneumolysin-deficient mutant produced by Johnson in this model 
(Tuomanen e? al 1985b; Johnson e? al 1992 and Prof A Tomasz, personal communication). 
From this the authors concluded that pneumolysin has no pathogenic role once 
pneumococci have entered the CSF space. However, they did not examine the brains 
histologically or seek other evidence of differences in end-organ damage. In a chinchilla 
otitis media model, a pneumolysin-negative derivative (P-1) of a type 3 pneumococcus 
induces an identical infection to a wild type strain, with a similar inflammatory cell response 
in the middle ear fluid and no differences in the concentrations of IL-1ß, IL-6 and IL-8 
(Sato et al 1996). These were not isogenic strains, so other unsuspected differences may 
explain the lack of activity of pneumolysin. 
In conclusion, it seems that pneumolysin expression augments intra-alveolar replication, 
provides one of the mechanisms by which pneumococci may invade capillary blood, and 
causes specific damage to mucosa and the organ of Corti. Once in the bloodstream, 
pneumolysin is necessary for continued exponential growth. The role of pneumolysin once 
pneumococci penetrate the CSF space or the middle ear is less clear but pneumolysin seems 
not to augment the inflammatory stimulus, at least during the exponential growth phase. In 
both the blood stream and CSF space, the haemolytic activity of pneumolysin seems to be 
more important than its ability to activate complement. Even if the concentration of 
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cytokines and leukocytes in the CSF is not altered by the absence of pneumolysin, there may 
still be important differences in end-organ damage. 
1.2.7. Neuraminidase. 
Neuraminidase cleaves terminal sialic acid residues (e.g. N-acetylneuraminic acid; NANA) 
from mucin, glycoproteins, glycolipids and oligosaccharides on cell surfaces and in body 
fluids. Of relevance to this thesis, the glyocalyx of the epithelial cell surfaces bordering the 
endolymphatic space in the inner ear has a high sialic acid content (Vanbenthem et al 1992). 
All clinical pneumococcal isolates express neuraminidase (Kelly et al 1967), although the 
quantity varies according to strain (Dr T Mitchell, personal communication). Neuraminidase 
activity can be enhanced in vitro by adding N-acetylmannosamine to the culture medium 
(Kelly et al 1966) and can be lost from organisms subcultured only on artificial media. 
Pneumococcal neuraminidase proved difficult to purify and many different molecular 
weights have been reported. Lock (1988b) purified neuraminidase with a molecular weight 
of 86 kD to electrophoretic purity. A polyclonal antibody to this molecule reacted with a 
larger species in crude pneumococcal extract (MW 107 kD), which was eventually purified 
intact, suggesting that proteolytic degradation during purification was responsible for the 
reports of multiple isoenzymes. One putative gene was cloned by Berry et al (1 988) (clone 
pJCP301) and a second gene ( n a d )  was cloned and expressed by Camara et al (1991). 
These genes are unrelated and have been shown to be present in all pneumococcal strains 
tested. NanA mRNA is definitely expressed during in-vitro growth (Camara et al 1994) and 
the gene product has a predicted MW of 144 kD. 
The pneumococcal neuraminidase(s) are classified with the “large” bacterial neuraminidases 
(>60 kD) which share a common feature of an “aspartic box” sequence. There remains 
some confusion over the specificity of certain bacterial neuramindases due to lack of 
specificity of older bioassays. For example, a purified Group B streptococcal enzyme 
previously thought to be a neuraminidase has in fact turned out to be a hyaluronidase (Savic 
and Ferretti, 1994). The MUAN cleavage assay (see appendix C) used in the work to be 
presented is however a specific assay. The cellular location of neuraminidase is also 
debated. Some evidence suggests that it is cytoplasmic (Lock et al 1988b) but certain 
features of the n a d  gene suggests that it encodes for a surface protein and this appeared to 
be confirmed by immunogold labelling (Camara et al 1994). 
The potential role of neuraminidase in pneumococcal adhesion to respiratory epithelium has 
been discussed (Krivan et al 1988). The evidence that neuraminidase may be directly 
involved in tissue damage in meningitis is conflicting and somewhat circumstantial. In 
support of a role is a clinical study which demonstrated a correlation between a poor 
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outcome from pneumococcal meningitis and the level of free NANA in the CSF (O'Toole et 
al 1971). Free NANA was found only in pneumococcal meningitis, and none of the isolates 
of H. influenzae or N.  meningitidis expressed neuraminidase activity. Kelly and Grieff 
(1970) challenged weanling mice with sonicated extracts of pneumococci grown in medium 
enriched with N-acetylmannosamine. Mice challenged by intracerebral or intraperitoneal 
injection developed neurological signs and died. However, such a crude extract may have 
been contaminated with cell wall, or even pneumolysin. There have been few reports 
published about the effects of purified pneumococcal neuraminidase on cultured cells or in 
vivo preparations. Mice immunized with purified neuraminidase are partially protected 
against pneumococcal infection (Lock et al 1988a). Intravenous injection of purified 
pneumococcal neuraminidase in rats promotes binding of circulating leukocytes to the 
kidney (Marin et al 1995) and neutrophils exposed to neuraminidase show increased 
adherence to endothelial cells (Dwarakanath et al 1995). 
In evidence against a role for neuraminidase in virulence, O'Toole et al (1975) induced 
meningitis in dogs by intrathecal injection of viable pneumococci or crude pneumococcal 
extract. Infection with viable organisms induces a rise in free NANA in the CSF. But 
challenge with the neuraminidase preparation causes no ill effects in the animals, although 
the NANA content of cortical brain subcellular organelles is reduced by some 30%. Kelly 
and Grieff (1 966) reported that lethality of pneumococcal strains in mice does not relate to 
neuraminidase activity. 
Because of the conflicting evidence about the role of neuraminidase, the construction of 
neuraminidase-negative isogenic mutants represents a significant step forward. The results 
to be presented in this thesis are among the first data from the use of these mutants in an 
infection model. 
1.2.8. Hyaluronidase. 
In common with other streptococci almost all strains of Streptococcus pneumoniae produce 
hyaluronidase, an enzyme which cleaves hyaluronic acid, a major constituent of the 
extracellular matrix (Paton et al 1993a). Very little is actually known about the role of 
hyaluronidases in virulence. It is assumed that breakdown of connective tissue contributes 
to bacterial spread and invasion. A pneumococcal hyaluronidase gene has recently been 
isolated (Berry et al 1994; Hill et al 1996). Other mucosal and wound pathogens also 
express hyaluronidases but the gene sequences appear to be unrelated (Canard et al 1994; 
Hynes et al 1995). 
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The only clinical evidence for the importance of hyaluronidase in bacterial meningitis comes 
from a study of pneumococcal meningitis conducted in St Petersburg. Hyaluronidase was 
expressed by all of 39 strains isolated from the CSF but by only 11% of capsulated strains 
carried in the upper respiratory tract (Kostyukova et al 1995). It was not expressed by non- 
encapsulated strains. Mice challenged intranasally with strains expressing high levels of 
hyaluronidase developed meningitis more readily. 
There have as yet been no reported studies of the toxicity of purified recombinant 
hyaluronidase in vivo or for cultured cells, and there are no data about protection from 
pneumococcal infection after immunisation. A hyaluronidase-negative isogenic mutant has 
recently been constructed (Hill et al 1996) and some of the first experimental infection data 
obtained with this organism are presented in this thesis. 
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1.3. Auditory anatomy and physiology. 
1.3.1. Gross anatomy. 
The auditory apparatus consists of the pinna and external auditory meatus of the outer ear, 
an air-filled middle ear containing an ossicular chain, and the inner ear. The middle ear is 
divided from the outer ear by the tympanic membrane and communicates with the inner ear 
at the oval and round windows. The ossicles consist of the malleus, incus, and stapes. 
These serve to transmit sound vibrations from the tympanic membrane to the oval window. 
The inner ear is encased in the temporal bone in humans and consists of the cochlea, the 
vestibule and the semicircular canals. The bony cochlea is a snail-shell shaped spiral which 
coils for just over 2 turns in humans and up to 5 turns in guinea pigs. It is divided into three 
compartments (fig 1.1, page 26). The scala vestibuli and the scala tympani communicate at 
the apex of the cochlea at the helicotrema. They are filled with perilymph, a fluid of a 
similar composition to cerebrospinal fluid 7 mM, Na+ 140 mM, 120 mM). The 
guinea pig cochlea contains about 8 of perilymph. The scala vestibuli is bordered by the 
oval window and communicates with the vestibular space. The scala tympani is bordered by 
the round window and communicates with the subarachnoid space via the cochlear 
aqueduct (see below). The basilar membrane stretches from the inner osseous spiral lamina 
(or modiolus) to the outer wall of the cochlea. The scala media is divided from the scala 
tympani by the basilar membrane and from the scala vestibuli by Reissner’s membrane. The 
sensory organ of the ear, the organ of Corti, rests on the basilar membrane. The scala media 
is filled with endohmph, an extracellular fluid rich in potassium with a composition more 
akin to intracellular fluid 150 mM, 1 mM, 130 mM). Spiralling around the 
outer rim of the scala media is found the stria vascularis, a site of intense ATPase activity. 
This regulates the composition of endolymph and maintains the electrical potential of the 
scala media some +80 mV above that of the scala tympani. 
1.3.2. The cochlear aqueduct. 
Figure 1.2 shows diagrammatically how the scala tympani and perilymphatic space 
communicate with the subarachnoid space via the cochlear aqueduct. The cochlear 
aqueduct is present in all mammals. It extends from the wall of the scala tympani in the 
basal turn and emerges medial to the jugular fossa. Within the aqueduct is the periotic duct, 
a potential space filled with a reticular meshwork of connective tissue, reticular cells and 
macrophages (Donaldson et al 1992; Duckert, 1974). It is thought that the duct facilitates 
exchange between CSF and perilymphatic fluid while the meshwork of tissue and 
macrophages acts as a damper to sudden pressure changes in the CSF and defends the inner 
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ear from microbial invasion (Blank et al 1994). Recent electron microscopic studies have 
confirmed that there is no physical barrier to fluid flow along the duct (Toriya et al 1991). 
There has been a great deal of debate about the functional patency of the cochlear aqueduct 
in humans and lower mammals. The cochlear aqueduct of the guinea pig appears to be 
widely patent, some 240 in diameter and about 2.5 mm long (Moscovitch et al 1973; 
Duckert, 1974). In the guinea pig there is no doubt that CSF flows into the perilymph. Salt 
et al (1994) calculated the flow rate into an unopened cochlea to be about 2 nl/min, or 
sufficient to replace the entire perilymph in just under 3 days. Such a communication is not 
essential for inner ear function as no ill effects are observed if the cochlear aqueduct is 
blocked for several months (Kimura e? al 1974). If the cochlea is opened (fistulized) much 
as for the cochlear perfusion experiments to be described in chapter 4 then the flow rate can 
rise to 500 nl/min, sufficient to replace the entire perilymph in around 10 minutes 
(Moscovitch et al 1973). Flow can be almost abolished by blocking the cochlear aqueduct 
(Sait et al 1991) or opening the cisterna magna to reduce the hydrostatic pressure of the 
CSF (Salt and Stopp, 1979). Particulate tracers easily pass from the CSF into the perilymph 
in the guinea pig (Duvall and Quick, 1969). Blocking the cochlear aqueduct prevents 
particles penetrating the inner ear (Sando et al 1971). 
Histopathological data from human post-mortem studies largely suggest that the cochlear 
aqueduct is patent. Palva (1970) found the cochlear aqueduct of six neonates to have a 
mean length of 3.5 mm, compared to 6.5 mm in adults, and a minimum diameter of 150 
In a study of adults, the cochlear aqueduct was blocked in only 3 of 82 post mortem 
specimens, with a mean length of 12.9 mm and minimum width of 140 (Rask-Anderson 
et al 1977). The aqueduct is wider in infants than adults but is still longer and narrower than 
in experimental animals. It is obviously difficult to study flow rates of CSF into perilymph to 
assess whether the cochlear aqueduct is functionally as well as anatomically patent in 
humans. 
Other communications routes between the CSF space and the inner ear include the internal 
auditory canal with its perineural and perivascular spaces, and the canal housing the inferior 
cochlear vein. 
1.3.3. Ultrastructure of the organ of Corti. 
Overview 
The spiral organ of Corti consists of a series of epithelial structures placed upon the upper 
surface of the basilar membrane (fig 1.3). The internal and external rods (or pillars) of 
Corti form an triangular arch enclosing the tunnel of Corti. On the medial side of the inner 
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rods lie a single row of inner hair cells and on the lateral side of the outer rods lie three to 
four rows of outer hair cells along with their supporting cells. The organ is covered by the 
tectorial membrane, a jelly-like structure which stretches out from the spiral lamina. 
Inner hair cells (IHCs). 
These are ovoid cells about 35 long and 10 in diameter with a central nucleus (see 
fig 1.4). They form a single rank along the whole length of the organ of Corti. Inner hair 
cells rest directly on the basilar membrane and at their free end are surrounded by inner 
phalangeal cells. On the medial side, there are slender border cells and these are succeeded 
in turn by the cuboidal epithelium lining the inner spiral sulcus. At the apical surface of the 
IHC there is a cuticular thickening, the cuticular plate, into which the rootlets of the 
stereocilia insert. A small area of the apical surface has no cuticular covering. Each cell has 
between 60 to 100 stereocilia arranged in 3 to 4 rows, with the shortest hairs closest to the 
modiolus. The stereocilia are packed with actin filaments in a paracrystalline array and are 
bound together by lateral links so that the row functions as a single unit. Fine tip links hold 
the tips of the shorter stereocilia in towards the longer stereocilia of the adjacent row 
(Osborne et al 1984). A thick layer of negatively-charged glyocalyx overlies the sensory 
cells (but not the supporting cells) and probably serves to keep the stereocilia separate. 
Stereocilia of the IHCs are not thought to contact the tectorial membrane directly (Lim, 
1986). 
Outer hair cells (OHCs) 
These are narrow, cylindrical cells about 25 to 40 long and 7 in diameter with a 
basal nucleus (see fig. 1.5). Three to five rows of OHCs are distributed radially around the 
organ of Corti. Outer hair cells rest in cup-like depressions of the externalphalangeal cells 
of Dieters which lie on the basilar membrane. Processes from the Dieters' cells reach up and 
surround the apical surface of the OHCs. The apical surface of the outer hair cells, together 
with the tight junctions between OHCs and the neighbouring phalangeal processes and 
supporting cells, form a common reticular lamina across which there is an electrochemical 
gradient between perilymph and endolymph. Therefore while the stereocilia and the apical 
cell surface membrane are bathed in endolymph, the rest of the cell body is bathed in 
perilymph. 
Outer hair cell stereocilia are arranged in a clear V or W shape, opening towards the 
modiolus with the tallest hairs outermost. It is likely that the tallest hairs meet the tectorial 
membrane (Lim, 1986). Stereocilia are anchored into a thick cuticular plate. The non- 
cuticular part of the apical surface of the OHC sometimes shows remnants of a kinocilium 
(basal Corpuscle). Later the effects of bacterial invasion on this particular area of structural 
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weakness will be documented. Mitochondria are situated both beneath the apical surface 
and basally. With abundant contractile elements and predominant efferent innervation, it 
seems that the OHC enables the cochlea to act as an 'active receptor' by modifying the local 
mechanical interaction between the tectorial membrane and associated stereocilia. 
Innervation 
Most of the data regarding innervation of the mammalian cochlea has been obtained from 
studies of rodents, guinea pigs and cats but is probably true for humans. Eybalin (1993) and 
Lim (1986) have provided succinct reviews. About 95% of the total neuronal population of 
the spiral ganglion are large myelinated type I afferent primary auditory neurons which are 
connected exclusively to the IHCs and project to the homolateral ventral subdivision of the 
cochlear nucleus. Each IHC receives innervation from up to 30 separate radial afferent 
dendrites. Afferent nerve units can be divided on the basis of spontaneous discharge into 
two populations with a high (>18 spike/s) or low-to-medium (0-18 spikes/s) firing rate. 
High spontaneous rate units formed by the thicker type I radial dendrites have a much lower 
auditory threshold. Some lateral efferent dendrites projecting mostly from the lateral 
superior olive form en passant synapses with the terminal portion of the radial dendrites. 
Glutamate is probably the principal IHC neurotransmitter. Evidence for this is derived from 
biochemical assays of different parts of the cochlea, electrophysiological findings when the 
cochlea is perfused with various glutamatergic agonists and antagonists, and 
immunolocalisation studies (Eybalin, 1993, p3 17). Glutamate and its agonists decrease the 
auditory nerve compound action potential (CAF') by inducing an excitotoxic block. 
Glutamate antagonists also decrease the CAP and block radial afferents. The presence of N- 
methyl-D-aspartate (NMDA) receptors in the cochlea has been disputed until recently (Puel 
et al 1991). NMDA antagonists reduce the CAF' amplitude with loud stimuli, but have little 
effect with quiet stimuli. On the other hand, nanomolar quantities of kainate perfused into 
the perilymphatic space irreversibly abolish the CAP without affecting the CM, and cause 
dramatic dendritic swelling, suggesting an important role for non-NMDA excitatory amino 
acid receptors. Glutamate antagonists also protect against some of the effects of agonist- 
and ischemia-induced excitotoxicity, and this will be of great relevance later when the 
mechanisms of damage to the organ of Corti during bacterial meningitis are considered. A 
glutamate-glutamine cycle has been proposed, whereby excess extracellular glutamate is 
taken up by local glial cells in the osseous spiral lamina and converted to glutamine by the 
action of glutamine synthetase. Inner hair cells take up this glutamine to generate glutamate. 
The predominant innervation of the outer hair cells comes from contralateral myelinated 
medial and lateral efferent neurons. About 5% of the spiral ganglion neurons consist of 
small unmyelinated type II afferent auditory neurons, which project from the basal poles of 
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OHCs to the homolateral cochlear nucleus. Each dendrite contacts up to 100 different 
OHCs. 
1.3.4. Sound transduction. 
Acoustic vibrations are transmitted from the tympanic membrane via the ossicular chain. If 
airborne vibrations were to act directly upon the oval window some 98% of the acoustic 
energy would be reflected. The ossicular chain acts as an impedance transformer, improving 
the efficiency of transfer of sound energy to about 67% (Buser and Imbert, 1992, p146). 
Vibrations at the oval window set up a standing wave in the basilar membrane. The stiffness 
of the basilar membrane varies from base to apex. Therefore sounds of different frequencies 
produce travelling waves that peak at different places along the cochlea. In this way the 
basilar membrane acts as a spatial separator. Low frequencies are detected at the apex of 
the cochlea, while higher frequencies are detected in the basal turn. The tuning mechanism 
is reinforced by the active involvement of the OHCs. The displacement of the basilar 
membrane causes a tangential slippage between the tectorial membrane and the reticular 
lamina. This deflects the hair bundles of the OHCs (the tips of the tallest stereocilia being in 
contact with the tectorial membrane), so depolarizing the cell. Contractions of the OHC 
modify the local displacement of the basilar membrane, refining the tonotopic tuning. The 
stereocilia of the IHC in this area are then deflected due to shearing forces between the 
stereocilia and the fluid immediately surrounding them. 
The transduction of vibrations into electrical current by the mammalian cochlea is 
astonishingly sensitive and capable of resolving remarkably high frequencies. This is due to 
the unique properties of sensory “hair cells”. Hair cells have evolved to detect prolonged 
vibrations of low energy compared to background noise (Hudspeth, 1985). The currently 
accepted model for mechanoelectrical transduction is as follows. Displacement of the 
stereocilia at right angles to the axis of the bundle stretches and compresses the fine tip- 
links which join the tip of the shorter stereocilia to the flank of the taller stereocilia in the 
adjacent row (Osborne and Comis, 1990). This opens a non-selective cation channel, 
admitting which is in high concentration in the fluid bathing the stereocila, and so 
depolarizing the cell. Voltage-sensitive channels open to augment the depolarisation, 
but the influx of in turn triggers the efflux of from the basolateral aspect of the cell. 
Random motion of the hair cell stereocilia due to Brownian motion of the surrounding 
molecules generates a certain amount of noise, but when the stereocilia are deflected by 
displacement of the basilar membrane the channels spend proportionately longer in the open 
phase. Because there is no second messenger and the channels alternate between open and 
closed states continuously, the response time is extremely rapid. Channels begin to carry 
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current within a few microseconds of a stimulus. The sensitivity of a typical mammalian 
cochlear hair cell is as great as 0.4 mV per nm displacement of the hair bundle tip (Buser 
and Imbert, 1992; p233). Each hair cell also appears to have a characteristic resonant 
frequency which further contributes to tonal discrimination. 
1.3.5. Electrophysiological measurements. 
Definition of sound pressure level 
Equipment for audiological measurements must be calibrated so that experiments are 
comparable. For much of the work to be described in this thesis relative rather than absolute 
changes are measured. Comparison of sound intensities is normally done by a ratio scale. A 
soundpressure level (Lp) is designated according to the logarithm of its ratio to a reference 
magnitude of sound pressure Usually a reference sound pressure level of 20 is 
taken, as this represents the typical human auditory threshold at 1 kHz. This is equivalent to 
1 in SI units. The ratio has units of Bels, or for convenience, decibels: 
Sound propagates at 340 m / s  in air at 15°C at sea level. Allowance must be made for this 
when calculating the latency of a measurement. For example, it would take 0.3 ms for a 
sound stimulus to travel 1 O cm from a transducer to the tympanic membrane. 
Compound action potential (CAP). 
The auditory nerve compound action potential (CAF') is built up from nearly simultaneous 
contributions of a population of primary auditory neurons (Kiang et al 1976). It is easily 
excited by a transient click or brief tone pulse. A typical CAP recorded from the round 
window membrane in response to a 1 O kHz tone pip is shown in fig 1.6. It consists of an 
initial positive peak a negative peak with a latency of about 1 ms, and a 
subsequent positive peak Further peaks and occur about 1 and 2 ms later 
respectively. The wave is thought to represent the summed far field current of the 
excitatory postsynaptic Potentials in radial dendrites (Eybalin, 1993; p 323). The peak is 
particularly due to receptors at the base of the cochlea and has been shown to reflect 
activity at the level of the auditory nerve (Kiang et al 1976). The CAP is frequency 
dependent when evoked by tonal stimuli at low to moderate sound intensities (Cody et al 
1980; van Heusden and Smoorenburg, 198 1; Eggermont, 1976). Audiograms obtained with 
CAP recording correlate with behavioural audiograms (Eggermont, 1976). CAP thresholds 
are some 0-20 dB less sensitive than single-fibre thresholds. 
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Cochlear microphonics (CM). 
The cochlear microphonics (CM) potential is easily recorded from the round window 
membrane. It originates from the massed activity of receptor cells which lie as a 
transversally arranged dipole across the high resistance reticular lamina. The potential 
exactly follows the amplitude of the stimulus (just like a microphone), has almost no latency 
and does not adapt. It can be recorded for some time after the death of an animal, well after 
the CAP can no longer be elicited. The log of the CM amplitude is linearly related to the 
stimulus intensity (in decibels) over a wide range of 90 dB and there is very little distortion 
in the CM even at saturation. Potentials from OHCs contribute the bulk of the CM. 
Kanamycin, which destroys 90% of the OHCs while sparing the IHCs, causes a 90% fall in 
CM potential (Buser and Imbert, 1992). 
When recorded from the round window, the CM potential only properly reflects cochlear 
function within a few millimetres of the round window (16 kHz and above) because 
contributions from the lower frequency zones are obscured by contributions from the nearer 
CM generators (van Heusden and Smoorenburg, 198 1). 
Brain stem auditory evoked Potentials (BAEP). 
Recording of CAP or CM involves invasive approaches to the cochlea. Far-field Potentials 
in response to an auditory stimulus can be recorded from scalp electrodes and by signal 
averaging various waves can be detected that relate to auditory activity. Even under good 
conditions at least 256 and more usually 1024 stimuli are necessary to extract the signal 
from background noise. In spite of these limitations this technique is of great use clinically 
because it is non-invasive. 
The different components are identified by the different latencies (Jewett and Williston, 
1971). The short latency components arise from the brain-stem with a latencies of between 
1.5 ms and 10 ms. At least five successive peaks are usually recognizable (see figure 3.3). A 
detailed derivation of the waves based on simultaneous recordings from the scalp surface 
and the brainstem can be found in Maller et al (1986) . The first peak of the brain-stem 
response is probably a far-field recording of the CAP and is usually of low amplitude. Wave 
III appears to be the most robust wave for analysis. It is probably generated by the cochlear 
nucleus. Thresholds obtained by BAEP recording are within 10 dB of those obtained by 
CAP recording under ideal conditions and demonstrate similar frequency selectivity (Brown 
and Abbas, 1987). 
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Figure 1.1: Diagram of the cochlea in cross-section. 
26 
Figure 1.2: Relationship of the inner ear to the subarachnoid space 
(After Bhatt et al 1993). 
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Figure 1.3: Three-dimensional impression of the organ of Corti. 
ISC: inner supporting cells; DC: Dieter's cells; PC: pillars (rods) of Corti. (from Lim (1986) 
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Figure 1.4: Diagram of the ultrastructure of an inner hair cell. 
From Lim (1 986) 
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Figure 1.5: Diagram of the ultrastructure of an outer hair cell. 
From Lim (1986) 
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1.4. Experimental bacterial meningitis. 
Harter and Petersdorf (1960) described the following criteria which remain ideal aims for 
any model of experimental meningitis. Compared with human infection, the experimental 
infection must: 
• 
• 
Have the same portal of entry and route of dissemination by the infecting organism; 
Show equivalent differences in virulence between serotypes; 
• Show similar histopathological lesions; 
• Have a predictable and reproducible course; 
• Be simple to perform. 
Clearly no one experimental model can satisfy all of these criteria. Nevertheless, 
experimental infections in animals have contributed greatly to understanding of the 
pathophysiology of meningitis, particularly with respect to the mediation of inflammation in 
the subarachnoid space. Several recently published comprehensive reviews summarize this 
work (Tunkel et al 1990a; Quagliarello and Scheld, 1992; Tunkel et al 1990b; Tunkel and 
Scheld, 1993 a; Tunkel and Scheld, 1993 b; Spellerberg and Tuomanen, 1994). 
1.4.1. Practical considerations. 
Systemic versus local inoculation 
It is worth pointing out at the outset that there are no good models for CSF invasion by the 
common pathogens. Only neonata1 rats and mice reliably develop meningitis when 
inoculated peripherally with invasive organisms. Neonata1 animals yield tiny quantities of 
CSF and are difficult to work with. Unfortunately, only a fraction of adult animals of any 
species develops meningitis after systemic inoculation of viable organisms (in the same way, 
of course, that not all bacteraemic patients go on to develop meningitis). The chance of 
inducing meningitis can be increased by giving the inoculum in combination with an 
adjuvant such as mucin or iron dextran. Because of the high wastage of animals if organisms 
are injected systemically, experimental meningitis is usually induced by directly injecting 
viable organisms (prepared by a wide variety of different culture techniques), bacterial 
components or inflammatory mediators into the subarachnoid space (usually the cisterna 
magna). This bypasses the initial stages of invasion and is therefore somewhat removed 
from the normal course of infection. In spite of this, much useful information has been 
obtained from such an approach. 
32 
Endpoints 
A large body of work rests on the analysis of CSF. CSF leukocyte count and protein 
concentration are usually used as measures of meningeal inflammation. However, a number 
of other biological variables have been measured in experimental meningitis according to the 
particular interest of the research group. These include: 
Mortality (judged by the LD50); 
CSF concentrations of leukocytes, viable bacteria, immunoglobulin, endotoxin (assessed 
by limulus lysate bioassay), and inflammatory mediators such as cytokines measured by 
bioassay or immunochemically by ELISA (Tuomanen et al 1985b; McCracken, Jr. and 
Sakata, 1985) 
Blood brain barrier structure investigated by transmission electron microscopy 
(Quagliarello et al 1991 a) and its function quantitated using intravenous 125I-labelled 
albumin as a tracer (Kim et al 1992b; Townsend and Scheld, 1994); 
Cerebral blood flow measured by laser Doppler flowmetry; direct monitoring of 
intracranial pressure; brain oedema calculated by drying the brain after death and 
subtracting dry weight from wet weight (Pfister et al 1990; Tauber et al 1993); 
Microvascular changes monitored with confocal laser scanning microscopy via a “pial 
window” (Lorenzl et al 1993); 
In-vivo microdialysis of brain tissue to measure concentrations of excitatory amino acids 
(Perry VL et al 1993) or pH (Andersen et al 1989); 
Histopathological analysis of brain tissues with quantitation of neural damage (Leib et al 
1996) or immunostaining for inflammatory mediators of interest (Tauber et al 1992a); 
Histopathological or ultrastructural analysis of the inner ear with or without 
measurement of hearing loss (Osborne et al 1995; Winter et al 1996; Rodriguez et al 
199 1 ; Kay, 199 1 ; Wiedermann et al 1986); 
Behavioural changes judged by standard rat psychology tests to demonstrate that 
meningitis impairs future learning ability (Konkol et al 1987). 
Choice of species 
Dacey and Sande (1974) first described the most widely used model of experimental 
meningitis which is in the rabbit. Serial CSF samples can be taken by repeated sterile 
cisternal puncture with transient sedation or anaesthesia. Intracisternal inoculation of S. 
pneumoniae (Tauber et al 1984), E. coli (Friedland et al 1993), N. meningitidis (Tuomanen 
et al 1989), Haemophilus influenzae (Mustafa et al 1989b) endotoxin, bacterial cell wall 
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products (Tuomanen et al 1985a), and proinflammatory cytokines (Saukkonen et al 1990) 
all induce meningeal inflammation. Because of the quantity of CSF available, rabbits are the 
main species used to investigate the effects of meningitis on CSF constituents and to assess 
the efficacy of new antibiotics against meningitis. Experiments with rabbit models have shed 
little light on the mechanisms of meningeal invasion but have greatly increased knowledge 
about local mediators of inflammation and potential disease modifiers. Recently, the cost of 
rabbits has become a major disadvantage both locally and in the USA (Prof. Tomasz, 
personal communication). 
Studies of experimental rat meningitis have particularly investigated blood brain barrier 
functions and the detailed histopathology of brain tissue. As rats are used widely in 
neuroscience, there are data available about local production of cytokines, cytokine 
receptors, prostaglandins, the febrile response, and neuroimmunoendocrine interactions. 
The study of neonata1 rat models helped define the route of meningeal invasion of 
Haemophilus influenzae type B (Hib) (Moxon and Ostrow, 1977). 
Meningococcal infection has mainly been studied in neonata1 mice (Salit and Tomalty, 
1986). Adult mice have been used to model cryptococcal meningitis (Ailendoerfer et al 
1991) and toxoplasma encephalitis (Hunter et al 1992). 
Experimental meningitis has also been induced in guinea pigs (S.pneumoniae, Blank et al 
1994; Streptococcus suis, Kay, 199 1), pigs (Streptococcus suis, Williams and Blakemore, 
1990b), dogs (S. pneumoniae, Scheld et al 1979), cats (Klebsiella, S. pneumoniae, 
Hochwald et al 1984), primates (Haemophilus influenzae, Scheifele et al 1980) and calves 
(E. coli endotoxin, Nakajima et al 1991). 
1.4.2. Pathogenesis of bacterial meningitis 
Invasion 
Pathogenic bacteria colonise and invade the nasopharyngeal mucosa and local lymph nodes, 
aided by a variety of factors discussed in section 1.2. Meningitis almost certainly results 
from haematogenous spread of organisms (Moxon and Ostrow, 1977). Circulating bacteria 
probably gain access to the CSF through the highly vascular choroid plexus (Daum et al 
1978), perhaps aided by specific receptors (Kim et al 1992a) or concealed within circulating 
monocytes (the so-called 'Trojan horse' hypothesis) (Williams and Blakemore, 1990a). 
Normal cerebrospinal fluid contains little complement or specific antibody (Zwahlen et al 
1982). Invading bacteria exploit this immune 'window' as phagocyte function is impaired in 
the absence of opsonization. Bacterial growth rate in the CSF is not enhanced in rabbits 
rendered neutropaenic before inoculation, suggesting that (at least initially) neutrophils are 
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unable to control the infection in the CSF (Ernst et al 1983). Organisms multiplying in the 
CSF space can secondarily invade the blood stream. This can occur early and before the 
peak of the CSF leukocyte response (Scheld et al 1979). 
The cytokine response 
As part of the local inflammatory response, a host of toxic intermediates is liberated. 
Complement components and arachidonic acid metabolites (Ernst et al 1984; 
Kadurugamuwa et al 1989), pro-inflammatory cytokines (TNFa, interleukin (IL)- 1 ß, IL-6, 
IL-8, PAF (Frei et al 1993)), excitatory amino acids such as glutamate (Perry et al 1993; 
Guerra-Romero et al 1993), reactive oxygen intermediates (Pfister et al 1992d), and nitric 
oxide (Koedel et al 1995; Boje, 1995) have all been detected but their relative importance in 
bacterial meningitis remains uncertain. Some of the brain damage in meningitis may well be 
mediated by cytotoxic effects of these mediators. For example, IL-1 and TNFa in 
combination are cytotoxic for cultured human foetal neurons. This damage is reduced both 
by blockade of NO synthase and independently by N-methyl-D-aspartate (NMDA)- 
antagonists (Chao et al 1995). Similar results are obtained if co-cultures of microglial cells 
and cerebellar granule neurons are challenged with cytokines or lipopolysaccharide (Boje 
and Arora, 1992). The current understanding of the complex mechanisms which account for 
cytokine-mediated neurotoxicity in bacterial meningitis has been reviewed in a recent 
workshop summary (Pfister et al 1994). 
The lipopolysaccharide component of Gram-negative bacteria, endotoxin, has long been 
recognised as an important mediator of inflammation, and indeed clinical studies have 
shown that poor outcome after Gram-negative meningitis is correlated with the 
concentration of free endotoxin in the CSF (Mustafa et al 1989a; Mertsola et al 1991). 
Endotoxin can activate complement by the alternate pathway and triggers the release of 
"Fa, IL-1 and IL-6 from leukocytes and other cells (Ulich et al 1989; Ulich et al 1990; 
Ulich et al 1992; Spangelo et al 1990). These and other cytokines such as macrophage 
inflammatory proteins 1 and 2 (MIP-1, MIE'-2) and IL-8 can induce an inflammatory 
response in the CSF when inoculated intracisternally in rabbits (Ramilo et al 1990; 
Saukkonen et al 1990). It is probable therefore that bacterial products stimulate release of 
pro-inflammatory cytokines which are then the chief inducers of meningeal inflammation. As 
discussed in section 1.2.4, Gram-positive cell wall components trigger inflammation in 
Gram-positive infection in a way analagous to endotoxin (Tuomanen et al 1995; Cundell et 
al 1995). Interestingly, indomethacin prevents the cytokine expression triggered by 
pneumococci but has no effect on that induced by endotoxin, suggesting that arachidonic 
acid metabolites help mediate cytokine induction in pneumococcal infection (Simpson et al 
1994). 
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The predominant action of endotoxin appears to be to promote a leukocytosis in CSF, 
whereas other components of the Gram-negative cell wall appear to promote damage to the 
blood brain barrier (Burroughs et al 1992). Endotoxin induces a localised CSF 
inflammatory response when administered a variety of animals (Nakajima et al 1991), and 
causes specific damage to the organ of Corti and tectorial membrane when microperfused 
into scala tympani of the guinea pig (Tarlow et al 1991; Comis et al 1991). Endotoxin 
impairs the function of cultured astrocytes (Koller et al 1994) and isolated outer hair cells 
(Dulon et al 1990) but is not known to be directly cytolytic (in contrast to pneumolysin, for 
example). 
Lytic antibiotics have the potential to release large amounts of bacterial cell products over a 
short time, and this phenomenon has certainly been observed in experimental meningitis 
(Tauber et al 1987). In a rabbit Escherichia coli meningitis model, a single intravenous dose 
of cefotaxime, cefpirome, meropenem, chloramphenicol, or gentamicin provokes a 2- to 10- 
fold increase in cerebrospinal fluid concentrations of free endotoxin within 2 h of starting 
treatment. By contrast, free endotoxin concentrations increase almost 1 00-fold in untreated 
animals 4 h later as bacteria continued to multiply. Antibiotic therapy in E. coli meningitis, 
irrespective of the agent used, may result in an increase in free endotoxin but the amount of 
endotoxin liberated is considerably smaller than that shed by untreated bacteria (Friedland et 
al 1993). There is some evidence that under carefully controlled conditions in experimental 
meningitis, administration of an antibiotic bolus can transiently enhance the concentrations 
of inflammatory mediators in the CSF such as TNFa (Mustafa et al 1989b; Friedland et al 
1995). This so-called antibiotic-induced inflammatory burst has been blamed for 
exacerbating brain damage in meningitis. However, it occurs only if the antibiotic bolus is 
given as the organisms enter log-phase growth (Pfister et al 1994) (and Prof. Tomasz, 
unpublished findings). Any earlier and the infection is aborted; any later and the 
inflammatory cascade is already well advanced and antibiotic treatment adds little to it. The 
clinical relevance of such an antibiotic-induced inflammatory burst in meningitis therefore 
remains controversial. 
The role of leukocytes 
There is conflicting evidence about the role of leukocytes in causing damage to host tissues 
in bacterial meningitis. Survival time in dogs with pneumococcal meningitis is increased if 
the animals are rendered leukopaenic before inoculation (Petersdorf and Luttrell, 1962). 
However, raised intracranial pressure and brain oedema are not diminished in neutropaenic 
rabbits with pneumococcal meningitis (Tauber et al 1988). 
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Evidence available suggests that the C5a component of complement is chiefly responsible 
for the initial phase of Chemotaxis in the CSF. Chemotactic ability in CSF from rabbits with 
pneumococcal meningitis appears some 2 h before the onset of leukocytosis and can be 
blocked by preincubating the neutrophils with rabbit C5a (Ernst et al 1984). Intracisternal 
injection of C5a into rabbits provokes a polymorph leukocytosis in the CSF within one 
hour, faster than any other putative inflammatory mediator (Kadurugamuwa et al 1989). 
Rabbits treated with cobra-venom factor to deplete complement and then inoculated 
intracisternally with viable pneumococci die earlier than normal animals. In complement- 
depleted animals CSF leukocytosis is of similar magnitude but slightly delayed whereas it is 
almost abolished by cyclooxygenase inhibitors (Tuomanen et al 1986). Therefore 
arachidonic acid metabolites are responsible for the bulk of leukocyte invasion, but 
opsonization is essential for leukocyte function. 
The primary site of leukocyte extravasation in meningitis appears to be the pial post- 
capillary venules. Leukocyte adherence to the vascular endothelium can be seen as little as 
one hour after induction of pneumococcal meningitis (Lorenzl et al 1993). The mechanisms 
of leukocyte adherence can be inferred from work conducted on isolated endothelial cells 
(Beilke, 1989). Selectins, including the endothelial cell adhesion molecules ELAM- 1 (E- 
selectin) and P-selectin (CD62) and leukocyte L-selectin, mediate initial adherence. P- 
selectin is stored in endothelial granules and platelets, and is rapidly mobilized after 
stimulation. ELAM-1 is transiently expressed on endothelial cells 2-8 hours after exposure 
to endotoxin, TNFa or IL1ß (Bevilacqua et al 1989). Both specifically recognise myeloid 
cells and are preferentially expressed in postcapillary venules. Before firmly binding to the 
endothelial surface, leukocytes "roll" slowly along the venular endothelial lining. This 
dynamic and reversible step can be inhibited by fucoidin, a polysaccharide which binds to 
leukocyte L-selectin. Fucoidin almost completely inhibits the influx of leukocytes into the 
subarachnoid space in response to intrathecal administration of heat-killed pneumococci in 
rabbits (Granert et al 1994; Tuomanen, 1994). There are no data about the ability of 
fucoidin to minimise brain oedema or neuronal damage in experimental meningitis induced 
by viable organisms 
The next step in adherence and extravasation is mediated by the second major group of 
adhesion molecules which belong to the immunoglobulin supergene family. TNFa, IL1 ß 
and trigger endothelial cells to express surface ICAM-1 (CD54). This binds firmly to 
the leukocyte glycoprotein complex ß2-integrin (CD 1 1/CD18). Endothelial IL-8 activates 
neutrophils, upregulates ß2-integrin and reduces leukocyte adhesion to ELAM, so 
promoting diapedesis across the endothelium. Another inducible endothelial ligand, VCAM, 
primarily recruits lymphocytes and monocytes by binding to their VLA-4/ß1-integrin 
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complex. It is probably less important early in bacterial meningitis, but may contribute 
towards more chronic infiltrate and resolution. Interestingly, the CNS parenchyma itself is 
remarkably resistant to leukocytic invasion. Injection of various pro-inflammatory cytokines 
directly into the hippocampus of the rat induces a brisk leukocytosis in the CSF but does 
not cause a localised abscess (Andersson et al 1992). 
Specific inhibition of leukocyte adherence with an anti-CD1 8 monoclonal antibody (IB4) 
reduces CSF leukocytosis, mortality and histological brain damage in rabbits with 
pneumococcal meningitis (Tuomanen et al 1989). IB4 is less effective at preventing 
endotoxin-induced meningeal inflammation, but acts synergistically with dexamethasone to 
greatly reduce meningeal inflammation in experimental H. influenzae type B meningitis 
without affecting bacterial clearance from the subarachnoid space (Saez-Llorens et al 
1991). 
Blood-brain barrier, brain oedema and cerebral perfusion 
Brain oedema in bacterial meningitis is clearly caused by a number of factors. Raised blood- 
brain barrier (BBB) permeability causes vasogenic oedema as protein and fluid leak out 
(Quagliarello et al 199 1 a). This particularly affects the subcortical white matter. Arachnoid 
villi become plugged with neutrophils, increasing CSF outflow resistance and producing 
interstitial oedema as CSF fails to be reabsorbed. Toxic inflammatory intermediates induce a 
cytotoxic oedema by altering the permeability of cell membranes and damaging cell 
metabolism and homeostasis. 
The anatomical site of the BBB is the cerebral capillary endothelium, which has a number of 
unique properties. Systemic capillaries are fenestrated to allow passage of macromolecules. 
In contrast, cerebral capillary endothelial cells are fused together with continuous intact 
intercellular tight junctions (zonulae occhdentes). Pinocytic vesicles are very rare (Reese 
and Karnovsky, 1967). Sheets of cultured rat cerebral endothelial cells maintain a very high 
trans-endothelial electrical resistance (some 1 00 This can be disrupted by 
cytokines (TNFa, IL- 1 ß and IL-6) but not in the presence of indomethacin, suggesting that 
prostaglandin activation in endothelial cells may contribute to breakdown of the BBB in 
bacterial meningitis (Devries et al 1996). Intracisternal administration of H. influenzae type 
B, E. coli K1, or type III S. pneumoniae in the rat all cause a uniform time-dependent injury 
to the cerebral capillary endothelium. Four hours after inoculation, there is an increase in 
pinocyctic vesicle formation. This is followed by progressive breakdown and separation of 
up to 20% of the zonulae occludentes accompanied by a rise in BBB permeability 
(Quagliarello et al 1986). The precise site of the albumin leak across the injured BBB has 
been localized to open intercellular junctions in pial venules (Quagliarello et al 199 1 a). 
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Intracistemal injection of just nanogram amounts of IL1 ß or picogram amounts of Hib LOS 
can cause BBB injury in the rat (Quagliarello et al 1991b; Wispelwey et al 1988). There is 
reasonable evidence that leukocyte products contribute to brain oedema in bacterial 
meningitis. Brain oedema induced by intracranial injection of cytokines is completely 
abolished by the anti-CD18 antibody IB4 (Saukkonen et al 1990). Intracistemal injection of 
Hib LOS has no effect on BBB permeability in leukopaenic rats (Wispelwey et al 1988). 
In the early stages of meningitis cerebral blood flow rises, probably as a result of 
dysregulation of the pial arterioles which pass through the inflamed subarachnoid space 
(McKnight et al 1992). Nitric oxide is likely to be involved in this process. Heat-killed 
pneumococci induce the production of nitric oxide by cultured rat cerebral endothelial cells 
(Haberl et al 1994). Intravenous administration of N-nitro-L-arginine (L-NA) or N-G-nitro- 
L-arginine methyl ester (L-NAME) (nitric oxide synthase inhibitors) reduce the early 
changes in cerebral blood flow and prevent brain oedema and pial arteriolar dilation in 
experimental pneumococcal meningitis in rats (Haberl et al 1994; Koedel et al 1995). 
However, mortality increases in animals treated with NO synthase inhibitors. Another 
mechanism of injury may be due to the action of oxygen free radicals. In early experimental 
pneumococcal meningitis in rats, Superoxide dismutase (a free radical scavenger) or the 
antioxidant desferroxamine both attenuate brain oedema, CSF leukocytosis, and the rise in 
intracranial pressure and regional cerebral blood flow (Pfister et al 1992d; Koedel et al 
1995). 
Later in the course of the illness, autoregulation fails and cerebral blood flow varies 
passively with mean arterial blood pressure (Tureen et al 1990). Cerebral perfusion is 
compromised by the rise in intracranial pressure combined with the systemic hypotension 
common in septicaemic illness. Large vessel abnormalities documented on angiography in 
patients with focal neurological deficits include sagittal sinus thrombosis, occlusion of 
branches of the middle cerebral artery, and narrowing of the internal carotid artery (Pfister 
et al 1992a). 
In conclusion, the combination of inflammatory mediators, bacterial products (Tauber et al 
1992b; Kim et al 1995), brain oedema, altered cerebral blood flow and vasculitis, and brain 
hypoxia in varying degrees result in parenchyma1 brain damage in bacterial meningitis. 
1.4.3. Anti-inflammatory strategies. 
The assumption that much of the damage in meningitis could be mediated by an excessive 
host inflammatory response has led to a great deal of work to identify agents which might 
modulate this. Only dexamethasone is routinely used in such a way clinically (see section 
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1.5.3). Dexamethasone inhibits pro-inflammatory cytokine production by monocytes in 
response to endotoxin (van Furth et al 1994) and by glial cells in response to pneumococcal 
cell wall (Chao et al 1992). It inhibits induction of nitric oxide synthase in glial cells (Freyer 
et al 1996) and vascular endothelium (Rees et al 1990). In a variety of meningitis models, 
adjuvant treatment with dexamethasone reduces a variety of indicators of meningeal 
inflammation, particularly when administered just before the first antibiotic dose 
(Syrogiannopoulos et al 1987; Mustafa et al 1989b; Saez-Llorens et al 1991). 
Pentoxfylline suppresses endotoxin-induced TNFa gene transcription in vitro and in a 
rabbit model diminishes the meningeal inflammatory response to both Hib LOS and IL1ß 
(Saez-Llorens et al 1990). Pentoxifylline is less effective in this model than dexamethasone, 
which blocks human monocyte production of IL1ß in addition to TNFa (van Furth et al 
1994). 
Thalidomide also diminishes TNFa production and can be used clinically to treat graft- 
versus-host disease. In experimental rabbit meningitis induced by pneumococcal cell wall 
material, thalidomide reduces the concentration of TNFa and leukocytes in the CSF. 
However, it has little impact on meningeal inflammation induced by Haemophilus 
influenzae cell lysate (Burroughs et al 1995). 
Non-steroidal cyclo-oxygenase inhibitors such as indomethacin and oxindac reduce 
morbidity and death in pneumococcal meningitis in rabbits (Tuomanen et al 1987). They 
also reduce the burst of meningeal inflammation induced by ampicillin treatment and greatly 
diminish brain oedema in this model (Tureen et al 1991). There are conflicting data about 
the ability of indomethacin to reduce CSF leukocytosis in experimental meningitis 
(Tuomanen et al 1987; Tureen et al 1991). 
Anti-endotoxin molecules were beneficial in experimental Gram-negative infections, but 
clinical trials were disappointing because it proved difficult to select patients with septic 
shock due to Gram-negative infection rather than other causes (Ziegler et al 1991). 
However a clinical trial of HA-IA (a humanised anti-endotoxin monoclonal) in childhood 
meningococcal septicaemia with shock is due for publication soon. There has been some 
enthusiasm for the idea that anti-cytokine treatment could be used to modi@ the host 
response to meningitis (Kornelisse et al 1995). However because of the many different ways 
in which bacterial products trigger inflammation, such a strategy would seem doomed to 
fail. Recent evidence from a rabbit model showed that neither soluble TNF receptor or IL-1 
receptor antagonist alone could prevent Haemophilus influenzae lipooligosaccharide (Hib 
LOS) from inducing a meningeal inflammatory response (Paris et al 1995). Even if it proved 
effective, such adjuvant treatment would be exorbitantly costly if used clinically. 
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A problem common to all anti-inflammatory strategies is that they assume that modulating 
meningeal inflammation will also reduce the chance of hearing loss. Data to be presented 
later suggest that at least some meningogenic deafness is mediated directly by bacterial 
products. An additional objection is that by the time a patient presents with meningitis, the 
meningeal inflammatory cascade is already well advanced and agents acting early in this 
cascade are unlikely to have a great impact. More promise might lie in cytoprotective agents 
that could modify the putative final common mechanisms mediated by glutamate, nitric 
oxide and reactive oxygen intermediates that underlie neuronal damage (Leib et al 1996). 
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1.5. Deafness in clinical and experimental meningitis, 
1.5.1. Epidemiology. 
Almost all cases of acquired sensorineural deafness in the UK are secondary to meningitis, 
accounting for about 6% of all childhood deafness or approximately 60-70 children per year 
in the UK (Fortnum, 1992). Table 1.3 (after Dodge et al, 1984) compares the level of 
hearing loss as defined by audiometric testing with the expected disability. 
dB loss Hearing class Functional definition 
<30 Normal Within normal limits 
30-55 Mild loss Difficulty with conversation 
beyond 3-4 feet 
55-70 Moderate loss Hearing aids and special training 
essential 
70-90 Severe loss Difficulty hearing speech with 
hearing aid. Educated as deaf 
person 
>90 Profound loss Deaf. Hearing aid of little benefit 
Table 1.3. A classification of hearing loss . 
Before the advent of antibiotics almost everyone who contracted pneumococcal meningitis 
died of the disease and there were few worries about late neurological sequelae. Once 
effective antibiotic treatment became available for pneumococcal disease it became evident 
that many sufferers were left severely handicapped by neurological damage. Trolle (1 950) 
was one of the first to draw attention to the long-term audiological deficits that sometimes 
occurred after meningitis. In a review of studies of meningococcal meningitis published 
between 1905 and 1948 the overall incidence of defective hearing was around 16% (range 
2.5% to 50%). The use of quinine as a therapy although itself ototoxic may have 
confounded these figures. Case reports in the 1960s and 1970s contained several theories 
about the causes of sensorineural hearing loss but little hard evidence (Liebman et al 1969; 
Roesor et al 1975). Good epidemiological studies were aided by the advent of audiological 
evaluation in the form of brain-stem evoked response testing and a systematic approach to 
follow-up. Fortnum (1 992) has recently provided an authoritative review which included a 
meta analysis of well-conducted clinical studies published between 1977 and 1992. In 1175 
unselected cases in 8 reports, the overall incidence of any permanent sensorineural hearing 
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loss was 9.6% (range 6.3-11.7%) (Ozdamar et al 1983; Vienny et al 1984; Dodge et al 
1984; Guiscafre et al 1984; Salwen et al 1987; Dawson et al 1988; Lebel et al 1988; Odio 
et al 1991). Profound bilateral or total hearing loss occurred in 1-4% of cases. In 66 cases 
of pneumococcal meningitis, the incidence was 3 1.8% (range 21-50%), whereas after 398 
cases of meningococcal meningitis estimated overall hearing loss was 7.5% (range 5-10%). 
There are several issues which cloud the interpretation of such studies. Retrospective 
studies are prone to bias, particularly in over-reporting the incidence of neurological 
sequelae due to pneumococcal disease since it is possible that these patients will have been 
followed up more closely. Two large prospective trials provide conflicting data about the 
importance of bacterial aetiology in meningogenic hearing loss. Dodge et al (1 984) found 
that patients with pneumococcal meningitis had a higher incidence of sensorineural hearing 
loss than those with meningitis due to other aetiologies (31% vs. 6% for Hib and 10.5% for 
N meningitidis). In a more recent prospective study, seven of 20 (35%) children with 
pneumococcal disease sustained hearing loss, compared to eight of 39 (20%) with Hib 
meningitis and two of 13 (15%) with meningococcal disease (Wald et al 1995). These 
differences did not achieve statistical significance. Prospective studies also present problems 
because endpoints (which range from any degree of deafness to severe bilateral loss only) 
have sometimes been chosen to emphasise "significant" results (e.g. Schaad et al 1995 and 
Kanra et al 1995) and it is rarely made explicit whether the endpoints were chosen in 
advance. One study enrolled for evoked response testing only those thought to be at "high 
risk" of developing complications (Kaplan et al 1984). The antibiotic management of 
meningitis has changed over the last ten years with the advent of penicillin resistance. For 
example, it has become clear that treatment with cefuroxime is less effective and has a 
greater incidence of neurological sequelae than treatment with a third-generation 
cephalosporin (Lebel et al 1989). Finally, immunisation against Haemophilus influenzae 
type B has already greatly reduced the incidence of Hib meningitis in some countries and 
thereby increased the proportion of cases due to the pneumococcus (Baer et al 1995; 
Schaad et al 1995). Therefore clinical data from the pre-immunisation era may not be 
helpful in predicting the future incidence of post-meningitic deafness. 
There are also geographical differences in the incidence of post-meningitic deafness. In 
studies from countries with a poor health care infrastructure, meningitis patients usually 
present late, often after visits to local practitioners. An Egyptian study reported that two- 
thirds of patients with meningitis (both adults and children) were admitted comatose (Girgis 
et al 1989). On the Pacific island of Vanuatu some 32% of meningitis cases sustained 
neurological sequelae, about half of these being severely disabled (Carroll and Carroll, 
1994). The situation is similar in the Sudan where 1 1 %  of cases had a profound, persistent 
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hearing loss (Salih et al 1991). In the UK by contrast, a recent study found that only three 
of 123 (2.5%) children admitted with bacterial meningitis sustained long-term hearing loss 
(Richardson et al 1995). This is a lower incidence than reported from the USA perhaps 
because the UK’s well-developed primary care system and public-health education of 
parents in the light of recent meningitis “scares” mean that patients present earlier. 
Recent evidence has shown that hearing loss in patients with bacterial meningitis occurs 
early in the course of illness and is in many cases transient (Wilken et al 1995; Kaplan et al 
1984; Richardson et al 1995; Vienny et al 1984; Guiscafre et al 1984). Recovery of 
audiometrically-confirmed hearing loss was first reported in the 1960s and 1970s (Liebman 
et al 1969; Roesor et al 1975). In their major US study, Dodge et al (1984) found no cases 
of recovery among 19 of 185 children with a sensorineural hearing deficit, but did 
demonstrate recovery in several patients with a conductive-type loss. However, initial 
audiometric testing was not performed until at least ten days after admission. Vienny et al 
(1984) addressed the question of early hearing loss directly by assessing 51 children 
presenting with meningitis within 48 h of admission with auditory evoked brain-stem 
response testing. Eleven patients (22%) developed transiently abnormal evoked responses 
while a further 5 (10%) went on to have permanent hearing impairment. These findings 
were confirmed by a recent well-conducted prospective multi-centre study from the US in 
which auditory brain-stem evoked responses were elicited within 24 h of admission on 173 
children with meningitis aged between 8 weeks and 12 years (Wald et al 1995). Among 22 
children (13%) with bilateral moderate or severe hearing loss at presentation, 13 had 
recovered normal hearing in at least one ear six months later. Nine of the 10 children with 
persistent bilateral deafness had been deaf at the first assessment. Richardson et al (1995) 
prospectively assessed the hearing of 123 children presenting with meningitis to hospitals in 
the south-west region of the UK. Otoacoustic emissions were recorded within 6 h of 
admission. Of the 13 children with hearing impairment at presentation, 9 had recovered 
hearing within 48 h. The use of this newly developed technique provides the first direct 
clinical evidence that early hearing loss is due to cochlear damage rather than disturbance of 
brain stem function or auditory nerve damage. There now seems to be general agreement 
that little further auditory impairment occurs more than 48 h after admission. It is also 
encouraging that many cases of cochlear hearing loss appear to be transient. Early case 
detection and prompt treatment before hearing loss progresses should reduce the chance of 
permanent sensorineural hearing loss. It might also be possible to design specific 
interventions to increase the chance of recovery if many patients are admitted with 
potentially recoverable hearing. A better understanding of the pathogenic mechanisms of 
cochlear damage in meningitis is therefore crucial. 
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1.5.2. 
Clinical studies 
Mechanisms of post-meningitic hearing loss. 
Several findings suggest that hearing loss occurring after meningitis is due primarily to 
cochlear damage rather than to auditory nerve neuritis or brain damage at higher levels: 
Cochlear implantation is successful in many cases of meningogenic deafness (Johnson et 
al 1995); 
Hearing loss is frequently unilateral, occurs very early in the course of illness, and is 
often not accompanied by other brain damage (Dodge et al 1984; Fortnum, 1992; 
Vienny et al 1984; Wald et al 1995); 
Post mortem studies demonstrate suppurative labyrinthitis (Perlman and Lindsay, 1939); 
CT studies of the temporal bone show a high proportion of cochlear abnormalities 
(Johnson et al 1995); 
Otoacoustic emissions are reduced in children with meningogenic hearing loss 
(Richardson et al 1995). 
There was little doubt in the pre-antibiotic era that post-meningitic deafness was due to a 
neurolabyrinthitis (Trolle, 1950). Trolle's review lists several post-mortem studies published 
between 1886 and 1940. The main limitation of such post-mortem studies is that they can 
only include cases with severe disease who may not be entirely representative. The 
preparation of temporal bones for histological analysis is also extremely difficult to do well 
and autolytic changes are inevitable. Trolle listed the potential causes of post-meningitic 
deafness thus: 
Infiltration of the eight cranial nerve and secondary degeneration of the neural structures 
of the cochlea; 
• Purulent labyrinthitis; 
Septic embolism of the internal auditory artery. 
• Hydrops labyrinthi (secondary to a toxic or serous labyrinthitis) 
Otitis media (accessory role only in some cases); 
Disturbance of brain stem and higher auditory centres. 
The sole alteration needed today would be to add that bacterial products are directly 
ototoxic (Comis et al 1993; Dulon et al 1990) (and evidence cited in this thesis). 
Leichenger (1 937) also reported a case of meningococcaemia who survived but suffered 
hearing loss and suggested that the deafness was due to the effects of an exotoxin on the 
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inner ear. Of course, this list does not explain the actual mechanisms of hearing loss; that is, 
how labyrinthitis itself can affect the structure and function of the auditory apparatus. Some 
theories of this will be outlined in chapter 5 .  
Perlmann and Linsey (1939) investigated histopathological changes in the temporal bones of 
30 patients who died from meningitis. In the first stage of labyrinthitis, polymorphs were 
found around the facial and acoustic nerves. In later stages, pus cells were seen invading 
along the cochlear aqueduct and filling the scala tympani. Eavey (1985) demonstrated 
retrograde invasion of the inner ear in four of eight fatal cases of pneumococcal meningitis. 
No studies have shown a direct route of extension from middle ear sepsis to the inner ear. 
The two major routes for the transmission of infection between the meninges and the 
labyrinth are agreed to be the cochlear aqueduct and the eighth cranial nerve (Igarishi and 
Schucknecht, 1962). Igarishi (1974) emphasised that bacteria could also invade the 
endolymphatic space via the blood stream, and described the destruction of the stria 
vascularis by bacterial thrombi in pneumococcal meningitis. It has been suggested that 
serous labyrinthitis induced by spread of "toxic" factors from the CSF may cause reversible 
deafness while true purulent labyrinthitis causes permanent inner ear damage (Liebman et al 
1969; Fortnum, 1992). There is in fact little histopathological evidence to support such a 
contention. In less severe (i.e. non-fatal) cases, radiological studies of the temporal bone 
performed prior to cochlear implantation are frequently abnormal. In one study, 70% of 
patients with post-meningitic deafness had either cochlear stenosis or cochlear ossification 
demonstrable on high-resolution thin-section CT scanning (Johnson et al 1995). It is beyond 
reasonable doubt therefore that the vast majority of cases of post-meningitic deafness result 
from damage to the inner ear. 
Experimental meningitis 
Four other groups besides the Meningitis Research Group in Birmingham have published 
data related to meningogenic deafness in animal models. This body of work will be 
discussed in greater detail in the discussion (Chapter 5) ,  but there follows a brief overview. 
Sheldon Kaplan's group at Texas Childrens' Hospital have induced meningitis in infant rats 
by systemic inoculation of H. influenzae type b or (with less success) pneumococci. They 
demonstrated the development of labyrinthitis (detected with light microscopy), but did not 
measure hearing loss (Wiedermann et al 1986; Rodriguez et al 1991). The development of 
labyrinthitis was not related to the potential of the strain of Hib to induce deafness clinically. 
Sensitive immunofluorescent techniques were used to demonstrate Hib invasion of the 
cochlea. Labyrinthitis was not observed when rats were given ampicillin treatment one day 
after inoculation (Kaplan et al 1989). Blank et al (1 994) reported that meningitis induced by 
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intrathecal inoculation of pneumcocci in the guinea pig causes a labyrinthitis. Hearing loss 
was not assessed in this study either. Kay (1993) showed that inoculation of Streptococcus 
suis by intraperitoneal, intracranial or intrabullar routes in the guinea pig could induce a 
suppurative labyrinthitis. Hearing loss was assessed rather inadequately by click evoked 
auditory brain-stem response testing of animals surviving to the end point. Elaine 
Tuomanen's group at the Rockefeller have preferred to use the traditional Dacey and Sande 
rabbit pneumococcal meningitis model assessing hearing with of click- and tone-evoked 
auditory brain stem Potentials to give a frequency-specific assessment of hearing loss 
(Bhatt et al 1991; Bhatt et al 1993). Rabbits begin to lose hearing 12 h after intracisternal 
inoculation of S. pneumoniae CFU). This correlates with the onset of a leukocytosis in 
the CSF. Suppurative labyrinthitis occurs but the organ of Corti appears to be undamaged 
at a light-microscopic level. More recently, the effect of antibiotic treatment on the course 
of hearing loss has been studied in this model. Hearing assessments were performed up to 4 
days after the induction of meningitis. Cefotaxime treatment improves auditory outcome but 
adjuvant dexamethasone treatment has no additional benefit (Bhatt et al 1995). 
Ultrastructural damage of the organ of Corti during experimental E coli or Hib meningitis 
was reported in detail by Osborne et al (1 995) from the University of Birmingham. Hearing 
loss was assessed by click-evoked auditory brain stem response testing. Specific 
ultrastructural lesions are detected once hearing loss exceeds 20 dB. 
Whether meningitis is induced by systemic inoculation or by intracranial injection 
inflammation of the perilymphatic space is common whereas inflammation of the 
endolymphatic space is rare. This is consistent with inflammation spreading from the CSF 
space rather than by haematogenous dissemination. All reports agree about the importance 
of the cochlear aqueduct in allowing the spread of infection and, in one study, in defending 
the inner ear from such invasion (Yanagita et al 1984). N o  study has reported hearing loss 
at the cochlear level, but the ultrastructural damage observed is consistent with cochlear 
damage being the main cause of meningogenic hearing loss. These findings are certainly 
consistent with the postmortem studies and clinical investigations discussed above. 
Evidence from cochlear perfusion studies 
Four studies all conducted in Birmingham have reported the deleterious effects of the 
bacterial products endotoxin and pneumolysin on the electrophysiological function and 
ultrastructure of the organ of Corti when micropertused into the scala tympani of the guinea 
pig (Comis et al 1991; Tarlow et al 1991; Comis et al 1993; Amaee et al 1995). The 
relevance of these findings to the damage observed in experimental meningitis and putative 
mechanisms of meningogenic deafness will be discussed in Chapter 5. 
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1.5.3. The steroid controversy. 
A great deal of controversy exists about the benefits of giving dexamethasone as adjuvant 
therapy to patients with meningitis. Glucocorticoids have many biological activities that 
might ameliorate the neurological damage caused by bacterial meningitis. These include 
anti-inflammatory effects such as reducing the liberation of cytokines in response to various 
inflammatory stimuli in vitro and in vivo (Velasco et al 1991; van Furth et al 1994; Mustafa 
et al 1989b; Ulich et al 1990; Mustafa et al 1990), as well as reducing brain oedema, 
intracranial pressure and blood-brain barrier permeability in experimental meningitis (Koedel 
et al 1994). Other agents which have been shown to modulate inflammation in the CSF 
space include indomethacin (Tuomanen et al 1987; Tureen et al 1991), pentoxifylline (Saez- 
Llorens et al 1990) and anti-CD-18 antibodies (Cabellos et al 1992) as discussed in section 
1.4.3. Several assumptions have been used to support the use of such agents to reduce the 
incidence of neurological sequelae: 
• The bulk of the neurological damage which ensues is caused by an excessive host 
inflammatory response. 
• The underlying pathophysiology is broadly similar in meningitis due to Haemophilus 
influenzae, Neisseria meningitidis and Streptococcus pneumoniae. 
• Modern lytic antibiotics provoke a significant and damaging rise in local inflammation 
compared to bacteriostatic agents. 
Based on such theoretical considerations, a number of clinical trials were conducted in the 
late 1980s to assess the impact of dexamethasone treatment on the incidence of various 
neurological sequelae, including sensorineural deafness (Lebel et al 1988; Girgis et al 1989; 
Odio et al 1991). No significant benefit was seen unless the incidence of sequelae was 
raised because of sub-optimal antibiotic treatment or supportive care; two of the studies 
were conducted in under-resourced countries where patients presented very late in the 
course of disease. However, because of the theoretical arguments and the beneficial trends 
seen in such studies, adjuvant dexamethasone therapy was endorsed by the Committee on 
Infectious Diseases of the American Academy of Paediatrics in 1991 (although they 
suggested that the decision should be “individualised’) and the Meningitis Working Party of 
the British Paediatric Immunology and Infectious Disease Group in 1992. 
Recommendations suggested administering dexamethasone (0.4-0.6 mg/kg/day) for 4 days 
starting about 15 min before the first antibiotic dose. A large prospective trial studying 115 
children admitted with bacterial meningitis in Switzerland appeared to show that 
dexamethasone reduces the incidence of any neurological complications (Schaad et al 
1993). But there were no significant differences between groups in the incidence of severe 
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neurological sequelae or bilateral moderate to severe hearing loss, endpoints of perhaps 
greater importance. A meta-analysis of this and other recent studies conducted in developed 
nations where optimal treatment was given also suggested a significant benefit for adjuvant 
dexamethasone treatment (0.4 mg/kg/day) in bacterial meningitis, with a relative risk of 
developing any neurological or audiological sequelae without dexamethasone of 2.29 (95% 
CI 1.2 to 4.3) (Schaad e? al 1995). A study from Greece demonstrated that 2 days of 
dexamethasone treatment was just as effective as 4 days, with an overall incidence of any 
neurological or audiological sequelae of 1.8% or 3.8% respectively (Syrogiannopoulos e? al 
1994). 
Many of the cases of meningitis in these studies were due to H. influenzae type b and it 
remains controversial whether these findings are applicable to the spectrum of disease 
encountered now Hib immunisation is widespread. More specifically, none of the studies 
have recruited sufficient numbers to assess the impact of dexamethasone in pneumococcal 
disease. A retrospective analysis from Dallas covering the years 1984 to 1990 purported to 
show a benefit for dexamethasone treatment but there were differences in the composition 
of groups and some children received an inferior antibiotic (cefuroxime). A prospective 
study from Turkey utilising behavioural audiometry showed no significant benefit from 
dexamethasone treatment (0.6 mg/kg/day) in 56 cases of pneumococcal meningitis at 6 
week follow up, but with some judicious data dredging found a just-significant benefit at 3 
month follow up (P=0.04) (Kanra e? al 1995). 
The conclusions of the most recent and best conducted prospective study of the use of 
dexamethasone in childhood bacterial meningitis are decidedly more guarded. Wald and 
colleagues (1995) in the study of 173 children referred to above (page 44) found that 
dexamethasone (0.6 mg/kg/day for 4 days) reduced bilateral hearing loss in meningitis due 
to H. influenzae type b but was of no benefit in reducing other neurological sequelae or in 
meningitis due to other pathogens. The outcomes for the various aetiologies are given in 
table 1.4. 
The most likely explanation for the differences observed in these subgroups is that there 
were insufficient subjects, even in such a large, multi-centre trial. The initiai power 
calculations suggested 300 subjects were needed, but the advent of Hib immunisation 
curtailed recruitment. This does not bode well for other trials of adjuvant therapy. The 
major criticism of this trial is that dexamethasone was administered up to 4 hours after the 
first antibiotic dose (which at least reflects typical practice if antibiotics are administered in 
primary care). It is most important that none of the children found to be deaf at the time of 
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first assessment (within 24 h) recovered hearing; that is dexamethasone failed to reverse 
cochlear damage. 
Aetiology Dexamethasone Placebo P (two-tailed by 
(bilateral deafness) (bilateral deafness) Fisher's exact test) 
H. infuenzae type b 0/43 (0%) 5/39 (13%) 0.02 
S. pneumoniae 3/13 (23%) 2/20 (10%) 0.36 
A? meningitidis 0/11 (0%) 0/13 (0%) 
TOTAL 3/67 (4.4%) 7/72 (9.4%) 0.33 
Table 1.4: Final audiological outcome in 142 children with meningitis 
(taken from Wald et al 1995) 
Steroid therapy is not without adverse effects. Gastrointestinal bleeding (which is usually 
occult) and a higher incidence of secondary fever are not particularly worrying. Of more 
concern is that dexamethasone treatment reduces penetration of vancomycin into the CSF 
and delays CSF sterilization in experimental meningitis induced with penicillin-resistant 
pneumococci in the rabbit (Paris et al 1994). In areas where vancomycin is used as a first 
line agent, the use of dexamethasone does not appear sensible. In addition, many cases of 
meningitis are in fact viral in aetiology and there is no firm data that steroid treatment is 
without harm in this situation (Kaplan, in Schaad et al, 1995) 
In conclusion, then, the theoretical benefits expected with adjuvant dexamethasone therapy 
have been more difficult to demonstrate in well-conducted clinical trials. This has not 
stopped various authors promoting steroid therapy quite vigorously, often relying heavily on 
data from experimental meningitis and arguing from hypotheses (rather than firm evidence) 
about the pathogenesis of infection (Quagliarello and Scheld, 1992; Tunkel and Scheld, 
1993b). The most important findings from recent prospective trials have been the low 
incidence of severe neurological sequelae in developed countries and the fact that deafhess 
occurs early in the course of the illness. Clearly, the most beneficial intervention to prevent 
meningogenic deafness will be immunisation against the common pathogens causing 
childhood bacterial meningitis. This is even more important in developing countries where 
meningitis is more common and carries a much greater morbidity. 
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1.6. Conclusions. 
Towards a new paradigm of meningogenic hearing loss. 
It is clear from the preceding review that there are likely to be many mechanisms which 
cause hearing loss in bacterial meningitis. The current paradigm is dominated by the concept 
that a largely frustrated host inflammatory response liberates toxic intermediates that cause 
end-organ damage. This does not really explain the much worse prognosis in meningitis due 
to S. pneumoniae as opposed to meningococcal or Hib meningitis, other than to assume 
(without a lot of evidence) that Gram-positive cell wall is in general more “inflammatory”. 
The crucial link in this hypothesis - that inflammatory mediators are the major cause of 
brain and auditory damage - has not been satisfactorily proven. There are in fact few 
experimental studies of end-organ damage (as opposed to endpoints such as CSF 
leukocytosis) although recent studies of putative adjuvant agents have included histological 
data. Several studies have shown that bacterial products such as pneumolysin and 
pneumococcal cell wall are themselves cytotoxic, irrespective of the host inflammatory 
response. There are as yet few data about the role in the pathogenesis of meningitis of 
pneumococcal accessory virulence factors such as pneumolysin or neuraminidase. 
Although it seems to be accepted that the cochlea is the site of meningogenic deafness, the 
available evidence is largely circumstantial. There is no published evidence that conclusively 
shows that the hearing loss measured in experimental bacterial meningitis reflects cochlear 
damage rather than brain stem disturbance. All but one clinical study has relied on brain 
stem recording or behavioural audiometry to assess hearing loss. Evidence from 
experimental rabbit meningitis does suggest that specific ultrastructural lesions of the organ 
of Corti underlie meningogenic deafness but more data are needed especially in different 
species. 
In conclusion a new paradigm of hearing loss in bacterial meningitis needs to be constructed 
which takes into account: 
Evidence gathered from histopathological and neurophysiological studies of tissue 
damage which sheds light on the effects of bacterial meningitis on brain and auditory 
function. 
Evidence about the role of bacterial products in direct cytotoxicity and the contribution 
to virulence of the various proteins elaborated by S. pneumoniae. 
A better model of the molecular and bioelectric phenomena which underlie 
meningogenic hearing loss whether induced by inflammatory mediators or toxic bacterial 
products. This should satisfactorily explain reversible hearing loss. 
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Summary of experimental data to be presented. 
The following data from a model of experimental meningitis in the guinea pig are now 
presented: 
• The scanning and transmission electron microscopic appearance of the organ of Corti in 
the first twelve hours of experimental meningitis due to E coli or S. pneumoniae; 
An electrophysiological study of hearing loss measured by direct electrocochleography 
in experimental pneumococcal meningitis; 
• Hearing measurements and cerebrospinal fluid data in experimental meningitis induced 
by isogenic strains of S. pneumoniae lacking pneumoly sin, neuraminidase or 
hyaluronidase; 
The effects of antibiotic treatment on cochlear Potentials and ultrastructural damage to 
the organ of Corti after microperfusion of S. pneumoniae directly into the scala tympani 
of the inner ear. 
• 
• 
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2. MATERIALS AND METHODS 
2.1 Common methods 
2.1.1 Overall strategy 
Two different experimental models were employed. 
Meningitis model. Experimental meningitis was induced by Escherichia coli K-12, or a 
virulent serotype 2 Streptococcus pneumoniae D39, or its isogenic derivatives PLN-A, 
or deficient in pneumolysin, neuraminidase or hyaluronidase respectively. 
This work is referred to as the “meningitis model”, and is described in section 2.2 with 
experimental results given in chapter 3. The majority of the work was performed in guinea 
pigs, but meningitis was also induced in six rabbits. 
Cochlear perfusion. Suspensions of viable bacteria were perfused through the scala 
tympani of the cochlea of the guinea pig to mimic under controlled conditions what might 
happen when organisms invade the cochlea during bacterial meningitis. This work is 
referred to as “cochlear perfusion”, and is described in section 2.3 with experimental results 
given in chapter 4. 
The two primary endpoints in all studies were: 
• Hearing loss assessed by recording either auditory-evoked brain-stem far-field 
Potentials or the auditory nerve compound action potential. 
Ultrastructural changes in the organ of Corti observed by scanning and transmission 
electron microscopy. 
• 
The common methods for animal handling and bacterial preparation are now described. The 
composition of solutions used will be found in appendix A. The manufacture of isogenic 
derivatives of D39 is described in appendix B. 
2.1.2 Use of animals 
Consideration of alternatives. 
Before undertaking any animal study one has to consider the use of alternative strategies to 
investigate the problem. In order to study the pathophysiological events of meningitis a 
whole animal model is essential. The concern of this project was to investigate how 
inoculation of organisms into one compartment (the CSF space) would affect the behaviour 
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of an organ in another compartment (the perilymphatic and endolymphatic spaces). There is 
no in vitro system sophisticated enough to model these events. Much of the work challenges 
the currently accepted dogma on which such models might be based. 
Minimisation of animal use 
In all parts of the project the absolute minimum number of animals was used consistent with 
obtaining statistically valid results. In general this implied group sizes of 4-6 for each 
particular organism or treatment under investigation. Experiments were carefully planned to 
yield the maximum data. Strong ethical and financial constraints at times prevented 
repetition or extension of experiments where in a less rigorous environment this may have 
been considered useful. In particular, our group has a policy of not allowing nor seeking 
permission for “recovery” experiments where mid to long term sequelae can be investigated. 
The investigations to be reported therefore deliberately concentrate on the acute 
pathophysiological events occurring within the first twelve hours of induction of meningitis. 
Animal welfare. 
In the first part of the project pigmented guinea pigs were bred in our own colony and 
housed in open pens with free access to food and water. With the implementation of real 
costing, in-house breeding became financially unviable and for the later parts of the project 
pigmented guinea pigs were purchased from a breeding colony at Leeds University. These 
animals were housed under similar conditions. Rabbits were purchased from a commercial 
supplier. Ail experiments were conducted under a Home Office Project Licence and 
Personal Investigator Licence. 
2.1.3 Anaesthesia and conditions 
Pigmented guinea pigs of either sex weighing between 500 g and 700 g were anaesthetised 
by intraperitoneal injection of Urethane (5 .5 ml/kg body weight of 25% (w/v) ethyl 
carbamate in distilled water; Sigma, UK). This gave a stable deep surgical anaesthesia for 
up to 8 h before supplements were necessary. Animals never recovered consciousness and 
the level of anaesthesia was monitored regularly throughout each experiment by assessing 
withdrawal reflex. The rectal temperature was maintained at 38°C with a heat lamp or (in 
later experiments) with a 12 V DC home-built servo-controlled heating pad based around a 
Maplin temperature module (FE33). Animal temperature with the latter stabilised to 38°C 
0.3°C within one hour. For any experiment longer than 4 h fluid replacement was given as 
0.9 % (w/v) saline by intraperitoneal injection (66 ml/kg/24 h) (approx. 5 ml every 3 h for a 
600 g guinea pig). 
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Sites for surgery and electrode contact were carefùlly shaved. Ail animals underwent 
tracheotomy to protect the airway from nasal secretions. A 2 cm midline incision was made 
above the sternal notch. The trachea was blunt dissected free from overlying layers and 
sectioned transversely. A 2 mm diameter custom-made metal tracheotomy tube was 
inserted, tied tightly in place and the wound closed with cotton sutures. The trachea was 
cleared with fine tissue wicks at least hourly. 
Pigmented Dutch rabbits weighing between 1.4 and 1.7 kg were anaesthetised by 
intravenous injection of 30 mg/kg Sagatal (pentobarbitone sodium; RMB Animal Health 
Ltd). They were intubated with the veterinary assistance of Mr Paul Townsend. Light 
anaesthesia was maintained by continuous intravenous infusion of a 1 : 10 dilution of Sagatal 
in physiological dextrose/saline, which also provided fluid replacement. Rectal temperature 
was maintained by use of a heat lamp. 
2.1.4. Bacterial preparation 
General considerations. 
Streptococcuspneumoniae is designated a class II pathogen by the Advisory Committee on 
Dangerous Pathogens. All work with S. pneumoniae was approved by the University 
Microbiological Safety Committee. All laboratories used met the required containment 
standard. Cultures for inoculation (max. 1 ml) and inoculated plates for viable counting 
were transported between locations in sealed metal containers in accordance with good 
microbiological practice. A full gown, mask and gloves were donned when inoculating 
animals or dissecting the cochleas free at the end of an experiment because of the risk of 
aerosol formation. 
Sterile artificial perilymph (APL; see appendix A) was used as the final diluent for the 
inoculum in all cochlear perfusion experiments and all E. coli work. Pneumococcal cultures 
for meningitis work were washed and resuspended in filter-sterilised PBS. All bacterial 
cultures (broth and agar) were incubated at 37°C without shaking and with no added CO,. 
Macconkey agar plates for E. coli growth were made in the Department of Biological 
Sciences. Five percent horse blood agar plates for pneumococcal isolation were purchased 
from the Department of Medical Microbiology, Queen Elizabeth Hospital, Birmingham. 
Viable counting was performed by a modification of the drop count method of Miles and 
Misra (1938). Serial ten-fold dilutions of the inocuIum or CSF or blood were made (10 
into 90 of sterile APL or 0.9% saline) and 20 dropped onto a quadrant of the relevant 
agar plate. Three quadrants were inoculated per dilution and the plates incubated for at least 
18 h at 37°C. 
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The viable count was calculated thus: 
Viable count (log,, cfu/ml) = log,, ([mean quadrant count] x 50 x dilution) 
Escherichia coli 
Stock cultures of E. coli K-12 were stored in 50% glycerol at -70°C. For each experiment 
a fresh mid-logarithmic phase (3 h) culture was prepared as follows. A loopful of stock 
E. coli K-12 was plated out onto Macconkey agar and incubated overnight. Two to three 
colonies were scraped into 10 ml of brain-heart infusion broth (BHI) (Oxoid, Basingstoke, 
England) and cultured overnight. Fresh BHI (10 ml) was inoculated with 100 of the 
overnight culture and incubated for 3 h. An aliquot of the log-phase culture was diluted 1 :9 
in formal:saline and bacteria were counted in a Thoma chamber. Organisms were harvested 
by centrifugation (4000 rpm 2600 g, 10 min, 20°C) in a Mistral 2000 centrifuge. The 
pellet was resuspended in sterile APL to a final concentration of organisms/ml for 
meningitis experiments or organisms/ml for cochlear perfusion. In the first three 
experiments viable counts were performed by serial ten-fold dilution and overnight 
incubation on Macconkey agar plates. 
Streptococcus pneumoniae D39 and derivatives. 
S. pneumoniae serotype 2 strain D39 (NCTC 7466), and its derivatives PLN-A, and 
were a generous gift from Dr Tim Mitchell, Dept of Microbiology and Immunology, 
University of Leicester, UK. This strain is encapsulated and fully virulent in a mouse model 
of pneumococcal bacteremia(Berry et al 1989). The method of preparing the 
pneumococcal inoculum was modified from that of Alwmark et al (1 98 1) which allows 
preparation of a standardised inoculum. 
Outbred MF1 mice were inoculated by intraperitoneal injection of CFU of stock D39 
(or its derivative) in 0.2 ml PBS (Gibco) and bled by cardiac puncture 24 h later. Blood was 
grown overnight on Columbia agar. Four to five colonies of the mouse-passaged 
pneumococci were transferred into 10 ml BHI and cultivated overnight. Erythromycin ( 5  
was added to all subsequent liquid media when preparing PLN-A, or 
to maintain selection pressure. Bacteria were harvested by centrifugation (4000 rpm 
2600 g, 15 min, 20°C) in an IEC Centra 4R centrifuge and resuspended in fresh BHI to 
remove any autolysin present after overnight culture. Serum broth was prepared by adding 
as cryoprotectant 17 % (v/v) heat-inactivated fetal calf serum (Gibco) to BHI, and was 
filter-sterilized (0.2 Whatman). Fresh serum broth (10 ml) was inoculated with 400 
of pellet suspension (final and incubated for 5 h. Aliquots of 1 ml were rapidly 
frozen and stored at -70°C. Viable counts were performed in triplicate on one of the 
aliquots 24 h later. 
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Table 2.2 (page 59) lists the batches of S. pneumoniae which were used in the study. 
Batches were given consecutive letters irrespective of the intended phenotype. Batches A 
and F through N were prepared as above in Leicester. Batches B through E were 
subcultured in Birmingham. Batch B was prepared from an agar plate growth of batch A .  
Batch C was prepared from an agar plate growth of pneumococci recovered from the CSF 
from experiment D39 (8). Batch D was prepared from an agar plate growth of Batch C. 
Batch E was prepared from an agar plate growth of PLN-A obtained from Leicester. It only 
later became clear that for reliable in vivo growth, organisms needed to be animal passaged 
before the final overnight culture (see section 3.2.1). 
Derivatives of S. pneumoniae D39 deficient in accessory virulence factors: PLN-A, 
ANA1 & 
Three isogenic mutants of D39 were used in this study and full details of their construction 
are given in appendix B. This work was approved under the Genetically Modified 
Organisms (Contained Use) Regulations 1992 as ACGM Containment level II. 
Wild type D39 has full haemolytic, neuraminidase and hyaluronidase activity and is fully 
sensitive to erythromycin (ERY). Ail the derivatives are fully resistant to ERY and can be 
tested for lack of the gene product by a specific assay (details in appendix C). Routinely the 
sensitivity of both the inoculum and recovered organisms from CSF and blood was tested 
by streaking out a 1:100 dilution onto blood agar, adding a 5 ERY disk (Oxoid, 
Basingstoke, UK) and incubating overnight. There were problems throughout the study 
with the purity of PLN-A and cultures, hence batches E, G, H and K were found to 
be partially or fully sensitive to erythromycin. When this occurred, further phenotypic assays 
were performed in Leicester by Dr Mitchell’s staff These problems were finally traced to a 
clerical problem with the archive strains in Leicester and further batches J and L proved 
satisfactory. Recovered organisms from guinea pigs infected with PLN-A (Batch J) and A 
NA1 (Batch L )  were also assayed for the gene product to ensure the mutation was still 
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present. The titre of batch M dropped rapidly on storage due to a problem with the 
fetal calf serum. The final inoculum obtained with batch N of this derivative was also 
slightly less than desired. 
Preparation of final inoculum 
Prior to inoculation an aliquot was allowed to thaw completely at 20°C, centrifuged in a 
bench top microfuge (12,000 g, 1 min, 20°C), washed with ice-cold sterile APL (or PBS for 
the later meningitis experiments), recentrifuged and then resuspended in fresh ice-cold APL 
(or PBS) to an estimated concentration of CFU/ml for the meningitis experiments and 
CFU/ml for cochlear perfusion. The inoculum was held on ice until required (usually 
less than 1 h). Viable counts were not reduced after holding the inoculum on ice for up to 
3 h. Dilutions of the inoculum for viable counting were plated shortly after inoculation in all 
experiments. 
2.1.5 Pneumococcal cell wall preparation. 
Highly purified intact pneumococcal cell wall material (PCW) containing teichoic acid was a 
kind gift of Professor Alexander Tomasz, Rockefeller Institute, New York. Full details of 
the preparation of PCW from strain R36A are given in Tuomanen et al (1985). This strain is 
the non-encapsulated derivative of type D39 used elsewhere in this study. PCW (100-200 
reliably induces CSF inflammation in rabbits (Tuomanen et al 1985) and rats (Pfister et 
al 1992a; Pfister et al 1992b, personal communication Prof A Tomasz). For experiment 
PCW (1), PCW (1 mg) was suspended in sterile APL (1 mi) and sonicated for 2 min in a 
water bath sonicator before use. For subsequent experiments, this suspension was re- 
sonicated in a cup-horn sonicator (20 s) and dialysed overnight against 1000 volumes of 
APL at 4°C before storing in aliquots at -20°C. 
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2.2. Meningitis model 
2.2.1. Experimental design. 
The main purpose in establishing a new model of meningitis in the guinea pig was to 
examine the importance of accessory pneumococcal virulence factors in causing 
meningogenic deafness. A new method of measuring hearing loss was developed during the 
course of the investigation which allowed the final comparative studies to be performed. 
Subsidiary aims were: 
(i) To investigate the difference between pneumococcal and E. coli meningitis in terms of 
ultrastructural changes in the organ of Corti and hearing loss. 
(ii) To examine the effect of cefotaxime-treatment on the morphology of E. coli in vivo. 
(iii)To investigate whether hearing loss would occur as a result of sterile inflammation 
induced by pneumococcal cell wall material. 
The guinea pig meningitis work divided into two main parts: initial studies to perfect 
techniques and the final comparative study. For the initial studies with E. coli and S. 
pneumoniae D39, animals were killed at different times after inoculation. The final 
comparative study compared groups of guinea pigs infected with the different isogenic 
derivatives of S. pneumoniae with those infected by wild-type D39. Animals were killed at a 
predetermined time-point of 12 h after inoculation. This was chosen because in the initial 
experiments all animals infected with wild-type D39 had lost some hearing by this time. 
Animals that died earlier than 9 h were excluded from the hearing loss analysis. The tables 
of results given in chapter 3 include details of experimental numbering, duration and 
inoculum. 
Experimental numbering 
Guinea pig experiments were numbered serially (see table 2.3 overleaf). Some batches of 
the inocula of isogenic mutants were subsequently found to contain wild type phenotype 
organisms (see section 2.1.4 above). Therefore some experiments labelled as PLN-A or 
NA1 were included in the analysis as wild-type experiments. The work with E. coli was 
performed before the work with pneumococci because of delays in gaining safety approval 
for the latter. 
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CSF sampling 
One of the major disadvantages of the guinea pig model compared to the traditional Dacey 
and Sande rabbit model is that because of the low volume of CSF it is difficult to sample 
CSF sequentially. With practice it became possible to place a cisternal cannula (23G 
Butterfly, Abbot) using a stereotactic guide but it was difficult to maintain the position for 
the full 12 h without a CSF leak developing. Although only a small volume of CSF was 
required for analysis, a substantial dead space (some 100-200 needed to be flushed. 
Removing a substantial fraction of the free CSF at regular intervals might well have altered 
the course of the inflammatory response, so an indwelling cisternal cannula was inserted in 
only a few experiments. Another way of establishing in vivo growth curves and the time 
course of the CSF inflammatory response would have been to kill several guinea pigs at 
each of several time points. It was considered inappropriate to do this as some of this 
information was already published for the rabbit (Friedland et al 1995) and these data 
remained secondary endpoints. However, a terminal CSF sample was obtained in most 
animals and (for the comparative study) quantitative culture, white cell count and protein 
concentration were compared between the groups. 
E. coli meningitis (table 3.1). 
One animal each was killed at 3 h, 4.5 h, 6 h, 7 h, 9 h, and 12 h post inoculation (p.i.). 
Additional animals were killed at 3 h and 7 h. One animal inoculated with sterile APL was 
killed at 7 h. Five animals died within 4 h of inoculation; CSF measurements from these 
animals are included in the results but because of delayed fixation the cochleas were poorly 
preserved. 
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Cefotaxime-treated E. coli meningitis (table 3.2). 
Cefotaxime was chosen because it is commonly used as blind monotherapy for acute 
childhood bacterial meningitis. In experimental rabbit meningitis cefotaxime (amongst other 
antibiotics) induces a transient rise in CSF free endotoxin concentration (Tauber et al 
1993). The usual paediatric dose is 200 mg/kg/day in two divided doses. Doses of 100 
mg/kg body weight and 10 mg/kg body weight were used in this work. Cefotaxime 
(Claforan, Roussel, UK) was purchased from the Pharmacy, Queen Elizabeth Hospital, 
Birmingham and once opened the vial was stored sealed under desiccation at -20°C. 
Cefotaxime was diluted in 5 ml 0.9% w/v saline and administered by intraperitoneal 
injection 3 h after inoculation to allow infection to become established and organisms to 
reach the scala tympani. The half life of cefotaxime is some three times shorter in the guinea 
pig compared to man (Personal communication, Dr J Edwards, Zeneca Pharmaceuticals, 
Macclesfield, UK) so for experiments which lasted more than 6 h, cefotaxime was also 
administered 6 h and 9 h post inoculation. The morphological appearance of cefotaxime- 
treated E. coli in vivo was investigated by examining the surface of the basilar membrane 
facing scala tympani with high-resolution scanning electron microscopy. Other endpoints 
were the CSF parameters (viable count, Ieukocyte count, protein) and hearing loss assessed 
by click-evoked response testing as above. 
1) Cefotaxime IO0 mg/kg body weight: Two animals were killed at 1 h, 2 h, and 3 h post 
antibiotic (4 h, 5 h and 6 h p.i.) and one each at 4 h, 5 h and 6 h post-antibiotic. 
2) Cefotaxime IO mg/kg body weight. One animal each was killed 1 h and 3 h post 
antibiotic. 
Initial study of untreatedpneumococcal meningitis (tables 3.4 & 3.5). 
Three animals were used for dose-finding. Subsequently, one animal each was killed at 
4.5 h, 6 h and 12 h p.i. and two each at 9 h and 10 h p i .  One control animal was inoculated 
with sterile PBS and was killed at 10 h p.i. 
Comparative study between 039  and derivatives (tables 3.6 - 3.9). 
039: Eight animals were inoculated with wild-type D39; 7 were sacrificed 12 h later and 
1 died early. 
PLN-A: Fourteen animals were inoculated with PLN-A. Five were sacrificed 12 h after 
inoculation and evaluated for hearing loss. In 2 animals the inoculum leaked back 
and failed to induce meningitis. A further 7 animals were not evaluated either 
because the phenotype of the inoculum was in question (see section 2.1.4) or 
because they died prior to 12 h. 
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Six animals were inoculated with of which 5 were evaluated for hearing 
loss. Four were sacrificed after 12 h; a fifth was sacrificed at 7 h p.i. after losing all 
detectable hearing and another animal died 9 h p.i. 
Eight animals were inoculated with of which 5 were evaluated. Two 
received a low inoculum and a third died 7 h p.i. 
Pneumococcal cell wall material (table 3.1 O) 
Meningitis was induced by introducing 0.1 ml (100 of the PCW suspension into the 
subarachnoid space through a drill hole (as above) or (for expt PCW(2)) via an indwelling 
cisterna1 cannula (Butterfly-23). All animals had an indwelling cisterna1 cannula inserted and 
CSF samples (approx. 30 were withdrawn at intervals of 3 h for the duration of the 
experiment. 
2.2.2. Consideration of inoculum and antibiotic doses 
Guinea pigs are known to be susceptible to at least some strains of S. pneumoniae when 
inoculated intracisternally (Edwards and Nairn, 1992). Three inocula were tested: (5.0, 7.5 
and 9.0 loglo CFU) and 7.5 loglo CFU was chosen for subsequent experiments (see results 
section 3.2.2). It was found that O. 1 ml was sufficient diluent to allow reliable injection so 
the final concentration of the inoculum was adjusted to 8.5 CFU/ml PBS. 
E. coli K-12 is a disabled laboratory strain which has poor serum survival and produces no 
known cytolytic toxins. As will be seen in section 3.1.2 it also survives poorly in the CSF 
space of guinea pigs. Previous work in the laboratory with a rabbit model of meningitis 
suggested that a high inoculum (9.0 CFU) would be necessary to generate a significant 
inflammatory response. Work by Levy et al (1978) showed that E. coli K-12 was 
approximately 1000-fold less virulent for mouse bacteremia than a virulent E. coli strain . 
Therefore an inoculum of 9.0 CFU total in 0.2 ml APL was used. 
2.2.3. Induction of meningitis 
Subarachnoid inoculation 
The anaesthetised, tracheotomized guinea pig was transferred to an electrically-screened 
and sound-proofed laboratory where all experiments were performed. Subarachnoid 
inoculation was favoured over intracistemal inoculation because the arachnoid membrane 
covering the cisterna tended to leak CSF once punctured and this would reduce the chance 
of organisms penetrating the inner ear. A midline incision was made extending from the 
vertex of the skull to the occiput. The periosteum was scraped clean with a scalpel and a 
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burr hole 1 mm in diameter was drilled in the outer table of the left parietal skull bone with 
a hand-held dental drill. The inner skull table was carefully pierced with a 25 G needle. A 
slight give could be felt as the subarachnoid space was entered. The inoculum (0.2 ml for E. 
coli, total inoculum organisms; modified to 0.1 mi for S. pneumoniae, total inoculum 
CFU) was gently instilled over 1 min. The needle was left in situ for 5 minutes and 
the drill hole then plugged with a smear of silicone sealant (this was found to adhere easily). 
No attempt was made to withdraw CSF from the drill hole and the injection was never 
forcible. 
The contiguity of this route of injection with the intracistemal route was verified on two 
guinea pigs after death by injecting methylene blue dye via the parietal skull drill hole. This 
flowed immediately through the punctured arachnoid membrane overlying the cisterna 
magna. 
Analysis of CSF and blood 
At the end of the experiment blood (1 mi) was taken by intracardiac puncture and serial 
dilutions prepared for viable counting. The cisterna magna was exposed by extending the 
midline scalp incision and dividing the recti from the occipital ridge. A 23G butterfly 
(Butterfly-23; Abbot Venisystems, Kent, UK) was used to pierce the arachnoid covering 
and up to 150 CSF withdrawn gently. The brain stem was then destroyed. CSF 
leukocytes were counted in an improved Neubauer chamber after suitable dilution and 
nuclear staining with a counting fluid (acidic crystal violet; see appendix A) (10 CSF in 
10 or 90 counting fluid). Another 10 aliquot of CSF was used to determine the 
viable bacterial count as above. The remainder of the CSF was centrifuged (13,000 g, 5 
min, 20°C) in a bench-top microfuge and the supernatant stored at -20°C or -70°C for up to 
four months prior to protein assay. Protein concentration was measured with a standard 
BioRad microassay (BioRad, Munich, FRG), a colorimetric dye-binding assay (Bradford, 
1976). The assay was run on four occasions. CSF ( 5  pi) was diluted in PBS (795 (Gibco 
042-04200), and BioRad Dye reagent (Cat no. 500-0006) (200 added. The optical 
density at 595 nm was read after 10 min incubation. A standard curve was constructed with 
bovine serum albumin (BioRad) (1 g/l to 10 g/l). A regression line was fitted using the 
LINEST function in Excel and used to calculate the approximate protein concentration of 
the CSF samples. 
Brain histology. 
In some experiments brains were removed, rinsed in 0.9 % w/v saline in 0.2 M phosphate 
buffer, fixed by immersion in 10% (v/v) formalin in 0.2 M phosphate buffer (see appendix 
A) and routinely processed through to paraffin wax. Sagittal sections ( 5  were cut, 
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mounted on glass slides, stained with haematoxylin and eosin, and examined with a Zeiss 
photomkroscope. 
Fixation of cochleas. 
Immediately after death both temporal bones were removed and the cochleas fixed as 
described on page 72. 
2.2.4. Hearing loss assessment 
The methods for assessment of hearing loss changed substantially between groups of 
experiments. In E. coli experiments, hearing loss was determined by click-evoked auditory 
brain stem response testing. In the initial pneumococcal experiments, tone-pip evoked brain 
stem response testing was used to give an estimate of hearing loss at both high and low 
frequencies. In the final technique the transducer was closely coupled to the meatus via 
hollow ear bars and the auditory nerve compound action potential (CAP) induced by a tone- 
pip was recorded from the round window membrane. The reasons for this evolution are laid 
out fully in section 3.2.3. A strict comparison of hearing loss between experimental 
pneumococcal and E. coli meningitis was not therefore possible. 
Click-evoked auditory brain-stem responses 
Auditory click-evoked brain stem responses were recorded using commercial clinical 
apparatus (The Screener, Medelec, Surrey, UK) originally designed for use with neonates. 
This is calibrated in terms of normal human threshold (nHL) and prints a paper strip bearing 
the evoked response tracing. The ear piece (Medelec) was coupled loosely to the external 
auditory canal with a neonata1 eartip. The reference electrode (a gold-plated Crocodile clip) 
was attached to the vertex and a good electrical contact ensured by using conducting jelly. 
Another gold-plated crocodile clip attached behind the stimulated ear served as the ground 
electrode. Clicks of 100 ps duration were presented at 10 Hz. Far-field Potentials were 
bandpass filtered (150 Hz-2 kHz). The sweep time was 12 ms and 1024 presentations were 
averaged. No attempt was made to mask the unstimulated ear. Because of the time taken 
for data acquisition and printing it was impractical to find the visual detection threshold and 
still be able to measure hearing every hour. Therefore a set of control readings were 
obtained for each ear at 60, 40, 20 and O dB above normal human threshold (nHL). Every 
hour thereafter the response to a 40 dB nHL stimulus was recorded in both ears. Later, all 
printouts were analysed without reference to the experimental conditions and compared 
with their respective controls. Hearing loss, expressed as dB, was defined as the difference 
between the applied stimulus and the stimulus which had produced the control trace most 
closely matching the experimental tracing. Selected printouts were scanned into an Apple 
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Mac Quadra 800 and digitised with "DataThief" software before illustrations were prepared 
with Deltagraph software (see fig 3.3). The designation of waves I to V was derived from 
Jewett and Williamson (1 97 1) and Buser and Imbert (1 992). 
Tone specific recording with a MacLab and PowerMac: general description of 
equipment. 
The equipment for recording tone-pip induced responses is shown in fig 2.1 and described 
below; the MacLab settings for recording evoked brain stem responses or round window 
compound action Potentials are given later. Sine-wave pure tones generated by a Farnell 
LFM-4 oscillator were gated by a home-made ramp-gate modulator. The onset of the pulse 
was phase-locked to O" with a rise and fall time of <0.1 ms. Pulses were attenuated with a 
variable attenuator (Hatfield Model 2109, amplified by a home-built low noise audio driver 
(Maplin LM505), and delivered to the ear by a Motorola piezo-electric ceramic transducer. 
Recorded Potentials were amplified by a FET headstage (NL100, Neurolog, UK) and an 
AC preamplifier (NL104, Neurolog) and filtered (NL1 15, Neurolog). Electronic data 
acquisition was performed with a MacLab 2e (AD Instruments, Australia) connected to a 
PowerMac 6100/60 (Apple, UK). A sweep was triggered by the outgoing pulse. Incoming 
amplified Potentials were recorded via the second input and stored for on-line averaging. 
The maximum time base with this equipment was 40 kHz over a 5 ms window. A standard 
oscilloscope (Telequipment D63, UK) monitored the outgoing pulse and incoming signal. 
Brain stem evoked responses. 
The guinea pig was anaesthetised, inoculated as above, and laid on the heating pad. The 
transducer was held in an adjustable clamp and coupled to the outer ear canal via 4 cm of 
plastic tubing and a neonata1 eartip. The tip rested at the entrance to the external ear canal. 
Tone pips (10 kHz or 1 kHz; 1 ms) were delivered at 10 Hz. Gold plated crocodile clips 
were positioned as for click-evoked response testing. To reduce stimulus artefact from the 
transducer, the transducer was screened with foil and a grounded wire mesh screen placed 
beneath the animal. Satisfactory signals were then obtained in single-ended mode rather than 
with common-mode rejection, with the active electrode at the vertex. Far-field Potentials 
were amplified 20,000 times, bandpass filtered (100 Hz-10 kHz) and notch filtered at 50 
Hz. The output was AC coupled to the MacLab with sensitivity set to 20 mV and 512 
sweeps of 10 ms were averaged. The resulting data were smoothed by the software (this has 
the effect of a low pass filter of approximately 5 MIZ at the time base used). If a poor signal 
was obtained 1024 or 2048 sweeps were averaged but this rarely improved the resulting 
waveform; careful attention to electrical connections and screening was always more 
rewarding. 
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This equipment was not formally calibrated in terms of sound pressure level so only relative 
changes in stimulus intensity were recorded. 
Recording the compound action potential from the round window. 
The guinea pig was anaesthetised and tracheotomized and the neck and skull shaved. A 
midline incision was made from the vertex to the occiput. Two 2 cm transverse skin 
incisions were made parallel to the occipital ridge. The temporalis and occipital muscles 
were reflected and the outer cartilaginous meati cut close to the skull with careful attention 
to haemostasis. The occipital ridge and the posterior ridges of both bullae were cleared of 
muscle attachments. The animal was transferred to a stereotactic frame (Bonetti) and 
secured with two custom-machined hollow brass ear bars which were inserted into the 
meati. These also served to earth the animal. Each bulla was opened with bone forceps at 
the posterior ridge at the level of the meatus and enough bone removed with dissecting 
forceps to gain a view of the round window. The defect measured approximately 5 mm x 5 
mm. Great care was taken to avoid damaging the tympanic membrane. With the dissecting 
microscope illuminating the bulla the tympanic membrane appeared transilluminated with 
white light. The presence of this white light reflex was checked before each recording to 
ensure fluid or blood had not accumulate on or behind the tympanic membrane. 
Silver electrodes (8 thou (203 in diameter) were coated with epoxylite insulating resin 
(EPR-4, Clark Electromedical, UK), soldered to stainless steel wire and mounted in a 
perspex holder. The electrode assembly was secured in a Bonetti micromanipulator and 
connected to the FET headstage in single-ended mode as above. The ground connection 
was made via the ear bars. Before each recording the round window membrane and middle 
ear cavity were carefully mopped dry with fine tissue wicks and the transducer was securely 
coupled to the ear bar with a 2 cm length of plastic tubing. Tone pips of 1 ms duration at 1 
kHz intervals between 3 kHz and 10 kHz were delivered at a rate of 10 Hz. The silver 
electrode was advanced so that the tip of the wire rested on the round window membrane. 
Potentials were amplified (x 20,000), bandpass filtered (100 Hz-6 kHz) and notch-filtered 
at 50 Hz. The output was AC coupled to the MacLab (set to a sensitivity of 2 V) and 16 
sweeps of 5 ms duration were averaged. The intensity of the stimulus was adjusted with the 
attenuator to give a mean peak to peak potential of the wave of 2 V, equivalent to 
100 at the electrode (see fig 1.1). The choice of criterion level is fully discussed in 
section 3.2.3. 
Cochlear microphonic. 
The cochlear microphonic could also be recorded from the round window electrode. Tone 
pips (3 kHz, 100 ms) were delivered at 2 Hz. The stimulus intensity was increased in 10 dB 
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steps from 82 dB SPL to 112 dB SPL. The CM was recorded as the mean peak-to-peak 
height of 4 sweeps in a 5 ms sweep triggered 5 ms post-stimulus. The maximum peak-to- 
peak CM amplitude was used for analysis. 
Calibration. 
The transducer/ ear bar assembly was calibrated with a Bruel and Kjaer amplifier (2606) 
coupled with plastic tubing to a microphone (B+K 4134) at the position of the tympanic 
membrane. At O dB attenuation and a stimulus of 4 V peak-to-peak, a 3 kHz tone yielded 
1 12 dB SPL re 20 and a 1 O kHz tone yielded 102 dB SPL re 20 
2.2.5. Rabbit meningitis. 
The rabbit experiments were performed in conjunction with Dr MP Osborne and Dr SD 
Comis to investigate whether the differences in hearing loss and ultrastructural damage 
observed between meningitis due to D39 and that due to PLN-A would be maintained in a 
different species. Animals were inoculated via a hole drilled in the skull exactly as for the 
guinea pig. Three rabbits were inoculated with wild type D39 (RAB 36-RAB 38) and three 
rabbits were inoculated with pneumolysin-deficient S. pneumoniae (RAB 39-RAB 4 1) 
(PLN-A). Hearing was assessed by recording click-evoked brain stem auditory responses 
with the Medelec Screener. Rabbits were killed between 10 and 11 h after inoculation. A 
terminal CSF sample was taken when possible and the cochleae fixed exactly as for the 
guinea pig, albeit after a more difficult dissection. Blood samples were not taken. Results 
are shown in section 3.9 and table 3.17. 
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2.3. Cochlear perfusion 
2.3.1. Experimental design 
In this series of experiments the effect of microperfusion of live bacterial suspensions 
through the scala tympani was investigated. The aims were: 
i) to investigate whether suspensions of live bacteria were directly ototoxic and if so over 
what time course; 
ii) to investigate whether pretreatment of the animal with bacteriolytic antibiotics would 
exacerbate any ototoxicity by releasing cell wall material and intracellular toxin (the so- 
called antibiotic-induced inflammatory burst). 
Groups of guinea pigs were compared as follows: 
2.3.2. Preparation of the animal 
The inferolateral approach to the cochlea has been fully described by Comis and 
Leng (1979). Guinea-pigs were anaesthetised and tracheotomized as described above. The 
area over the left mandible and the whole of the neck was shaved. An incision was made 
along the inferior margin of the left mandible extending to the angle of the jaw, dividing the 
left masseter to reach the mandible. All the muscles attached to the left mandible were 
cleared and the mandible removed. The left bulia was exposed by blunt dissection beneath 
the styloid and digastric muscles. The meati were exposed and sectioned as described above 
(round window recording, page 67). The arachnoid membrane covering the cisterna magna 
was exposed and slit with a sterile 19 G needle to reduce CSF fluid flow through the 
opened cochlea (see discussion). The animal was mounted left side uppermost in a 
stereotactic frame and held by hollow brass ear bars inserted into the meati. The styloid 
process was removed and the bulla cautiously opened at its lower margin with artery 
forceps. A window was cut in the bulla sufficient to expose the cochlea. A hole 50 in 
diameter was drilled in the basal turn of the cochlea 2 mm from the round window and a 
hole about 100 in diameter was drilled at the apex to allow the perfusate to escape. A 
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machine-pulled tapered glass recording pipette containing a platinum wire electrode was 
filled with APL with the aid of a Treonic microinfusion pump (IP-3), and mounted in a 
Bonetti micromanipulator. The inoculum was drawn into a 1 ml syringe which was mounted 
in a home made micrometer device and attached to a second micropipette by a short length 
of plastic tubing. The bacterial suspension (10 was perfused into the scala tympani over 
1 min. For E. coli experiments the concentration of the inoculum was 5 x organisms/ml 
(amount delivered = 5 x organisms); for S. pneumoniae experiments the concentration 
was 5 x CFU/ml (amount delivered = 5 x CFU). Immediately after perfusion, the 
micropipette was removed and the recording pipette was inserted in the basal hole. Because 
of the taper a good seal was usually obtained and little perilymph escaped. Recordings were 
normally first obtained within 5 min of perfusion. The best recording achieved in the first 20 
min after perfusion was taken as the baseline. Measurements were then made every 20 min 
for the first hour, and every 30 min for the remaining 2 h. The experimental (left) cochlea 
was then fixed in vivo as described below (page 72). 
2.3.3. Recording techniques 
The equipment for delivering the tone pips was identical to that described above. The 
transducer was coupled to the ear bar with a 5 cm length of rubber tubing. The CAP was 
elicited with a 10 kHz, 1 ms tone pip delivered at 1 Hz. Potentials at the pipette tip were 
amplified by an identical system. The peak to peak height of the wave of the CAP 
was measured on an oscilloscope (Teleequipment D63, UK) or by computer averaging as 
described above and a value of 2 V taken as the reference (equivalent to 100 at the 
pipette tip); this is approximately 14 dB above the visual detection threshold (Comis et al 
1993). Before each reading the bulla was carefully mopped dry. The CAP loss (and for 
brevity in description, hearing loss) was defined as the dB increase in the intensity of the 
stimulus needed to restore the height to the reference value. 
The CM was elicited with a 5 kHz, 500 ms tone pulse. Data were stored on a Gould digital 
storage oscilloscope (Model 1602) and four tracings averaged. Stimulus response curves 
were plotted in 10 dB steps and the maximum peak-to-peak CM amplitude was used for 
subsequent analysis. The shape of the stimulus-response curve was altered if there was a 
conductive deafness (e.g. bleeding onto the tympanic membrane) and such guinea pigs were 
not included in the electrophysiological analysis. 
The equipment was calibrated as described above (page 68). A 5 kHz tone yielded 129 dB 
SPL re 20 a 10 kHz tone 110 dB SPL re 20 
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2.4 Electron microscopy and photo-micrography 
2.4.1. Fixation 
A 1 ml syringe was filled with ice-cold fixative (buffered 2.5% glutaraldehyde; see appendix 
A), mounted in a home-made micrometer device, and connected to a glass micropipette via 
Polyethylene tubing. In cochlear perfusion experiments, the left cochlea was intravitally 
fixed by perfusing 100 fixative via the drill hole in the basal turn. The brain stem was then 
destroyed. Both temporal bones were removed shortly after death and the bullae opened 
carefully with bone forceps. The apex of the right otic capsule was sectioned with a scalpel. 
and the scala tympani of the right cochlea was perfused via the round window with 100 
fixative. Both temporal bones were then immersed in fixative. In meningitis experiments 
both cochleas were fixed in this way immediately after death. 
2.4.2. Scanning electron microscopy. 
Specimens were fixed in glutaraldehyde for at least one week. Some specimens were 
prepared for scanning electron microscopy (SEM) after post-fixation with 1% osmium 
tetroxide (see appendix A) for 15 min. The modiolus was dissected out and trimmed above 
the second turn. Batches of eight to ten cochleas were dehydrated in graded acetone 
dilutions (1 h each in 50%, 70%, 80%, 90%, 95%, 100%, 100% (v/v) in Great care 
was taken to avoid premature drying. The modioli were critical point dried in liquid 
(Emscope CPD750 or Polaron E3000). Specimens were attached with Araldite (apex 
upright) onto copper SEM holders, sputter coated with platinum (Emscope SC500) and 
examined in a JEOL 120CXII TEM fitted with a TEMSCAN scanning attachment. Images 
were obtained with a secondary electron detector and accelerating voltage of 40 kV. 
Photomicrographs were taken onto Kodak Pan-X roll film. To examine the under surface of 
the basilar membrane (bordering scala tympani), specimens were carefully prised off the 
SEM holder, inverted, and remounted so that the basal surface of the first cochlear turn was 
upright. The specimen was then recoated with platinum. 
2.4.3. Transmission electron microscopy. 
For transmission electron microscopy (TEM) the modiolus was fixed in 2.5% (vh) 
glutaraldehyde (see appendix A) overnight then post fixed in 0.1% osmium tetroxide (see 
appendix A) for 15 min. A wedge of the organ of Corti was cut from the from the basal 
turn. This was dehydrated in graded ethanol dilutions (15 min each in (v/v) 70%, 90%, 
100%, 100%, 100% dried) and transferred to propylene oxide (15 min x 2). The specimen 
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was immersed in a 1 : 1 solution of Epon-substitute resin (see appendix A) and propylene 
oxide for 1 h then vacuum embedded in resin overnight at 80°C. Semi-thin sections were 
cut at 1 dried onto glass slides, stained with 1% toluidine blue and examined with phase 
contrast in a Zeiss photomicroscope. All bone was trimmed away. Ultrathin sections were 
cut at 90 nm with a diamond knife, mounted on Formvar-coated grids and stained with 
uranyl acetate and lead citrate in an Ultrostainer. They were examined with an accelerating 
voltage of 80 kV in a JEOL 120CXII TEM and photomicrographs taken onto cut film. The 
rest of the modiolus was usually prepared for scanning electron microscopy although as 
osmication alters the appearance of the stereocilia the results obtained were not as good as 
processing the whole modiolus for SEM. (Osborne et al 1984). 
2.4.4. Image processing 
Photomicrographs were processed with standard photographic techniques. Illustrations for 
publication were prepared on a Macintosh Quadra 800. Black and white enlargements (6 x 
4 in) were scanned into Aldus Photoshop using a flat-bed Mirror 600 scanner and enhanced 
as necessary to improve contrast. Scale bars and markers were added in Aldus Freehand and 
the final composite illustration output on a photographic quality dye sublimation printer. 
2.5 Data analysis 
For the final comparative study, data analysis was performed with Microsoft Excel v4.0 
(means, confidence intervals) and Arcus Pro-Stat v3 .01 (checks for normality, comparisons 
of means and medians, linear regression and analysis of covariance, correlation). Confidence 
interval analysis was preferred as this gives more information about the size of differences 
between groups and is less reliant on an arbitrary P value. In brief, the 95% confidence 
interval of the difference between the two sample means is the range of values in which it is 
95% certain the true difference between the populations should lie. Confidence interval 
formulae were derived from Gardner and Altman (1989) p 21: 
to 
where SE is the standard error of the mean and is the appropriate value from the t 
distribution with n - 1 degrees of freedom associated with a confidence of 100( i-a)%. In 
an Excel worksheet this is rendered as the following formula: 
where B3:K3 contain the data and the result is the 95% CI for the mean of that data. 
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Data were tested for normality with the Shapiro-Wilk 
the null hypothesis was that there was no difference 
test. For comparison between groups, 
expected in any parameter measured. 
The major quantitative endpoint in the meningitis model was the difference between hearing 
loss (judged by CAF' recording) induced by D39 wild type and that induced by the isogenic 
mutants (PLN-A, at 10 kHz and 3 kHz. CAP losses all fitted a normal 
distribution. Independence between left and right ears within each group was confirmed 
with Spearman's rank correlation coefficient (p) so the data were pooled. Differences were 
compared by Student's t-test if the variances were similar or a Mann-Whitney test if 
variances were unequal. The minimum number of significance tests was performed and 
hearing loss was not compared between groups infected with the different mutants. 
Confidence limits at 95% significance (or as close as possible for the Mann Whitney test) 
for the difference between the means were calculated using Arcus ProStat. Normal data for 
the audiograms were expressed as means with 95% confidence limits. 
Quantitative bacterial counts and CSF white cell counts were log transformed and the 
geometric mean calculated. Significance was assessed by Student's t-test. Protein 
concentrations did not normalise with log transformation; the geometric mean is however 
given. Significance was assessed by the Mann-Whitney test. 
Cochlear microphonic loss was non-normal and not log-transformable. The significance of a 
difference between the medians was compared with a Mann-Whitney test. The relationship 
between CM loss and CAP loss was assessed by calculating Spearman's rank correlation 
coefficient (p). 
Non-normal data were obtained from auditory evoked response testing in the rabbit 
experiments (these results were discontinuous variables of O, 20, 40, 60 or 80 dB loss). 
Medians were compared with the Mann-Whitney test and an approximate 95% confidence 
interval calculated. 
In the cochlear pertusion study, the main endpoint was the difference in CAP loss at 10 kHz 
3 h after pertusion between the 4 groups of guinea pigs (E. coli; S. pneumoniae with or 
without cefotaxime or amoxycillin pretreatment). Comparisons were with multiple t-tests. 
The rates of change of CAP loss over time during the period 60-180 min were tested for 
linearity and analysed by group linear regression and variance to determine whether the 
slopes were significantly different. 
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3. EXPERIMENTAL MENINGITIS. 
3.1. E. coli K-12 meningitis. 
3.1.1. Overview 
This section includes data obtained from the experiments where meningitis was induced by 
subarachnoid inoculation of E. coli K- 12. Experiments were numbered sequentially as they 
were performed as K-12 (n). Some animals received cefotaxime (100 mg/kg or in two cases 
10 mg/kg) i.p. 3 h after inoculation; for ease the two groups are sometimes referred to as 
“treated” and “untreated”. In the tables, data is given in order of duration of the experiment, 
Because these were the first meningitis experiments performed some techniques were not 
optimised, and several of them (particularly for electrophysiological recording) were 
improved for the pneumococcal meningitis studies. The CSF data were subsidiary 
endpoints, and no attempt has been made to group or analyse the data statistically. 
These initial experiments were highly investigative with no particular defined endpoints. 
Animals were studied until they succumbed to meningitis, or hearing loss became profound. 
It must be emphasised that all animals remained deeply anaesthetised. Early deaths (before 
4 h) were due to respiratory arrest and occurred in five of 12 untreated animals. In later 
work, the initial urethane bolus was given in two divided doses separated by 10 min and the 
tracheal cannula was kept meticulously clear of secretions. The use of a stereotactic 
apparatus to support the animal’s head in subsequent pneumococcal meningitis experiments 
also helped to reduce this early mortality. Late deaths (>4 h) occurred in two of five 
untreated animals and two of 10 treated animals. These deaths were assumed to be due to 
overwhelming infection as before death the respiration rate and heart rate became irregular 
and sometimes terminal convulsive movements were observed. 
3.1.2. Bacteriological preparation and CSF bacterial counts. 
The inoculum of organisms was chosen because in the rabbit meningitis model this 
caused cochlear damage without killing the animal (Osborne et al, 1995). A fresh log-phase 
culture was prepared on the morning of each experiment (animals were normally used in 
pairs) and the bacterial concentration adjusted to after counting organisms. Viable 
counting of serial dilutions of the inoculum on one occasion confirmed the count to be 9.1 
CFU/ml, some 0.6 log units below that intended. It was assumed this would make 
little difference to the course of meningitis. In this initial work viable counting of the 
inoculum was not routinely performed for each experiment. The surface of the brain beneath 
the drill hole was inspected in several animals at the time of dissection, and on only one 
occasion was the drill seen to have penetrated the cortex. To prevent this in later 
experiments the drill was used to breach the outer skull table and the final penetration was 
performed with a 25G needle. To prevent organisms escaping the drill hole was sealed after 
inoculation. The best material for this proved to be a small plug of silicone sealant. 
In most experiments a terminal CSF sample was obtained. Various venepuncture devices 
were tried but the optimal yield with minimal blood contamination was obtained by cisternal 
puncture with a 23G 'Butterfly' winged infusion device with the bevel inserted uppermost. 
Blood sampling for estimation of bacterial concentration was not performed for E. coli 
infection. 
Bacteriological data for individual experiments are shown in table 3 .1  and table 3.2 and 
displayed in fig 3.1 (page 83). Three points need emphasising. 
(i) Organisms were recovered from the cisternal CSF 2 h after subdural inoculation. This 
confirmed the contiguity of the subarachnoid and cisternal CSF spaces and means that 
organisms inoculated via a skull hole quickly established infection in the ventricular 
system. The volume of CSF in the guinea pig has not been documented to my 
knowledge; a working assumption of approx. 1 ml was used in this study. With an 
inoculum of ca. 9.0 log total CFU, a cisternal CSF concentration 2 h post-inoculation 
of 9.4-9.6 log CFU/ml is about that expected. 
(ii) The data constitute reasonable evidence that E. coli K-12 does not survive in the CSF 
space. Analysis is difficult because viable counts were not performed on the inoculum 
in each experiment, but the viable count trend seems to be downwards. This is not 
surprising in view of the relatively apathogenic nature of E. coli K-12 (see section 
5.1.1). 
(iii) Cefotaxime treatment seemed to reduce the viable count as expected (fig 3.1), 
although viable organisms were still recovered 3 h after treatment. 
3.1.3. Inflammatory response 
In spite of the decline in viable bacteria over time, in seven of nine untreated cases and all 
the treated cases the infection induced a CSF inflammatory response (fig 3.2 on page 84). 
All animals that survived longer than 6 h had an elevated CSF leucocyte count and a raised 
CSF protein concentration. Only a few protein assays were performed at this early stage. 
Data were insufficient to show any effect of antibiotic treatment on these inflammatory 
indices. Histological examination of two brains confirmed the presence of a severe 
leptomeningitis with acute inflammation extending into the lateral ventricles (not shown). 
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3.1.4. Electrophysiological data. 
In this initial work, the intention was to perform hourly recordings of hearing loss. A typical 
set of brain-stem auditory evoked responses from expt K12 (18) is shown in fig 3.3 
(page 85) .  The control traces were taken just before inoculation. These were then compared 
with the traces acquired 6 h post-inoculation. In the L ear (top) the 40 dB response at 6 h is 
clearly diminished, and resembles the 20 dB control response. However, in the R ear the 40 
dB trace is identical at O h and 6 h. The hearing loss was therefore estimated as 20 dB (L) 
and O dB (R). For every experiment at each timepoint, a similar process yielded an 
approximate hearing loss. The endpoint data for all experiments are recorded in tables 3.1 
and 3.2. 
There were three major problems with using the Medelec Screener 
(i) It required about 30 min to acquire a set of readings, even with a large stimulus step of 
20 dB. This was due to the number of repetitions required for averaging and the slow 
printout. In addition, the transducer was sometimes dislodged by small animal 
movements. Using a narrower interval ( 5  or 10 dB) would have increased accuracy but 
rendered it impossible to measure hearing more frequently than every 3 h. 
(ii) The estimation of hearing loss is very imprecise because of the large stimulus step and 
the crude method of visual comparison used to detect differences between traces over 
time. 
(iii) A click stimulus contains a broad frequency spectrum and stimulates a large proportion 
of the cochlea. Click-evoked responses are an insensitive way of detecting mild to 
moderate hearing loss. Conversely, a 40 dB loss to an auditory click represents quite 
profound hearing impairment. 
In the untreated group there was no significant hearing loss until 6 h post inoculation. Only 
one of five animals surviving over 6 h lost 40 dB or more (a total of 2 out of 10 ears). In the 
group which received cefotaxime (100 mg/kg) three of five animals surviving more than 6 h 
lost 40 dB or more (in a total of 4 out of 10 ears). There was no hearing loss in one control 
animal (K- 12(2 1)) studied for 7 h. No attempt was made to perform formai linear regression 
on the hearing loss data. Figure 3.4 (page 86) displays the hearing loss between 4 h and 7 h 
(as a scatter plot) for animals surviving 7 h or more. There is an impression that treated 
animals lost hearing earlier than untreated animals. 
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3.1.5. Ultrastructural findings (organ of Corti). 
The tables give a brief summary of the main histological findings in each experiment and 
plates 3.1  to 3 . 7  show the various lesions discussed. There were no clear differences in the 
pattern of damage observed in the treated and untreated groups, nor was there a consistent 
correlation between degree of damage observed and hearing loss as judged by click-evoked 
BAEP recording. Artefactual change caused by processing was limited to cracking deep in 
the inner sulcus, where the whole organ of Corti tended to curl away from the modiolus 
(plate 3 2). This was easily distinguishable from the specific damage seen after meningitis. 
Ultrastructural changes were usually confined to the basal turn with substantial portions of 
the organ of Corti remaining intact as judged by SEM (plates 3.1, 3.2).  Three types of 
damage were observed: 
• 
• 
Cratering of the apical surface of the border cells (BCs). 
Damage to IHC hair bundles with detachment and fusion of stereocilia. 
• 
Surface craters of the apical surface of the border cells were apparent by 5 h p.i. and were 
the commonest abnormality seen (plates 3 .4  and 3.5). The craters were shallow circular 
defects with intracellular contents sometimes visible through the defect. They occurred less 
frequently than after pneumococcal meningitis (see section 3 .2 .4  and plate 3.19). The fine 
craters suggest genuine damage to the border cells. Such shallow lesions were never 
observed in control specimens both from this series and other work not shown here. 
The hair bundles of IHCs adjacent to these craters were usually deformed, with fusion, 
splaying and detachment of stereocilia complete with rootlets (plates 3 .3  & 3.4). It is 
possible that such detachment could be an artefact of processing. Stereocilia that are 
embedded more firmly than normal in the tectorial membrane would be more prone to 
detach when the tectorial membrane rolled back. 
Some sporadic damage to OHCs. 
Abnormal OHC hair bundles were rarely found. Stereocilia were sometimes splayed apart or 
fused together, particularly in the longer experiments. A single TEM study was performed 
on the longest surviving animal, K-12 (5) (plates 3 .6  and 3.7). Initial semi-thin sections 
demonstrated occasional darkened OHCs in both row 1 and row 3 .  At higher magnification 
some row 3 OHCs appeared electron dense and contained vacuoles. Mitochondria in the 
nerve endings at the base of these cells were also vacuolated. At all levels examined normal 
outer hair cells with well preserved nerve endings could also be found. Similar but more 
severe damage was also seen after pneumococcal meningitis (see for example plates 3 . 3 2  
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and 3.57) but in E. coli meningitis the apical surface of the sensory cells remained intact and 
none of the cells were torn away from adjacent supporting cells. 
One of the most remarkable findings was the absence of inflammation and bacterial invasion 
of the scala media, given the huge number of organisms present on the undersurface of the 
basilar membrane (see below). No leukocytes were ever seen in scala media. Only one or 
two organisms were ever identified on the apical surface of the organ of Corti (not shown). 
As far as could be judged by the SEM and limited TEM data, the reticular lamina and the 
junctions between the hair cells and neighbouring phalangeal cell processes remained intact. 
This clearly represents a formidable barrier to invading organisms. 
3.1.6. Ultrastructural findings (basilar membrane and bacteria). 
Bacteria reached scala tympani within 3 h of inoculation into the CSF and were able to 
induce a local inflammatory response. On the surface of the basilar membrane bordering 
scala tympani there was patchy but dense bacterial infiltration from 3 h p.i. onwards (plates 
3.8 and 3.1 O). In untreated animals, E. coli appeared as regular bacilli approx. 1.5 x 
0.5 with a roughened cell surface and variable projections. They were normally 
clustered in microcolonies. Bacterial density was greatest in the basal turn and declined 
towards the apex. The surface of the basilar membrane itself consisted of a connective tissue 
meshwork with many cribriform pores and was undamaged in all animals. 
From 5 h onwards leukocytes were seen associated with the basilar membrane but were 
never numerous (plate 3.9). However, free floating white cells in perilymph would have 
been flushed out during fixative perfusion. The leukocytes appeared to be phagocytosing 
bacteria. Macrophages were rarely seen. 
3.1.7. Effects of cefotaxime on the SEM appearance of E. coli. 
There are few published pictures of the in vivo appearance of antibiotic-treated organisms, 
although the in vitro morphological effects of beta-lactam antibiotics on Gram-negative 
organisms are well documented (Greenwood, 1982 p11-26) . Differences between in vivo 
and in vitro effects might be expected for two main reasons (Comber et al 1977): 
In vivo organisms are exposed to a continuously changing concentration of antibiotic 
after administration of a single bolus. In vitro organisms are exposed to a constant 
antibiotic concentration. 
• Organisms in vivo are growing in a hostile environment and may be expressing 
different enzymes and cell wall constituents to those expressed by organisms growing 
in a rich nutrient broth. 
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M e r  treatment with cefotaxime (100 mg/kg body weight) there were gross changes in the 
SEM appearance of E. coli K-12 within the scala tympani. It was not possible to correlate 
the morphological changes with local antibiotic concentration. Cefotaxime (1 00 mg/kg) was 
administered 3 h post-inoculation and plates 3.11 to 3.16 are arranged in chronological 
order. 
One hour after treatment most organisms were elongated two to three times and had failed 
to separate completely during attempted cell division (plate 3.1 1). Plate 3.12 shows this 
effect more clearly 2 h after treatment, where so-called 'blunt constrictions' have appeared at 
the sites of attempted cell division. This implies there is predominant inhibition of penicillin- 
binding-protein (PBP) 3, which is needed to manufacture the spherical mucopeptide which 
forms the end-cap of the organism (Nanninga, 1985 p104). In addition, irregularities, blebs 
and grooves in the cell wall are also apparent (plate 3.13), which are features of inhibition of 
PBP 1 a, 1 b and 2, all partly responsible for formation of the cylindrical mucopeptide used in 
the rest of the cell wall (Spratt, 1975; Nanninga, 1985 p105). Three hours after treatment 
the surface of nearly all organisms was grossly deformed and convoluted, and many 
organisms appeared to be lysed leaving large quantities of cell debris on the surface of the 
basilar membrane (plate 3.14 and 3.15). Five hours after treatment most organisms 
appeared to be normal, but some still had obvious deformities (plate 3.16). 
Plates 3.17 and 3.18 show the effect of giving 10 mg/kg cefotaxime 3 h after inoculation. 
Three hours after treatment, this lower dose of antibiotic induces extensive long chain 
formation and the formation of blunt constrictions but does not damage the rest of the 
bacterial cell surface. This suggests that PBP3 inhibition is predominant at this dose. 
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CSF bacterial titre 
Figure 3.1: E. coli K- 12 meningitis: CSF bacterial concentration. 
Viable counts were performed on terminal CSF samples. 
Cefotaxime=cefotaxime 100mg/kg i.p. 3 h post inoculation. 
Inoculum was nominally organisms. 
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CSF white cell count 
Figure 3.2: E. coli K-12 meningitis: CSF white cell count. 
White cells in terminal CSF samples were stained and counted microscopically 
Cefotaxime= cefotaxime 1 00mgkg i.p. 3 h post inoculation. 
Inoculum was nominally organisms. 
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Figure 3.3: E. coli K-12 meningitis: click-evoked brain-stem auditory responses. 
Expt K-12 (18). Waveforms generated by the Medelec Screener were scanned, digitised and 
printed. Hearing loss was determined by visual comparison of control and final waveforms. 
O dB stimulus = normal human threshold (dB nHL) 
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Hearing loss (evoked response) 
Figure 3.4: E. coli K-12 meningitis: Summary of hearing loss. 
Estimated hearing loss over time in animals surviving at least 7 h. Treated animals received 
cefotaxime (100 mg/kg) 3 h post inoculation. 
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3.2. Pneumococcal meningitis: development of recording techniques. 
This section reports the preliminary part of the investigation of experimental meningitis 
induced by wild type S. pneumoniae D39. The main aims of this initial work were: 
• 
• 
to ensure that pneumococcal meningitis could be reliably induced in the guinea pig; 
to find an inoculum that was sufficient to cause hearing loss but that did not cause early 
death; 
• 
• 
to optimise the recording techniques for measuring hearing loss; 
to document the evolution of cochlear lesions over the first 12 hours of experimental 
meningitis. 
3.2.1. Bacteriological preparation and findings. 
Preparation and viability of the inocula 
The modified technique of Alwmark (1981) for preparing standard inocula of 
S.pneumoniae had been used by Dr Mitchell et al in Leicester for their work on 
experimental pneumococcal pneumonia in the mouse (Canvin, 1995). Inocula prepared in 
Leicester were readily transported on dry ice back to Birmingham, with suitable 
precautions. The only additional modification necessary to prepare inocula for experimental 
meningitis was to change the final diluent to PBS or (in some cases) filter-sterilized artificial 
perilymph. The pellet was typically resuspended in 700 to 1,400 (depending on viable 
count). Initial viable counts on each batch were always performed after storage at -70°C for 
at least 24 h. There was no noticeable decline in viable count over a period of 2-3 months, 
at which time inocula were discarded. The first batch (Batch A) had a count of 8.7 
log,, CFU/ml, and was used in the experiments reported in this section. 
The viable count of the inoculum was also determined in every experiment. The inocula 
were easily reproducible, varying between 7.1 and 7.5 log,, CFU. This confirmed the 
practicability of the modified Alwmark method, and the validity of the drop count method 
used to perform viable counting. A further benefit of the Alwmark method was that it took 
less than 20 min to prepare the inoculum, whereas to prepare a fresh log-phase culture of 
E. coli took around 4 h. This meant that for pneumococcal meningitis, animals could be 
inoculated by 9 am. In addition, the bacterial count did not significantly decline if the final 
inoculum was stored on ice for up to 3 h. so that two animals could be inoculated some 
time apart if necessary. 
The in vitro growth curve of D39 is shown in figure 3.29 (page 185). Organisms harvested 
at 5 h are in late log phase. Inoculation of a small quantity (100 into the CSF space (CSF 
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volume assumed to be 1 ml) should give a final concentration in the CSF similar to 
found in mid-log phase. In vivo growth curves were not constructed. 
CSF bacterial counts and bacteraemia 
Table 3.4 lists all data obtained from the CSF and blood samples of experiments D39( 
D39(13) in order of duration of the experiment. (Experiment D39(7) was used primai 
develop the round window recording technique and no CSF sample was taken.) The CSF 
bacterial count in animals inoculated with batch A was in all cases higher than the initial 
inoculum (assuming approximate CSF volume of 1 mi). This is reasonable evidence of in 
vivo growth. All animals in which a terminal cardiac blood sample was taken were 
bacteraemic, even as early as 4.5 h post inoculation. 
Passaging 
Batch A was prepared from organisms isolated from the blood of an MF1 mouse 48 h after 
intraperitoneal inoculation of stock D39. Such a passaging step had proved necessary for 
maximum virulence in the pneumonia model, where organisms are inoculated per-nasally. 
We did not want to use guinea pigs for such a passaging step for several reasons (ethical, 
financial, need for a license modification) and in any case it was not certain whether a 
similar stricture would apply to meningitis. To investigate this, batch C was grown from 
organisms recovered from the CSF of experiment D39(8) and used in experiments D39(10) 
and D39(11). Batch D was subcultured from Batch C and used in experiment D39(12). The 
final CSF bacterial count was in all cases was the about the same as or lower than the initial 
inoculum, although all animals developed a CSF leukocytosis. (Compare for example 
D39(10) (Batch C) with D39(6) (Batch A), both at 10 h post inoculation). These findings 
underlined the importance of using mouse-passaged organisms. This is not unexpected, 
although it is only possible to speculate what additional virulence factors are expressed by 
organisms having to invade the bloodstream from the peritoneum. For subsequent 
experiments in the comparative study all inocula were prepared in Leicester by passaging. 
3.2.2. Inflammatory response. 
Dose finding experiments. 
The first three experiments suggested that an inoculum of 7.5 log,, CFU would induce CSF 
leukocytosis yet allow animals to survive for 12 h (D39(2)). An inoculum of 9.0 log,, CFU 
(D39(3)) was fatal by 6 h post inoculation (p.i.). In addition, organisms at this concentration 
are unlikely to enter log-phase growth. An inoculum of 5.0 log,, CFU (D39(1)) evoked a 
minimal CSF leukocytosis (100 9 h p.i. No further dose finding experiments were 
performed. 
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CSF inflammation. 
In all cases inoculation of live S. pneumoniae D39 into the subarachnoid space provoked a 
CSF leukocytosis as early as 4.5 h after inoculation, as detailed in table 3.4. CSF protein 
concentrations seemed to be more variable, and not always consistent with the degree of 
CSF leukocytosis. Because of the variability in batches of inocula used this is not a firm 
conclusion. These experiments confirmed the feasibility of performing a comparative study 
with CSF data as subsidiary endpoints, and allowed refinement of the techniques used. 
3.2.3. Electrophysiological data and development of techniques. 
This section describes the development of the techniques used to investigate hearing loss. It 
may be helpful to refer to methods section 2.2.4. Upgrading to the MacLab system brought 
two benefits: 
• 
• data were acquired much faster and already digitised enabling rapid on-line 
the evoked response to pure tones could be measured; 
measurement of wave height and latency. 
Tone-pip ramp time and frequency specificity. 
Compound action Potentials are frequency dependent when evoked by low to moderate 
intensity tonal stimuli (Eggermont et al, 1976). In order to obtain a frequency-specific CAP, 
the stimulus administered must trigger only that restricted population of nerve fibres tuned 
to that frequency. At high sound pressure levels, other fibres contribute to the CAP, so 
diminishing selectivity. The traditional tone stimulus has a trapezoidal envelope to reduce 
spectral 'splatter' associated with a fast rise time (the faster the rise time the more the wave 
resembles a transient click stimulus). The ramp-gate modulator had been custom built to 
deliver a ramp time of <0.1 ms. Frequency specificity was investigated by averaging eight 
tone-pips (1 ms duration ) and subjecting them to fast fourier transform analysis at a time 
base of 40 kHz with the (default) Hamming window setting. Figure 3.5 (page 105) shows 
the power spectra of the unramped tone pips used in the final comparative study. Table 3.3 
and figs 3.6 and 3.7 show that addition of a 0.5 ms ramp apparently improved frequency 
selectivity by 18 dB at both frequencies tested. But it is the initial aspect of the waveform 
that determines which fibres contribute to the CAP, and the addition of a 0.5 ms ramp 
decreased the 100 threshold (see page 101) by at least 10 dB (presumably by 
diminishing synchronous firing). This problem was noted by van Heusden et al (1 98 1) when 
recording CAPS in cats. They found that a gradual onset tone produced smaller and wider 
A P s  with a longer latency, and preferred the use of rapid onset tones. 
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Evoked responses. 
Two problems remained with the evoked response technique: 
(i) Accuracy of threshold determination. A typical set of evoked response waveforms 
(from experiment D39 (2)) is shown in fig 3.8.  Threshold determination here is still a 
matter of judgement by eye. The baseline visual detection threshold is clearly below 20 
dB SPL, but the visual detection threshold at 12 h can only be approximately placed 
between 40 and 60 dB SPL. Note also that the height of the largest wave (wave III) is 
about an order of magnitude lower than the brain-stem evoked Potentials obtained in 
response to an auditory click (compare fig 3.3). 
(ii) Time to acquire data. Although the new equipment obtained readings more quickly 
than with the equipment used for the E. coli study, stimulus steps were still limited to 
1 O dB because at least 5 12 stimuli were needed for averaging. 
Fig 3.9 demonstrates the course of hearing loss in expt D39(6), where these two factors 
combine to give a rather coarse assessment of hearing loss, with apparent baseline wander 
in the left ear, and swings of 10-20 dB between consecutive hours. Could quantitative 
analysis of the evoked response waves improve this situation? Baseline wander was initially 
attributed to the insecure coupling between the earpiece and the meatus. This problem was 
overcome by surgically exposing the meatus as for round window recording, and coupling 
the transducer to the meatus via hollow ear bars. Brain-stem evoked response testing and 
round window recording of the compound action potential (see below) were then 
compared. In expt D39(1 1), the stimulus needed to maintain the CAF' was unchanged over 
a period of three hours at 70dB SPL (10 kHz). But figure 3.10 shows that the height of 
evoked response wave III (the largest wave) fell from 1.4 to 0.6 over the same 
period. However the height of Wave I at the same stimulus intensity rose from 0.6 to 
0.8 It is likely that the change in evoked response Potentials in the face of an 
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unchanging auditory nerve compound action potential reflects changes in brain stem 
activation particularly as the waves changed in different directions. Although these changes 
seem large they were most pronounced with loud stimuli and were less important with 
quieter stimuli. For example, the stimulus intensity required to maintain the height of wave 
III of the BAEP at 0.5 rose from 52 dB SPL to 62 dB SPL over this same time period. 
Latency analysis proved to be of little additional benefit in defining a criterion level. Wave 
latency is inversely proportional to sound intensity (data not shown). However this 
relationship flattens off at low stimulus intensity, making it difficult to define a stimulus level 
precisely with respect to a reference latency. 
In the face of such wide variability in evoked response Potentials with a constant CAP, 
quantitative analysis seemed to offer little improvement over 'eyeballing' the BAEP 
waveform. The anticipated difference in hearing loss between the wild-type pneumococci 
and virulence-deficient mutants was around 30-50 dB. The lack of precision of brain-stem 
evoked response testing would have required many subjects in each group to demonstrate a 
statistical difference satisfactorily. An alternative technique was therefore developed. 
Round window recording. 
The final method chosen was to record the auditory nerve compound action potential from 
an electrode positioned on the round window membrane. The height of the wave was 
recorded (see fig 1.1). Several advantages accrued: 
• Firm coupling between the transducer and the meatus eliminated one source of 
variability 
• The response of the cochlea alone was measured with no possibility of interference 
from the opposite ear or from the effects of CSF inflammation on the brain stem. 
Therefore any hearing loss observed could confidently be ascribed to cochlear damage. 
• As discussed below, the 'auditory threshold' could be determined to ± 1 dB SPL and 
more frequent readings were possible. 
Animals supported in a stereotactic apparatus appeared to have far fewer respiratory 
problems and therefore longer experiments could be conducted. 
• 
Some disadvantages were encountered: 
• Accumulation of fluid in the middle ear cavity and particularly on the round window 
membrane itself proved to be troublesome. 
The round window membrane was inadvertently punctured on a few occasions. 
Formation of a CSF/perilymphatic fistula would obviously affect the spread of 
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organisms from the subarachnoid space and almost certainly alter the function of the 
organ of Corti, and so ears thus affected were disregarded. 
Definition of auditory threshold. Were one to record the response of a single-auditory 
nerve fibre, it would be possible to find an auditory stimulus intensity which caused a just- 
perceptible change in firing pattern, and define this as the threshold. But such an all-or- 
nothing concept is less than helpful in a situation where we are dealing with a compound 
action potential or far-field potentials, which represent the massed activity of many nerve 
units. As shown in fig 3.1 1, it is clear that the heights of both wave I and wave III of the 
brain stem evoked response are not linearly related to stimulus at low intensities. In fact it is 
very difficult to determine accurately the exact point at which the wave disappears into 
background noise. In the example given this could be anywhere from 25 to 40 dB SPL for 
wave I and 40 to 60 dB SPL for wave III. The auditory nerve compound action potential 
behaves in a similar way (see fig 3.12); here the minimum stimulus needed to generate a 
just-detectable CAP response at 10 kHz could be anywhere between 20 and 35 dB SPL. 
One solution would be to record a series of CAPs at different intensities and plot a curve of 
mean intensity versus height, choosing the 'knee' of this curve as the genuine 
threshold. In fig 3.13 the apparent 'knee' of 9 dB SPL has a wide confidence interval, 
demonstrating the difficulty of determining this point repeatedly. Price et ai (1978) plotted 
similar curves of CAP amplitude as a function of stimulus intensity and extrapolated to 
obtain the intensity at zero amplitude (about 2 dB for fig 3.13). This approach was thought 
to be too cumbersome for the meningitis study. 
The solution adopted was to choose a reference (or criterion) level on the linear part of the 
stimulus intensity/response curve, exactly analagous to the technique for intracochlear CAP 
recording (see section 2.3.3) (Comis et ai 1993). In this method the stimulus intensity was 
adjusted to return the height to a reference level of 100 as measured at the 
electrode. The stimulus intensity needed to obtain the reference level of 100 is 
hereafter referred to as the CAP threshold. For the example in fig 3.13, it is 16 dB SPL, 14 
dB above the extrapolated O threshold. Hearing loss at a given frequency is defined as a 
rise in the stimulus intensity of that frequency needed to regain the reference level of 100 
With this approach it was possible to define the threshold to within 1 dB SPL. Frequent 
readings were possible because only 16 sweeps needed to be averaged at each intensity. A 
full set of threshold determinations on one ear in 1 kHz steps between 3 kHz and 10 kHz 
could be performed in under 10 minutes. 
Experimental results. Because the techniques were under continuous development, none 
of the recorded threshold alterations in this ultrastructural study can be regarded as 
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accurate. However, they are noted in table 3.5. They were the first indication of the level of 
hearing loss potentially caused by S. pneumoniae D39. Note that a 1 kHz tone pip (one 
cycle) was use to evoke the low frequency brain-stem auditory response. The lowest 
frequency that could evoke a reasonably well defined CAP was 3 kHz. 
3.2.4. Ultrastructural findings. 
Table 3.5 summarises the histological findings in each experiment of this series. Only 
micrographs from animals infected with the passaged organisms (batch A) are shown. 
Ultrastructural damage was dramatically more extensive than that seen after a similar 
duration of E. coli meningitis (see section 3.1.5.). From 6 h p.i. onwards surface cratering 
of the border cells could be found (plates 3.19-3.20, page 114). Severe derangement of 
some hair bundles of IHCs was apparent by 9 h p.i. (plate 3.20-3.21). Two additional 
lesions were seen: 
(i) As well as detachment of stereocilia from the surface of the hair cell, some sensory 
cells were torn away from their adjacent supporting cells (fig. 3.20). Occasionally the 
apical surface of the whole IHC appeared to be lifted clear of the surface of the organ 
of Corti (plate 3.21). 
(ii) The apical surfaces of outer hair cells were susceptible to ballooning and disruption, 
particularly so for row 2 cells (plates 3.23-3.24). The OHC stereocilia were sometimes 
severely atrophied. 
Structures resembling organisms were occasionally seen on the scala media surface of the 
organ of Corti (plate 3.22). On the scala tympani surface of the basilar membrane it was 
difficult to distinguish pneumococci from the large amount of cellular debris but there 
appeared to be more white cells present than in animals infected with E. coli (plate 3.25- 
3.26). 
The nature of the 'inflammatory string' seen in plate 3.25 is uncertain, but it may be a 
condensation of bacterial capsule. Such 'string' was only seen in conjunction with a 
labyrinthitis. 
A TEM section of a pneumococcus on the basilar membrane is shown in plate 3.27. The 
double-layered cell wall is clearly visible. Organisms fixed after in vitro growth in liquid 
media have a clearly defined capsule around the cell wall. In this case, the capsule appears 
to have condensed into projections. This phenomenon has also been observed in 
pneumococci recovered from experimental mouse pneumonia (Dr T Mitchell, personal 
communication). 
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Figure 3.8: Pneumococcal meningitis (D39): typical tone-evoked brain stem Potentials. 
Data from expt D39 (2); dB=dB SPL; h=h post-inoculation. 
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Figure 3.9: Pneumococcal meningitis (D39): example of hearing loss over time (BAEP). 
Data from expt D39(6) shows discrete steps (min 10 dB) and large fluctuations over time. 
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Figure 3.10: Tone-evoked brain stem Potentials: stimulus/response curve 3 h apart. 
Data from expt D39(11) where the CAP threshold was unchanged at O and 3 h post 
inoculation. 
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Figure 3.1 1: Tone-evoked brain stem Potentials: stimulus/response curve. 
Data from expt D39(10); dB=dB SPL. 
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Figure 3.12: Tone-evoked compound action potential: stimulus/response curve. 
Data from expt D39(11). 
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Figure 3.13: The definition of the compound action potential threshold in terms of a 
reference (criterion) level. 
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3.3. Experimental meningitis with wild type (D39) organisms. 
3.3.1. Introduction and exclusions. 
The experiments reported in section 3.2 laid the foundation for the final investigation of the 
differences between wild type and accessory virulence-factor deficient meningitis. The 
emphasis now was on maintaining recordings for 12 h and collecting sufficient data to allow 
a meaningful statistical comparison between relevant groups at this particular pre-defined 
time point. The data are presented for the wild type and each mutant in turn. Section 3.8 
outlines the statistical comparison between the groups. 
A single batch of D39 was used in experiments D39(14) to D39(19) reported here (Batch 
F). In addition, the wild-type data series includes animal PLN-A(2) (Batch G) which was 
inoculated with a pneumolysin-producing strain (wild type phenotype), rather than the 
intended PLN-A. Animals labelled NA+( 1) and NA+(2) (Batch K) were inoculated with a 
strain expressing neuraminidase activity, rather than the intended NA-deficient strain, and 
were also included. All inocula tested were ERY sensitive as expected. Expt D39(18) was 
excluded because the initial CAP thresholds were over 70 dB SPL in both ears. No CSF 
sample was obtained in expts. D39(19) and NA+(2). The right-side round window 
membrane was perforated in expt D39(16). Therefore a total of 8 experiments and 15 
cochleas were evaluated. 
Experimental data is given in table 3.6 and figs 3.14 to 3.19. Scatter plots of all the data can 
be found after section 3.8 (page 186 et seq). The raw electrophysiological data for each 
experiment can be found in the appendix. 
3.3.2. Bacteriological findings. 
The mean inoculum was 7.5 log,, CFU (range 7.3-7.7; n=8). The mean CSF viable count 
12 h p.i. was 8.7 log,, CFU/ml (range 8.1-9.3; n=6) (fig 3.31). 
In experiment D39(17), inoculated with 7.3 log,, CFU, CSF was sampled every 3 h via an 
indwelling cisterna1 needle. Viable counts were obtained as follows: 
Time (h) 
CSF viable count 
(log,, CFU/ml) 
CSF WCC 
3 6 9 12 
6.7 7.0 7.4 8.1 
540 3,920 3,860 6,600 
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Taken together, the data support the hypothesis that the inoculum is diluted on injection 
into the CSF space and enters log phase growth, and constitute reasonable evidence for in 
vivo growth. It is likely that with this inoculum bacteria would probably have reached 
stationary phase by 12 h p.i. The absence of a significant lag phase in the single experiment 
above is in accordance with the published data for D39 meningitis in the rabbit (Friedland et 
al 1995). 
Ail animals from which a terminal cardiac sample was obtained were bacteraemic with a 
mean viable count in the blood of 6.6 log,, CFU/ml (range 6.2-7.1; n=5) (fig 3.34). 
3.3.3. Inflammatory response. 
A CSF leukocytosis was seen in all animals from which a CSF sample was obtained. The 
geometric mean CSF white cell count 12 h p.i. was 10,500 (range 1,700-32,000; 
n=6) (fig 3.32). The geometric mean CSF protein concentration was 1.6 g/l (range 0.4-4.0; 
n=6) (fig 3.33). In experiment D39(17), no white cells were observed 1 h after inoculation 
but a CSF leukocytosis was apparent by 3 h p.i. 
3.3.4. Electrophysiological data. 
The improved precision of round window CAP recording meant that differences in hearing 
loss between groups of animals could be confidently detected. For each group in this and 
subsequent sections the following are reported: 
• Mean CAP loss (+ 95% confidence intervals) at 10 kHk and 3 kHz 12 h post 
inoculation; 
• Mean rate of hearing loss over time at 10 kHz and 3 kHz (D39 and PLN-A only). 
CAP loss (mean+95% CI) in steps of 1 kHz between 3 kHz and 10 kHz at 3, 6, 9 and 
12 h post inoculation (the 'audiogram'). 
Typical experimental recordings are shown in fig 3.14 (control expt PLN-A(14)) and fig 
3.15 (expt D39(17) left). In the control experiment (where the inoculation failed and no 
CSF inflammation resulted) there is little change in peak cochlear microphonic or in CAP 
threshold over the course of 10 h. By contrast, fig 3.15 demonstrates the typical findings 
during experimental wild-type meningitis. There is hearing loss of around 45 dB at 12 h p.i. 
which is, in this example, evenly distributed across the frequency range tested. The cochlear 
microphonic is also significantly reduced 12 h p.i. 
Mean percentage change in cochlear microphonic 12 h p.i. 
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Compound action potential 
Ail animals infected with wild type D39 had lost hearing by 12 h post inoculation. The mean 
CAP loss 12 h p.i. was 50 dB (range 21-75; n=15) at 10 kHz and 42 dB (range 23-70; 
n=15) at 3 kHz. It was sometimes difficult to elicit a clear CAP with a stimulus frequency of 
3 kHz, as interference from the cochlear microphonic could be difficult to filter out. There 
was a strong correlation in terms of individual ears between 10 kHz CAP loss and 3 kHz 
CAP loss at 12 h p.i. (r=0.85, 95%CI 0.57 to 0.94, F=5.4 p=0.0001). The scatter plots (see 
fig 3.35 and 3.36) revealed no particular differences in CAP loss between left or right ears 
at either 10 kHz or 3 kHz. 
Figure 3.16 shows CAP loss as a function of time post-inoculation for 10 kHz and 3kHz 
stimuli. By grouped linear regression over the post-inoculation period O h to 12 h, the mean 
rate of CAP loss was calculated as 4.4 dB/h at 10 kHz and 3.6 dB/h at 3 kHz. 
Hearing loss in relation to stimulus frequency. 
Figures 3.17 and 3.18 show what will be referred to as the 'audiogram'. CAP loss 
(mean+95% CI) is plotted in 1 kHz steps from 3 kHz through 10 kHz at 3 h, 6 h, 9 h and 
12 h after inoculation. Full data was not collected in all wild-type experiments where n=15 
for 3 kHz and 10 kHz but n=11 for other frequencies. There is a suggestion that hearing 
loss at 10 kHz occurred very slightly earlier than losses at other frequencies, but from 9 h 
p.i. onwards hearing loss most affected the frequency range 5-7 kHz. These data contradict 
a previous study of experimental pneumococcal meningitis in the rabbit which had 
suggested that high frequency hearing loss would occur substantially earlier than low- 
frequency loss (Bhatt, 1993). 
Cochlear microphonic 
Cochlear microphonics elicited at 3 kHz declined steadily in almost all experiments from 3 h 
p i  onwards. The median final CM amplitude was just 18% of baseline (range O-90%; 
n=15). All five animals with unrecordable cochlear microphonics had a CAP loss of at least 
54 dB. Cochlear microphonic amplitude at 12 h p.i. (as percent of baseline) correlated 
inversely with the amount of CAP loss at 10 kHz (Spearman's p=-0.71, 95% CI -0.90 to - 
0.32; p=0.004; scatter plot fig 3.37). There was less correlation with CAP loss at 3 kHz 
(perhaps because at this frequency reliable CAPS were more difficult to elicit). 
Shape of the CAP waveform 
The shape of the CAP was noted to change during an experiment as a greater stimulus was 
needed to regain the reference level. In normal ears and ears with a moderate CAP loss (fig 
3.19a), successive compound action Potentials were uniform, with a small initial and 
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identical waves occurring with precisely the same latency. In ears which had lost 
substantial hearing (>50 dB), the CAP sometimes 'dropped out' for every third or fourth 
stimulus, and could not be elicited. This phenomenon was not usually apparent until 9 h p.i. 
Closer inspection of successive CAP recordings (fig 3.19b) in such an affected ear 
demonstrates two important findings: 
i) Successive CAPs are dissimilar. The height of the wave varies markedly, although 
the mean peak-peak height is of course 100 The latency also varies slightly, and this 
would have a significant effect on the averaging process. 
ii) In several recordings a prominent is apparent. This wave is thought to represent 
massed synaptic depolarisation at the base of the sensory cells, and is normally dwarfed by 
the subsequent action potential response (Eybalin, 1993 p 323). 
Reasons why the compound action potential might become non-uniform include impairment 
of the cochlear filter (in the light of the pronounced OHC damage) allowing varying groups 
of fibres to contribute to the CAP, disturbance of synaptic transmission at the base of the 
hair cell, and axonal pathology such as spontaneous firing that would mean some axons 
were refractory and could not be recruited by the stimulus. 
3.3.5. Ultrastructural findings. 
Nine cochleas were examined by SEM (of which two were not evaluated because the organ 
of Corti had curled during processing). One cochlea was subjected to a detailed TEM study. 
A summary of the histological changes is detailed in table 3.6. The same pattern of damage 
was observed as in the preliminary study, namely cratering of border cells with associated 
disruption of IHC stereocilia (plate 3.28) and damage to the apical surface of outer hair 
cells and their hair bundles (plates 3.29-3.34). 
Damage to outer hair cells 12 h p.i. was strikingly more extensive than in the preliminary 
study. In general, row 1 and 2 OHCs were more affected than row 3 OHCs, and the basal 
turn more affected than the mid turn. Four main categories of damage were seen: 
i) There were gross defects in the apical cell membrane (plates 3.30, 3.31), which was 
usually breached at the site of the basal corpuscle (plate 3.32) at the apex of the 'V’ 
formed by the stereocilia. A higher power view (plate 3.33) shows what appear to be 
cell contents extruding from a row 2 OHC. The bordering phalangeal process appears 
to be intact. 
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ii) 
iii) 
iv) 
Many hair bundles were devastated (plate 3.31). Stereocilia were detached from the 
sensory cell or had degenerate plasma membranes (plate 3.33). Other stereocilia were 
fused together (plate 3.34). 
OHCs appeared to be swollen and ballooned with breaks in the basal plasma membrane 
(plates 3 .32  & 3.40). Mitochondria were abnormal and vacuolated. Intercellular 
junctions were also damaged; at times the cuticular plate seemed to be lifted clear of 
the bordering phalangeal cell processes (plate 3.34). 
Nerve endings suffered pathological damage as judged by TEM (plate 3.32). 
Mitochondria within nerve endings were vacuolated and highly abnormal. 
Hair bundles of IHCs were also affected. Stereocilia were sometimes fused together (plate 
3.35).  In other cells, the lateral links were disrupted and the hair bundle had collapsed onto 
the cell (plate 3.36). The rootlets appeared to be stretched at the insertion into the cuticular 
plate (plate 3.37). 
Border cells and phalangeal cells were also damaged with craters in their apical surfaces 
seen by SEM (plate 3.38.).  Sometimes the contents of a phalangeal cell could be seen 
extruding into scala media (plate 3.40). These cells also appeared to be swollen and 
contained abnormal mitochondria. Colonies of what appeared to be pneumococci could 
sometimes be found closely associated with the inner hair cell surface (plate 3.39). 
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Figure 3.14: Control round window recording. 
Typical data from a control experiment (here PLN-A( 14)) 
showing no loss of CAP or CM over time. 
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Figure 3.15: D39 meningitis: hearing loss over time in a typical experiment. 
Data from expt D39(17). h=hours post inoculation. 
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Figure 3.16: D39 meningitis: mean hearing loss over time. 
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Figure 3.17: D39 meningitis: audiograms (3 h and 6 h) 
Frequency-specific CAP loss; h=h post inoculation.; 
means + 95% CI 
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Figure 3.18: D39 meningitis: audiograms (9 h and 12 h) 
Frequency-specific CAP loss; h=h post inoculation.; 
means + 95% CI 
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Figure 3.19: Serial CAP recordings from unaffected and affected ears. 
Composite recordings from experiment D39 (19). 
A: (18 dB loss) successive CAPs are uniform; 
B: ( 5 5  dB loss) successive CAPs are variable, some have a prominent wave. 
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3.4. Experimental meningitis with pneumolysin-deficient organisms 
(P L N- A). 
3.4.1. Introduction and exclusions. 
Five experiments were evaluated from fifteen performed. Four animals died before the 
endpoint of 12 h was reached. It is unclear why a run of animals died early. No significant 
CAP loss was noted in these animals, so their exclusion is unlikely to have materially 
influenced the hearing loss comparison. Four animals received an inoculum of indeterminate 
phenotype (discussed below). In two animals the inoculation failed to induce a leukocytosis 
and no organisms were recovered from the CSF. These exclusions are summarised below: 
PLN-A (1), Low inoculum (6.6 log,, CFU) of batch E 
PLN-A (2) wild-type phenotype (Batch G) (included in wild type series) 
(3), & (4) Batch H. Indeterminate phenotype; mostly ERY sensitive. 
Mean 10 kHz CAP loss 15 dB (range 4-29; n=4) 
PLN-A (6) to (8) these four animals all died of respiratory failure between 2 h and 7 h p.i. 
PLN-A (1 2) Maximum recorded CAP loss at 10 kHz was 8 dB. 
PLN-A (9), (14) Failed inoculation. PLN-A(9) bacteraemic (7.1 log,, CFU/ml) 
A formal comparison of PLN-A and D3 9 wild type infection is given in section 3.8. 
3.4.2. Bacteriological findings. 
Batch E was grown in Birmingham without erythromycin selection pressure, which would 
encourage the loss of the genetic insert. Batch G was obtained from Leicester and (like 
Batch H) found to be fully erythromycin sensitive (rather than resistant) on checking in 
Birmingham, with zones of 2 cm in diameter around a 5 pg ERY disk. CSF recovered from 
expt PLN-A(2) was analysed in Leicester. The proportion of ERY sensitive (likely D39) to 
resistant (likely PLN-A) colonies was estimated at about 100:1 by colony picking. A cell 
lysate of recovered CSF organisms had full haemolytic activity. Although this would be 
consistent with reversion to wild type in vivo, where the genetic insert falls out and the 
wild-type emerges as dominant, further tests on the inoculum suggested that the organisms 
inoculated were in fact wild-type phenotype. It emerged that the 'stock' inocula might in fact 
have been animal passaged several times. Batch H experiments were therefore also 
excluded, although the zone of inhibition around the ERY disk was not completely clear 
suggesting a mixed inoculum, and hearing loss was not as great as with wild type infection. 
Batch J was then prepared from original stock PLN-A from Adelaide (Berry et al 1989) as 
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detailed in the methods and the resulting standard inocula found to be free of haemolytic 
activity and fully resistant to 60 pg ERY. It was used for the experiments listed in table 3.6. 
All organisms isolated from the CSF and blood in animals inoculated with batch J were 
ERY resistant. 
The mean inoculum in animals included in the analysis was 7.5 log,, CFU (range 7.4-7.7; 
n=5). The mean CSF viable count 12 h p.i. was 8.1 log,, CFU/ml (range 7.7-8.6; n=5) (fig 
3.31). 
All included animals from which a terminal cardiac sample was obtained were bacteraemic 
with a mean viable count in the blood of 6.0 log,, CFU/ml (range 4.2-8.0; n=4) (fig 3.34). 
3.4.3. Inflammatory response. 
A CSF leukocytosis was seen in all included animals from which a CSF sample was 
obtained. The geometric mean CSF white cell count 12 h p.i. was 4,790 (range 
2,025-10,950; n=5) (fig 3.32). The geometric mean CSF protein concentration was 0.6 g/l 
(range 0.4-0.8; n=5) (fig 3.33). 
3.4.4. Electrophysiological data. 
Animals infected with PLN-A had lost little hearing by 12 h post inoculation. The mean 
CAP loss 12 h p.i. was 12 dB (range -3 to 27; n=10) at 10 kHz and 18 dB (range 6-26; 
n=10) at 3 kHz. Successive action Potentials were always uniform. The median final CM 
amplitude was 65% of baseline (range 30-102%; n=10). There was no correlation between 
the final CM (as a proportion of baseline) and CAP loss (Spearman's p:-0.3, P=0. 19) 
Figure 3.20 shows CAP loss as a function of time post-inoculation for 10 kHz and 3kHz 
stimuli. The mean rate of CAP loss over the post-inoculation period O h to 12 h was 1.0 
dB/h at 10 kHz and 1.4 dB/h at 3 kHz., significantly lower than in meningitis due to D39 
(see section 3.8). 
Figures 3.21 and 3.22 show the 'audiogram'. It is clear that at every frequency tested, PLN- 
A caused significantly less hearing loss than the parent D39 strain. 
The two animals in which the inoculum failed to induce a meningitis lost almost no hearing 
over the course of 12 h. For these animals, mean CAP loss was 6 dB (range 0-10; n=4) at 
10 kHz and 5 dB (range 0-13; n=4) at 3 kHz. The data for PLN-A(14) are shown in fig 
3.14. 
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3.4.5. Ultrastructural findings. 
Eight cochleas were examined by SEM of which two were not evaluated because the organ 
of Corti had curled. Two cochleas were subjected to a detailed TEM study. 
All six cochleas observed appeared to be virtually intact as judged by SEM (plate 3.41). 
Organisms were seen on the scala tympani surface of the basilar membrane (plate 3.42), and 
a gross labyrinthitis was evident in several specimens on initial dissection. Therefore the 
absence of damage is not because PLN-A failed to invade scala tympani. 
Close inspection of OHCs revealed pitting at the site of the basal corpuscle in some cells 
(plate 3.43), but the breakdown of the apical surface membrane characteristic of wild type 
infection was never observed. Most OHCs and their associated hair bundles appeared to be 
completely intact (plate 3.44 and 3.46). Inner hair cell hair bundles were usually regular 
(plate 3.46 and 3.49). Just one border cell crater was found, and here there was some 
disruption of the lateral links of the stereocilia on the adjacent IHC, some of which had 
collapsed (plate 3.47). Organism-like structures were occasionally observed adjacent to the 
IHC/border cell junctions with localised disruption of the IHC stereocilia (plate 3.48) 
Transmission electron microscopy however revealed some specific damage to OHCs: 
i) 
ii) 
There was some evidence of loss of sensory cell turgor (plate 3.45) 
Nerve ending damage was apparent (plate 3.50 and 3.51). Mitochondria within the 
nerve ending were vacuolated, as were some within the basal region of the OHC itself. 
There was however no breakdown of the junctions between sensory cells and adjacent 
phalangeal cells, and the apical cell surface of the OHCs and IHCs was spared (plates 3.45, 
3.50, 3.52). 
As far as could be assessed by SEM and TEM, the critically important reticular lamina 
appeared to remain intact. 
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Figure 3.21: PLN-A meningitis: audiograms (3 h and 6 h) 
Frequency-specific CAP loss; h=h post inoculation.; 
means + 95% CI 
I44 
Figure 3.22: PLN-A meningitis: audiograms (9 h and 12 h) 
Frequency-specific CAP loss; h=h post inoculation.; 
means + 95% CI 
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3.5. Experimental meningitis with neuraminidase-deficient organisms 
3.5.1. Introduction and exclusions 
Eight experiments were performed. Two animals were inoculated with batch K and included 
in the wild-type series (see section 3.3.1). One animal (NA1(2)) was killed 7 h p.i. after 
losing all detectable hearing. The hearing loss data were included (assuming there would 
have been no recovery) but the CSF and blood findings were excluded. Another animal 
(NA1(4)) died 9 h p.i (before hearing was assessed). Data from the terminal CSF sample 
were included in the analysis. No CSF could be obtained from expt NA1(3), although 
pneumococci were isolated from a brain smear and the animal was bacteraemic. A formal 
comparison with wild type infection is given in section 3.8. 
3.5.2. Bacteriological findings. 
All animals included in the analysis were inoculated with batch L This batch 
expressed both haemolytic (i.e. pneumolysin) and hyaluronidase activity. Neuraminidase 
activity by the MUAN cleavage fluorescence assay (see appendix C) was found to be 0.41 
mU/mg cell protein when organisms were grown in non-selective medium, and 0.55 mU/mg 
cell protein after growth in selective medium ( 5  erythromycin). This is at the lower 
limit of detection for this assay (about 0.5 mU/mg). As a control, Batch N 
expressed 6.4 mU neuraminidase activity per mg cell protein, about that expected by wild 
type organisms. Organisms recovered from the CSF of expt NA1(5) and NA1(6) expressed 
no neuraminidase activity (<0.5 mU/mg cell protein) after growth in either selective or non- 
selective media. This is good evidence for the stability of the mutant in vivo. 
The inoculum was 7.5 log,, CFU in all 6 evaluated experiments. The mean CSF viable 
count 12 h p.i. was 9.0 log,, CFU/ml (range 9.0-9.5; n=4) (fig 3.31). 
All animals from which a terminal cardiac sample was obtained were bacteraemic with a 
mean viable count in the blood of 6.1 log,, CFU/ml (range 5.9-6.7; n=3) (fig 3.34). 
3.5.3. Inflammatory response. 
A CSF leukocytosis was seen in all animals from which a CSF sample was obtained. The 
geometric mean CSF white cell count 12 h p.i. was 19,700 (range 9,500-27,600; 
n=4) (fig 3.32). The geometric mean CSF protein concentration was 2.1 g/l (range 1.1-3.3 
n=4) (fig 3.33). In experiment NA1(2) at 7 h p.i. the CSF WCC was already as high as 
11,000 
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These data suggest that the absence of neuraminidase expression in no way impedes the in 
vivo growth of serotype 2 S. pneumoniae and does not modify the host inflammatory 
response, at least in the CSF space (see section 3.8.2). 
3.5.4. Electrophysiological data. 
Ail animals infected with lost hearing as judged by CAP recording. The mean CAP 
loss 12 h p.i. was 52 dB (range 19-75; n=10) at 10 kHz and 45 dB (range 10-66; n=10) at 
3 kHz. The median final CM amplitude was just 12% of baseline (range O-39%; n=10). 
Final CM amplitude (as a proportion of baseline) did not correlate with CAP loss 
(Spearman's p= -0.33, P=0.4). 
Figure 3.23 shows CAP loss as a function of time post-inoculation for 10 kHz and 3kHz 
stimuli. The mean rate of CAP loss over the post-inoculation period O h to 12 h was 4.3 
dB/h at 10 kHz and 3.4 dB/h at 3 kHz. Figures 3.24 and 3.25 shows that if anything, 
induced a more rapid hearing loss in the first 6 h of infection than did wild type D39. 
The pattern of loss across the frequencies tested at 12 h p.i. is absolutely indistinguishable 
from that due to wild type infection. This reflects the reproducibility of the inocula and 
recording techniques used especially as the D39 experiments were performed some six 
months prior to the series. 
Changes in the CAP waveform were similar to those during wild type infection, with a 
progressive loss of uniformity and the appearance of a prominent wave. 
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3.5.5. Ultrastructural findings. 
Nine cochleas were examined by SEM of which five were not evaluated because the organ 
of Corti curled during processing. Both cochleas from expt were subjected to a 
detailed TEM study. Table 3.8 summarises the histological data for each experiment. 
Plates 3.53 to 3.56 show that the pattern of ultrastructural damage was identical to that 
seen in wild type infection, with cratering of the border cells, deformation of the apical 
surface of OHCs and disruption of their hair bundles. However, the organ of Corti in one 
specimen (NA1 (6)) was relatively undamaged. 
The TEM findings confirmed the pattern of damage seen with wild type infection. The 
normal space between sensory cells was sometimes enlarged and filled with an electron 
dense material (plate 3.57 and 3.60). Some hair cells themselves appeared to be swollen and 
filled with extremely abnormal vacuolated mitochondria (plate 3.58). This damage extended 
to the neighbouring phalangeal cells (plates 3.58 and 3.60). Pathologically damaged nerve 
endings were more obvious than with wild type infection (plate 3.59). In some sections the 
apical surfaces of the neighbouring supporting cells were themselves ballooned out (plate 
3.60). 
The basilar membrane itself appeared to be relatively normal (plate 3.61). No convincing 
evidence was obtained with TEM that organisms had penetrated through this layer and into 
the spaces surrounding the hair cells. Some of the cells adjacent to the basilar membrane do 
however show signs of pathological damage. 
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Figure 3.23: ANA1 meningitis: mean hearing loss over time. 
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Figure 3.24: ANA1 meningitis: audiograms (3 h and 6 h) 
Frequency-specific CAP loss; h=h post inoculation. ; 
means + 95% CI 
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Figure 3.25: ANA1 meningitis: audiograms (9 h and 12 h) 
Frequency-specific CAP loss; h=h post inoculation.; 
means + 95% CI 
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3.6. Experimental meningitis with hyaluronidase-deficient organisms 
3.6.1. Introduction and exclusions 
Eight experiments were performed. Exclusions included: 
(i) and (2) low inoculum 
(ii) 
(iii) R initial auditory threshold > 100 dB SPL; 
(iv) bleeding into auditory bulla; 
(v) 
Therefore recordings from only six cochleas were included in the analysis 
last recording 6 h p i ,  died at 7 h; 
last recordings 6 h p.i., died 9 h p.i. 
3.6.2. Bacteriological findings. 
Viability of the inocula and evidence for maintenance of the phenotype. 
The in vitro growth curve for is shown in fig 3.29. The first batch of (batch 
used to inoculate expts. and (2) had a viable count of only 6.3 log,, CFU/ml 
after storage at -70°C, a 99% loss of viability. This was attributed to the use of a defective 
batch of fetal calf serum as cryoprotectant. A second batch (batch N) also had a low count 
(fig 3.30), and the mean inoculum in animals included in the analysis was only 7.1 log,, total 
CFU (see section 3.8.1 for comparison). A sample of this batch had no detectable 
hyaluronidase activity, but did express neuraminidase with a specific activity of 6.4 mU/ mg 
cell protein, some 20-fold higher than that expressed by (see section 3.5.2). 
Organisms recovered from the CSF of expt were grown overnight on blood agar 
plates and transported to Leicester. Colonies were inoculated into both selective and non- 
selective media (BHI with or without erythromycin ( 5  cultivated overnight at 37°C, 
and cell lysates prepared (see appendix C ) .  There was no detectable hyaluronidase activity 
in either lysate. 
CSF count and bacteraemia. 
Table 3.9 and fig 3.31 show data from expts. to (8) which were included in the 
comparative analysis. The mean CSF bacterial count 12 h p.i. was just 6.2 
(range 5.4-7.2; n=5). Expts. and (2) were inoculated with 5.4 total CFU (batch 
M) and yielded viable counts of 6.5 and 4.6 CSF respectively. Experimental 
animal died 7 h p.i. following a prolonged episode of respiratory irregularity. The 
CSF bacterial viable count was only 5.1 
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Only two of six animals had detectable bacteraemia 12 h post inoculation (4.7 and 4.0 
log,, CFU/ml). The lower limit of detection was approximately 1.7 log,, blood. CFU/ml 
In spite of the small numbers, these data suggest that : 
(i) In contrast to wild type infection with D39, survives poorly in vivo in 
cerebrospinal fluid and the blood stream. 
(ii) Under these experimental conditions there is no evidence that the phenotype reverts to 
wild type. 
3.6.3. Inflammatory response. 
Among included animals, the geometric mean CSF WCC 12 h p.i. was 2,000 (range 
100-7,600; n=5). In expt the CSF WCC was just 100 even though the 
CSF bacterial count was 7.0 log,, CFU/ml. There were no obvious reasons why this 
inoculum had failed to induce an inflammatory response. No leukocytes were seen in the 
CSF of one of the two animals inoculated with 5.4 log,, CFU; the other animal developed a 
moderate meningitis (CSF WCC=1200 In contrast, in the animal which died 
unexpectedly early (expt there was a huge CSF leukocyte response (CSF 
WCC=28,000 
The geometric mean CSF protein concentration was 0.3 g/l (range O. 15-0.30; n=3). 
3.6.4. Electrophysiological data. 
Mean CAP loss 12 h p.i. was 40 dB (range 11-94; n=6) at 10 kHz and 24 dB (range 1-52; 
n=6) at 3 kHz. Figure 3.26 shows CAP loss as a function of time post-inoculation for 10 
kHz and 3kHz stimuli. The mean rate of CAP loss over the post-inoculation period O h to 
12 h was 3.4 dB/h at 10 kHz and 2.2 dB/h at 3 kHz. The median final CM amplitude was 
65% of baseline (range 25-90; n=6). Final CM amplitude (as a proportion of baseline) did 
not quite significantly correlate with CAP loss (Spearman's p= -0.83, P=0.06). 
Audiograms are displayed in figs 3.27 and 3.28, where it is clear that the pattern of loss 
across the frequencies tested at 12 h p.i. is broadly similar to that due to wild type infection. 
The confidence limits are wide because of the small numbers and because the range of 
measured hearing loss was greater in this group than in animals infected with D39, or 
PLN-A. 
The pattern of the change in CAP waveform was similar to that of wild type with a 
progressive loss of uniformity and the appearance of a prominent wave. 
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The two animals inoculated with the low inoculum and (2)) lost almost no 
hearing (mean CAP loss 9 dB at 1 O kHz and 15 dB at 3 kHz (n=4)). 
3.6.5. Ultrastructural findings. 
A total of seven cochleas were examined by SEM. Labyrinthitis was noted to be particularly 
severe in the left cochlea of expt (94 dB loss), which disintegrated on dissection. 
Table 3.8 summarises the other findings shown in plates 3.62 to 3.65. 
Ultrastructural damage was more patchy than with wild type infection. Some areas of the 
organ of Corti in some experiments were intact (plate 3.62). But in other experiments, all 
the characteristic lesions were present: damage to apical surface of OHCs and OHC hair 
bundles (plate 3.63), craters in the apical surface of border cells (plates 3.64 and 3.65) and 
irregularity, collapse and detachment of IHC stereocilia (plate 3.65). 
No TEM study was undertaken. 
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Figure 3.26: AHY1 meningitis: mean hearing loss over time. 
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Figure 3.27: meningitis: audiograms (3 h and 6 h) 
Frequency-specific CAP loss; h=h post inoculation.; 
means + 95% CI 
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Figure 3.28: meningitis: audiograms (9 h and 12 h) 
Frequency-specific CAP loss; h=h post inoculation.; 
means + 95% CI 
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3.8. Statistical analysis of the comparative experiments 
In this section the data from the comparative experiments are tabulated by heading. Scatter 
plots (figs 3.30 to 3.38) allow easy inspection of differences between groups. 
Differences in inoculum, CSF bacterial counts and bacteremia. 
There is known to be no difference between the in vitro growth rates of D39 and PLN-A 
under the conditions used in Leicester (Canvin et al, 1995). In vitro growth curves for the 
new mutants ANA1 and and wild type D39 are shown in fig 3.29. While the growth 
of is slightly slower, this is probably not biologically significant. 
The variation between the inocula given in different experiments was satisfyingly low (fig 
3.30). The main problem was the concentration of batch N, which meant that the mean 
inoculum in the group was 7.1 log,, CFU/ml. While this is statistically significantly 
different from the mean inocula in the other groups, this difference (0.4 log,, CFU) is 
unlikely to be biologically significant. 
There were no differences between the final (12 h) mean CSF bacterial count in infection 
due to D39, PLN-A and all of which were higher than the initial total inoculum. 
However, did not appear to grow in vivo: the mean viable count 12 h p.i. was 
significantly lower than that in the other groups and well below the original total inoculum 
(fig 3.3 1). 
CSF (12 h) 95% CI for difference vs. D39 P 
D39 (n=6) 8.7 
PLN-A (n=5) 8.1 
(n=4) 9.0 
0 to 1.1 
-1 to 0.1 
0.05 NS 
0.09 NS 
(n=5) 6.2 1.6 to 3.4 <0.0001 
Students t-test (data already log transformed). 
Table 3.11: CSF viable counts in comparative study 
also survived poorly in the bloodstream when compared to the other three groups. 
Indeed, bacteraemia was detected in only two out of six animals. There was no significant 
difference in the mean viable count of D39, PLN-A and recovered from the blood 12 
h p.i. (fig 3.34) 
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.Blood (12 h) 95% CI for difference vs. D39 P 
D39 (n=5) 6.6 
PLN-A (n=4) 6.0 
ANA1 (n=3) 6.1 
-2.5 to 1.8 
-0.6 to 0.9 
0.8 NS 
0.68 NS 
(n=5) (1.7) 1.9 to 7.1 0.007† 
Students f-test (data already log-transformed) except †: Mann-Whitney test due to unequal variances. 
Table 3.12: Blood viable counts in comparative study. 
3.8.2. Differences in CSF inflammatory markers. 
No significant differences were observed between the mean CSF leukocyte counts (fig 
3.32). Differences in mean protein concentration were difficult to assess due to the wide 
scatter and small numbers. Neither PLN-A nor seemed to induce as great a protein 
elevation as D39 or (fig 3.33). There were insufficient numbers in the PCW group to 
allow a formal comparison between the inflammatory response due to PCW and that due to 
live infection. 
CSF (12 h) Mean WCC 95% CI for difference vs. D39 P 
D39 (n=6) 10,500 
0.18 NS 
ANA1 (n=4) 19,700 * 0.35 NS 
(n=5) 2,000 * 0.08 NS 
0.24 NS 
PLN-A (n=5) 4,790 * 
PCW (n=3) 3,440 * 
Geometric means. Students t-test on log-transformed data; * 95% CI not calculated. 
CSF (12 h) Mean protein Approximate 95% CI for P 
(g/l) difference vs. D39 
D39 (n=6) 1.6 
PLN-A (n=5) 0.6 -3.2 to 0 0.04 
ANA1 (n=4) 2.1 -1.2 to 2.8 0.8 NS 
(n=3) 0.3 not calculated (0.04) 
Geometric means. Mann-Whitney test on untransformed data. 
Table 3.13: CSF inflammatory response in comparative study. 
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3.8.3. Comparison of CAP loss at 12 h in the comparative study groups. 
This was the major predetermined endpoint of the study. Data from left and right cochleas 
for CAP loss at 10 kHz and 3 kHz in groups D39, PLN-A and ANA1 were found to be 
independent within each group by Spearman's rank correlation (P=0.72, 0.78 and 0.08 
respectively for 10 kHz; P=0.3, 0.5 and 0.23 for 3 kHz) (only two pairs of ears were 
included in the analysis for Data from left and right ears were therefore pooled 
together within the groups and statistical significance between means was assessed with 
Student's t-test or (if variances were unequal) with a Mann-Whitney test. 
Guinea pigs infected with the pneumolysin deficient isogenic mutant PLN-A lost 
significantly less hearing at both 10 kHz and 3 kHz than those infected with wild type strain 
D39. The audiograms (fig 3.21 and 3.22) confirm that the difference between wild type and 
pneumolysin-deficient infection was apparent across all frequencies tested. There were no 
significant differences in the mean CAP loss in meningitis induced by the other mutants, 
ANA1 and compared to wild type. Animals with meningitis induced by 100 
pneumococcal cell wall lost significantly less hearing than animals with live D39 
pneumococcal infection. 
10 kHz Mean CAP loss (dB) Difference vs. D39 95% CI P† 
D39 (n=l5) 50 
PLN-A (n=10) 12 
ANA1 (n=10) 52 
38 dB less 25 to 51 <0.0001 
2 dB more -16 to 12 0.76NS† 
(n=6) 40 10 dB less -11 to 30 0.35 NS† 
PCW (n=5) 9 41 dB less 22 to 56 0.000 1 
3kHz Mean CAP loss (dB) Difference vs. D39 95% CI P 
D39 (n=15) 42 
PLN-A (n=10) 18 
(n=10) 45 
24 dB less 12-34 <0.0001 
3 dB more -17 to 10 0.64 NS† 
(n=6) 24 18 dB less 0.7 to 35 0.04 NS† 
PCW (n=5) 11 31 dB less 18 to 47 0.0001 
P by Mann-Whitney test because of unequal variances except for †: Student's t-test 
n refers to number of ears evaluated. 
Table 3.14: CAP loss in comparative study. 
182 
3.8.4. Comparison of rates of CAP loss. 
Data for each time point within each group were pooled to determine the approximate rate 
of hearing loss. Grouped linear regression and analysis of variance were used to assess 
differences between groups. At both 10 kHz and 3 kHz, the rate of CAP loss was 
significantly lower with infection due to the pneumolysin negative mutant than with wild 
type infection (fig 3.20). There were no highly significant differences in rates of CAP loss at 
either 10 kHz or 3 kHz between D39, and infection (fig 3.23 and 3.26). The 
difference between the rate of CAP loss at 3 kHz in the group compared to the D39 
group is not significant given the multiple comparisons. 
Although the rate of CAP loss at 3 kHz was different to that at 10 kHz in every group, this 
never reached statistical significance (D39, PLN-A, ANA1 and P=0.37, 0.08, 0.14 
and 0.13 respectively). 
10 kHz Slope (dB/h) Difference vs. D39 95% CI P 
D39 (n=15) 4.4 
PLN-A (n= 10) 1 .0 3.4 n/a <0.0001 
(n=10) 4.3 0.1 n/a 0.47 NS 
(n=6) 3.4 1 .0 n/a 0.1 NS 
3kHz Slope (dB/h) Difference vs. D39 95% CI P 
D39 (n=15) 3.6 
PLN-A (n= 10) 1.4 2.2 n/a <0. 000 1 
ANA1 (n=10) 3.4 0.2 n/a 0.34 NS 
(n=6) 2.2 1.4 n/a 0.02 NS 
Grouped linear regression and analysis of variance. n refers to number of ears evaluated. 
Table 3.15: Rate of CAP loss in comparative study. 
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3.8.5. Comparison of cochlear microphonics. 
There was a clearly significant difference in CM loss (expressed as the ratio of final CM 
amplitude at 12 h p.i. to baseline CM amplitude) between animals infected with wild type 
and those infected with PLN-A. A possibly significant difference was seen between wild 
type and groups but no significant difference was apparent between groups infected 
with wild-type and ANA1 (fig 3.37). 
Figure 3.38 shows the ratio of final CM amplitude to baseline CM amplitude plotted as a 
function of CAP loss at 12 h p.i. for all experiments. No ear completely lost CM unless 
there was at least a 56 dB change in CAP threshold. However, in ears with a fall in CAP 
threshold of less than 20 dB there was sometimes up to a 90% fall in CM. In spite of this, 
there was a strong overall correlation between final CM (as a proportion of baseline) and 
CAP loss (Spearman's rank correlation coefficient p: -0.7; 95% CI for p -0.8 to -0.5; 
P<0.000 1). 
Median final CM Approx. 95% CI P 
(as a proportion of for difference vs. 
baseline) D39 
D39 (n=15) 0.18 
PLN-A (n= 10) 0.65 0.26 to 0.65 0.0003 
(n=10) 0.12 -0.24 to 0.11 0.32 NS 
(n=6) 0.65 0.07 to 0.66 0.01 
Mann-Whitney test because of non-normal distribution. n refers to number of ears evaluated. 
Table 3.16: Cochlear microphonic loss in comparative study. 
184 
Growth curves of S. pneumoniae in vitro 
Figure 3.29: In vitro growth curves of S. pneumoniae D39, and 
Conditions as described in Methods; growth determined by optical density at 600 nm. 
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Figure 3.30: Pneumococcal meningitis: inoculum given. 
Bars are means. 
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CSF bacterial count 
Figure 3.31: Pneumococcal meningitis: CSF bacterial count. 
Bars are means. P by Student's t-test. 
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CSF white cell count 
Figure 3.32: Pneumococcal meningitis: CSF white cell count. 
Bars are geometric means. P by Student's t-test on log-transformed data. 
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CSF protein 
Figure 3.33: Pneumococcal meningitis: CSF protein concentration. 
Bars are geometric means. 
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Blood bacterial count 
Figure 3.34: Pneumococcal meningitis: blood bacterial count. 
Bars are means. 
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Figure 3.35: Pneumococcal meningitis: scatter plot of 10 kHz hearing loss. 
CAP recordings. Bars are means. P by Mann-Whitney test. 
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Hearing loss 3 kHz 
Figure 3.36: Pneumococcal meningitis: scatter plot of 3 kHz hearing loss. 
CAP recordings. Bars are means. P by Mann-Whitney test. 
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Figure 3.37: Pneumococcal meningitis: scatter plot of CM loss 
Bars are medians. 
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CM loss vs CAP loss 
Figure 3.38: Pneumococcal meningitis: scatter plot of CAP vs. CM. 
CM loss at 12 h p.i. is related to CAP loss, although there is a wide scatter 
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3.9. Pneumococcal meningitis in the rabbit: a comparison of wild-type 
(D39) and pneumolysin-deficient (PLN-A) infection. 
These experiments were performed in conjunction with Dr Spiro Comis and Dr Michael 
Osborne. 
3.9.1. Introduction and exclusions 
Three rabbits (RAB 36-38) were inoculated with D39 and three (RAB 39-41) with PLN-A 
to confirm that the differences in hearing loss and ultrastructural damage induced by these 
two organisms were not just limited to the guinea pig. No CSF was obtained from RAB 37 
or RAB 4 1. Blood samples were not taken. Hearing loss was not assessed for the left ear of 
RAB 37. Experiments ran for between 9.5 and 11 h. All animals were successfully 
inoculated (mean inoculum D39, 7.9 log,, CFU; PLN-A, 7.5 log,, CFU) and viable 
organisms were recovered from all animals from which a CSF sample was obtained. 
3.9.2. Inflammatory response. 
Table 3.17 shows that the four animals in which a CSF sample was taken developed a CSF 
leukocytosis and elevated protein concentration. There appeared to be no difference 
between the inflammatory response in either group. 
3.9.3. Electrophysiological data. 
Hearing loss was assessed by tone-pip-evoked brain stem response audiometry (BAEP). 
Final BAEP recordings were compared with the initial control tracings and an approximate 
dB loss assigned. As far as possible this comparison was performed blind to the 
experimental group. There was a significantly greater loss in rabbits infected with D39 
compared to PLN-A. Median hearing loss was 40 dB greater (97% CI 20 to 80 dB; n=5; 
P=0.01 by Mann-Whitney test) at 10 kHz and 30 dB greater (97% CI 20 to 40 dB; n=5; 
P=0.02 by Mann-Whitney test) at 3 kHz in the D39 group (see fig 3.39). 
3.9.4. Ultrastructural findings. 
Two cochleas in the wild type group and three cochleas in the PLN-A group were examined 
by SEM. Only the mid-turn of the organ of Corti could be examined except in RAB (41). 
This was due to curling of the basal turn during processing. A direct comparison with the 
guinea pig should therefore be made with caution, as the lesions characteristic of 
pneumococcal infection in the guinea pig occurred mostly in the basal turn, and only rarely 
were seen to affect higher turns. Plates are arranged in order of experiment. 
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In wild-type infection the following lesions were observed: 
i) Cratering of the apical surface of the phalangeal cells above the tunnel of Corti 
(between the inner hair cells and the first row of outer hair cells) was much more frequent 
than in the guinea pig (plate 3.70 and 3.71). The size and appearance of the craters were 
broadly similar however. Plate 3.68 shows defects in the apical surface of inner sulcus cells 
with intact border cells. The apical surface of the border cells seemed to be less vulnerable 
in the rabbit. 
ii) Disruption of the intercellular junctions between sensory cells and neighbouring 
phalangeal processes was seen in both cochleas examined (plate 3.69 and 3.71). However 
less pitting of the apical surface of the outer hair cells was observed. 
iii) In normal rabbit cochleas (historical controls), the hair bundles of inner hair cells are 
not quite as well preserved as in the guinea pig. But there is no doubt that plates 3.70 and 
3.71 reveal severe devastation of the hair bundles of the inner hair cells. Most IHC 
stereocilia in plate 3.71 are missing completely and those that are still attached to the 
surface of the sensory cell are swollen and shortened. 
In pneumolysin deficient meningitis, there was significantly less ultrastructural damage as 
judged by SEM. There was some irregularity of the hair bundles of inner hair cells (plates 
3.72 and 3.73). A single crater was found in a border cell (plate 3.74). Outer hair cells 
appeared to remain intact (plate 3.75). 
In conclusion there are three points: 
Experimental pneumococcal meningitis in the rabbit results in profound sensorineural 
deafness and induces three specific ultrastructural lesions in the organ of Corti: cratering 
of the apical surface of supporting cells, disruption of hair bundles and breakdown of the 
intercellular junctions between sensory cells and supporting cells. 
These lesions are broadly similar to those induced by experimental pneumococcal 
meningitis in the guinea pig. In the rabbit, border cells are spared at the expense of more 
damage to phalangeal cells, and inner hair cells and their hair bundles suffer more 
damage than outer hair cells. In the guinea pig outer hair cells are more affected. 
Infection with a pneumolysin-deficient derivative causes significantly less hearing loss 
and almost abolishes ultrastructural damage in both species. 
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4. COCHLEAR PERFUSION 
4.1. Introduction. 
4.1.1. Overview. 
In this study, a suspension of either S. pneumoniae or E. coli was microperfused into the 
scala tympani to model what might happen to the organ of Corti when organisms reach the 
inner ear during meningitis. Some animals were pretreated with antibiotics or 
dexamethasone. The compound action potential (CAP) evoked by a 10 kHz tone pulse, and 
the peak cochlear microphonic (CM) potential (at 5 kHz), were measured at intervals for 3 
h after perfhion. The cochlea was then intravitally fixed and processed for examination by 
scanning electron microscopy. Initial experiments were conducted with E. coli K-12 to 
perfect the techniques and ensure that the requirements for containment for S. pneumoniae 
could be met. To avoid contamination of the tubing and wire in the recording pipette the 
inoculum (1 0 was administered via a separate perfusion line and micropipette. Baseline 
readings taken prior to perfhion were often quite different to those obtained on reinserting 
the recording pipette minutes after inoculation, especially for the cochlear microphonic 
potential. This is likely to be due to (i) a change in coupling impedance (due to a variation in 
the seal obtained) and (ii) a slight change in the position of the pipette tip within the cochlea 
relative to the generator units. Therefore 'baseline' stimuli in the following experiments refer 
to readings taken within a few minutes of inoculation, rather than just before. 
The arguments behind the definition of the reference level for the compound action potential 
(CAP) threshold are given in section 3.3 .3 .  For brevity, the terms 'CAP loss' and 'hearing 
loss' are taken as synonymous with the increase in stimulus intensity needed to restore the 
mean height of the wave of the CAP to its reference level of 100 
The experimental numbering is not always sequential as other workers were conducting 
similar work at this time (not reported here). Exclusions are listed under the relevant 
section. 
4.1.2. Inocula. 
For E. coli experiments, a fresh 3 h log-phase culture was prepared for each experiment, 
and the bacterial titre was adjusted by counting organisms. An inoculum of 6.5 loglo 
organisms was used. For S. pneumoniae perfhion, identical aliquots of either Batch A or 
Batch B were used to give a desired inoculum of 6.5 CFU in 10 Colony counts 
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were performed for each experiment. All inocula were within 0.4 log units of the desired 
amount. The use of reproducible inocula allowed a formal comparison between untreated 
and antibiotic-treated animals. 
4.2. E. coli perfusion 
4.2.1. Electrophysiological data. 
Mean CAP loss 3 h after perfusion was just 7 dB (95% confidence interval -5 to 19 dB) 
with a maximum loss of 13 dB in expt K-12 Perf 5. The mean fall in cochlear microphonic 
was 20% (range 62% loss to 31% gain). Table 4.1 lists all the electrophysiological data, 
which are shown graphically in figure 4.2 and 4.3 (page 220 et seq). 
4.2.2. Ultrastructural findings. 
Damage to the organ of Corti assessed by scanning electron microscopy (SEM) was patchy 
and not at all severe, in keeping with the limited effects of E. coli K-12 on CAP loss and 
cochlear microphonics. The right-hand cochleae when examined were intact, and acted as 
controls for the processing. 
K12 Perf 2: This cochlea was destroyed during dissection. 
K12 Perf 5: The organ of Corti was mostly intact with no damage to hair cells (plate 4.1). 
There were occasional areas where inner hair cell (MC) stereocilia had become detached 
from the sensory cell and there were a few craters in the apical surface of border cells (plate 
4.2). Organisms were seen on the scala tympani surface of the basilar membrane (plate 4.3). 
This confirmed that the micro perfusion technique used was adequate to inoculate the scala 
tympani. Plate 4.3 shows nicely the loose reticular structure of the basilar membrane when 
viewed with SEM. Organisms appeared to be dividing. 
K12 Perf 7:  No craters were seen in the border cells, but there was some minor disruption 
of the lateral links of MC stereocilia (not shown). 
K-12 Perf 9: This cochlea was fixed 4 h after inoculation. There was some areas where IHC 
stereocilia appeared to be missing and some craters in the apical surface of border cells were 
observed (plate 4.4). 
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Time K12 Perf 2 Perf5 Perf7 Perf9 Mean 95%CI 
(min) 
CAP loss 5 0 0 0 0 0 0 
(dB) 180 5 13 0 8 7 12 
10 kHz 
Baseline stimulus 45 35 40 55 
dB SPL) 
44 14 
CM (0 h) (mV) 0.289 0.359 0.368 0.605 
CM (3 h) (mV) 0.180 0.385 0.482 0.340 
CM ratio 0.38 1.07 1.31 0.56 0.8 0.7 
Inoculum was 5x 10(6) organisms in 10 of artificial perilymph. CAP=compound action potential; 
CM=cocNear microphonic; CI=confidence interval; 
Table 4.1: Cochlear perfusion with E. coli K-12: electrophysiological data 
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4.3. Pneumococcal perfusion alone 
4.3.1. Experimental details and exclusions. 
Four animals were included in the analysis. The mean inoculum was 6.7 log,, CFU (range 
6.5 to 6.9). Experiment D39 Perf 3 was excluded because the cisterna magna was not 
opened and there was doubt whether the inoculum was successfully perfused. In expt Perf 
12 the apex of the cochlea was fractured during surgery and in expt Perf 16 there was 
bleeding into the meatus causing conductive deafness. Both of these experiments were 
therefore excluded from the evaluation. The CAP losses measured in three historical control 
experiments (where APL alone was perfused) are included in fig 4.2 for interest. Because of 
the minimal CAP loss after perfusion with E. coli K-12 additional APL-only perfusions 
were not conducted. 
4.3.2. In vitro growth. 
Assessing the in vivo growth of organisms in the perilymphatic space would seem almost 
impossible due to the tiny volume of fluid. It was not known whether APL could support 
the growth of D39. An aliquot of S. pneumoniae D39 (batch B) was prepared exactly as for 
a perfusion experiment, but then inoculated into 4 ml sterile APL at 37°C and incubated (no 
shaking, no additional Every hour, an aliquot (10 was removed and the titre 
determined. Fig 4.1 (page 21 1) shows a steady decline in viable counts over 6 h. This 
information merely suggests that D39 may not grow well in perilymph, but as artificial 
perilymph may well lack trace nutrients interpretation is tricky. 
4.3.3. Electrophysiological data. 
These are summarised in table 4.2 below, and in figures 4.2 to 4.5 on pages 220 to 223. 
Mean CAP loss at the 3 h endpoint was 44 dB (95% confidence interval 32 to 56 dB). The 
pattern of CAP loss was consistent in all four experiments. Apart from the initial variation in 
baseline, there was little change in CAP during the first 60 min post-perfusion. Over the 
subsequent 30-60 min there was a rapid fall in CAP which then levelled out. The mean rate 
of CAP loss over the post-perfusion period 60-180 min was 19 dB/h (see section 4.4.2 for 
detailed discussion of this analysis). 
There was no change in mean peak cochlear microphonic potential over the course of the 
experiments (range 14% loss to 14% gain). 
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4.3.4. Ultrastructural findings. 
Two specific ultrastructural lesions in the organ of Corti were noted: (i) disruption and 
detachment of hair cell stereocilia and (ii) cratering of the apical surface of the border cells. 
Three cochleae were examined after pneumococcal perfusion and all had extensive areas of 
damage with gross deformation of stereocilia and much debris scattered over the surface of 
the organ of Corti in both basal and mid turns. Damage was predominantly limited to inner 
hair cell stereocilia. In contrast to the damage incurred during experimental pneumococcal 
meningitis (see section 3.3.4 et seq), there was only some pitting of the apical surface of the 
hair cells rather than frank cratering. 
D 3 9  Perf 1: This cochlea was badly curled but in one area of the basal turn the IHC 
stereocilia were clearly detached from the cuticular plate. However, when examined by 
transmission electron microscopy the hair cell plasma membranes, nerve endings and the 
surfaces of the border cells all appeared intact (not shown). 
D 3 9  Perf 2: Both types of damage were seen (plates 4.5 and 4.6). On the scala tympani side 
of the basilar membrane, micro colonies of what appeared to be pneumococci could be 
observed (plate 4.11and 4.12). 
D 3 9  Perf 4: The control (right) cochlea is shown here to demonstrate the appearance of 
undamaged stereocilia after osmication (plate 4.7). There were widespread areas of damage 
in the experimental cochlea (plate 4.8). Plates 4.9 and 4.10 show at higher power the 
devastation wrought on the stereocilia. Many hair bundles were disrupted and some were 
collapsed on the cell surface. 
D 3 9  Perf 10: This cochlea was not examined. 
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Time Perf1 Perf2 Perf4 Perf10 Mean 95%CI 
(min) 
CAP loss 5 
10 kHz 20 
(dB) 40 
60 
90 
120 
150 
180 
0 5 
5 0 
0 3 
8 3 
28 18 
35 22 
41 32 
46 40 
0 
0 
0 
0 
25 
38 
34 
35 
0 
0 
4 
7 
20 
37 
51 
53 
1 
1 
2 
5 
23 
33 
40 
44 
4 
4 
3 
6 
7 
12 
14 
12 
Baseline stimulus 25 40 40 36 35 11 
dB SPL) 
CM (0 h) (mv) 0.580 0.228 0.499 0.359 
CM (3 h) (mv) 0.499 0.228 0.570 0.315 
CM ratio 0.86 1 .00 1.14 0.88 1.0 0.2 
Inoculum (log10 CFU) 6.7 6.5 6.9 6.7 6.7 0.3 
Inoculum in IO of artificial perilymph. CAP=compound action potential; CM=cochlear microphonic; 
CI=confidence interval; 
Table 4.1: Cochlear perfusion of S. pneumoniae D39: electrophysiological data. 
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D39 in APL 
Figure 4.1: Growth of S. pneumoniae D39 in artificial perilymph. 
Means (95% confidence intervals) of three replicate colony counts. Incubated at 37°C with 
no added or shaking; total volume 5 ml. 
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4.4. Pneumococcal perfusion with antibiotic pretreatment. 
4.4.1. Experimental details and exclusions 
Two further groups of animals received 100 mg/kg cefotaxime (CTX, n=4) or amoxycillin 
(AMOX, n=4) by intraperitoneal injection 30 min prior to inoculation of the scala tympani. 
The mean inoculum in the cefotaxime group (6.9 log CFU) was comparable to that in the 
untreated group (6.7 log CFU), but was slightly lower in the amoxycillin group (6.3 log 
CFU). These differences are unlikely to be clinically significant. The mean baseline stimuli 
did not differ between the groups. In expt D39 Perf 19, a new technique 
allowed the inoculum to be perfused through the recording pipette, so establishing the 
baseline stimulus prior to perfusion 
4.4.2. Electrophysiological data. 
Both antibiotics afforded substantial protection from CAP loss. The course of CAP loss was 
almost identical in the two groups. Tables 4.3 and 4.4 and figures 4.2 to 4.5 (page 218 et 
seq) summarise the electrophysiological data. Significance of the difference between the 
means was assessed by Student's t-test. 
Expt CAP loss Difference from D39 Significance 
(dB) (95% confidence interval) (dB) 
D39 (n=4) 44 N/A 
CTX (n=4) 23 7 to 35 p=0.01 
AMOX (n=4) 20 7 to 40 p=0.01 
CTX=cefotaxime pretreatment; AMOX=amoxycillin pretreatment. 
A further analysis of the rate of CAP loss was performed by grouped linear regression. This 
is more robust than simply fitting a single regression line to the mean data for each group. 
The slopes were then compared by analysis of variance. Such analysis needs to be 
interpreted with a great deal of caution as the data here are not strictly independent and (for 
the untreated group) the rate of loss over the period 60 to 180 min was barely linear 
(although passing the test for linearity). The mean rate of CAP loss over the post-perfision 
period 60- 180 min was 19 dB/h. This was significantly reduced by pretreatment with CTX 
(8 dB/h, p=0.003) or AMOX (6 dB/h, p<0,001). There was no significant difference 
between the rates of CAP loss in the CTX and AMOX groups (p=0.24). 
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The cochlear microphonics were again surprisingly preserved, with a mean loss of 20% in 
the CTX group (range 12% to 32%) and no change in the AMOX group (range 10% loss to 
17% gain). 
4.4.3. Ultrastructural findings. 
Morphological changes in the organ of Corti 
0 3 9  Perf 5 (CTX): In the basal turn some MC stereocilia were detached from the cell 
surface but the border cells remained intact. However in the mid-turn there was an area of 
extensive devastation (plate 4.13). Because of the extent and the quantity of debris, some of 
this damage is probably artefactual. 
0 3 9  Perf6 (CTX): A single crater was found in a border cell in the basal turn. There was 
mild disruption of the IHC hair bundle (plate 4.14). 
0 3 9  Perf 7 and Perf13 (CTX): The organ of Corti appeared intact. 
0 3 9  Perf15 and 19 (AMOX): Some mild irregularity of IHC hair bundles was seen (plate 
4.15) but no other damage was found. A well preserved OHC hair bundle is shown in plate 
4.16 
0 3 9  Perf 14 and 17 (AMOX): These cochleae were not examined. 
Morphological changes in bacteria 
The purpose of administering antibiotic 30 min prior to bacterial perfusion was to load the 
tissues of the inner ear and perilymphatic spaces with a bactericidal concentration of either 
cefotaxime or amoxycillin. Perilymph was not collected for antibiotic assay. In expt D39 
Perf 18 (an animal pretreated with 100 mg/kg of amoxycillin) the experimental cochlea was 
intravitally fixed 75 minutes after pneumococcal perfusion and the scala tympani surface of 
the basilar membrane examined by SEM. Plates 4.18 through 4.20 demonstrate typical 
morphological effects of cell-wall active antibiotics on gram-positive organisms: long 
filamentous forms, cell wall irregularity and chain formation. (Compare chapter 3.2.4 for 
similar effects in gram-negative bacteria.) This is qualitative evidence that antibiotic 
penetrated the inner ear and could be having a biologically relevant effect such as inducing 
cell wall shedding and arresting bacterial growth. One possible result of antibiotic treatment 
is that the organisms can be cleared more effectively. Plate 4.17 shows that few organisms 
were found on the underside of the basilar membrane 3 h after CTX treatment (compare 
plate 4.11). 
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Time Perf5 Perf6 Perf7 Perf13 Mean 95%CI 
CAP loss 5 
10 kHz 20 
(dB) 40 
60 
90 
120 
150 
180 
12 0 
0 0 
5 12 
5 10 
30 8 
17 6 
20 12 
22 16 
5 
8 
3 
0 
3 
8 
12 
17 
0 
3 
0 
6 
4 
22 
28 
35 
4 
3 
5 
5 
11 
13 
18 
23 
9 
6 
8 
7 
20 
12 
12 
14 
Baseline stimulus 25 40 35 33 36 10 
dB SPL) 
CM ratio 
0.665 0.725 0.525 0.755 
0.585 0.499 0.359 0.585 
0.88 0.69 0.68 0.77 
Inoculum CFU) 6.9 7 7 6.6 6.9 0.3 
Inoculum perfused into scala tympani in 10 of artificial perilymph. Cefotaxime 100 mg/kg given i.p. 30 
min pre-inoculation.. CAP=compound action potential; CM=cochlear microphonic; CI=confidence interval. 
Table 4.2: Cochlear perfusion of S. pneumoniae D39 with cefotaxime pretreatment: 
electrophysiological data. 
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Time Perf14 Perf15 Perf17 Perf19 Mean 95%CI 
(min) 
CAP loss 5 
10 kHz 20 
(dB) 40 
60 
90 
120 
150 
180 
0 
10 
15 
20 
25 
30 
32 
35 
0 -20 12† -2 21 
2 0 7 5 7 
2 5 5 7 9 
2 10 3 9 13 
6 1 8 10 17 
15 7 5 14 18 
16 8 8 16 18 
15 20 9 20 18 
Baseline stimulus 30 56 30 35 38 20 
dB SPL) 
CM (0 h) (mv) 0.499 0.865 0.490 0.464 
CM (3 h) (mv) 0.490 0.780 0.482 0.545 
CM ratio 0.98 0.90 0.98 1.17 1.0 0.2 
Inoculum (log,, CFU) 6.2 6.3 6.4 6.3 6.3 0.1 
Inoculum perfused into scala tympani in 10 of artificial perilymph. Amoxycillin 100 mg/kg given i.p. 30 
min pre-inoculation. CAP=compound action potential; CM=cochlear microphonic; CI=confidence interval. 
†: Baseline from pre-perfusion reading (see text) 
Table 4.3: Cochlear perfusion of S. pneumoniae D39 with amoxycillin pretreatment: 
electrophysiological data. 
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Compound action potential 
Figure 4.2: Cochlear perfusion: scatter plot of change in compound action potential. 
CAP loss (mean) 3 h after inoculation with: (i) 6.5 log,, CFU S. pneumoniae D39 with no 
treatment (D39) 100 mg/kg cefotaxime (+CTX) or 100 mg/kg amoxycillin (+AMOX) 
given 30 min prior to inoculation; (ii) 6.5 log,, E. coli K-12 or (iii) artificial perilymph alone 
(APL, historical controls included for interest only). 
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Cochlear microphonic 
Figure 4.3: Cochlear perfusion: scatter plot of change in cochlear microphonic. 
CM loss (mean) 3 h after inoculation with: (i) 6.5 log,, CFU S. pneumoniae D39 with no 
treatment (D39), 100 mg/kg cefotaxime (+CTX) or 100 mg/kg amoxycillin (+AMOX) 
given 30 min before or (ii) 6.5 CFU log10 E. coli K-12 
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Cefotaxime 
Figure 4.4: Effect of cefotaxime on pneumococcal-induced hearing loss. 
Mean CAP loss (bars: 95% confidence interval). 
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Amoxyci I I i n 
Figure 4.5: Effect of amoxycillin on pneumococcal-induced hearing loss. 
Mean CAP loss (bars: 95% confidence interval). 
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4.5. Pneumococcal perfusion with dexamethasone pretreatment. 
4.5.1. Experimental details. 
In an uncompleted study, two animals received dexamethasone (1 mg/kg body weight by 
intraperitoneal injection) 90 minutes prior to cochlear perfusion to find out whether such 
anti inflammatory adjuvant treatment would also diminish hearing loss. The dose is higher 
than that used in clinical practice (around 0.4 mg/kg; Schaad et al, 1995). 
4.5.2. Results 
The electrophysiological data suggested that dexamethasone was unable to prevent at least 
some damage to the organ of Corti. The cochlear microphonics were once again preserved. 
D39 Perf 8 Perf 9 Time (min) 
CAP loss 5 
10 kHz (B) 180 
0 0 
32 19 
Baseline stimulus 
B SPL) 
32 36 
CM ratio 1.14 0.88 
Inoculum CFU) 6.7 6.2 
CAP=compound action potential; CM=cochlear microphonic; 
Table 4.4: Cochlear perfusion of S. pneumoniae D39 with dexamethasone pretreatment: 
electrophysiological data. 
In expt D39 Perf 8, a few craters were found in the apical surface of border cells (plate 
4.21) but hair cells appeared intact by SEM. No damage was seen in expt D39 Perf 9 (plate 
4.22). Dexamethasone may therefore offer some protection against or defer the onset of 
pneumococcal-induced ultrastructural damage. 
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5. DISCUSSION 
The main experimental results can be summarised as follows: 
Experimental pneumococcal meningitis in guinea pigs causes a profound cochlear 
hearing loss as judged by electrocochleography; 
Both pneumococcal and E. coli meningitis cause ultrastructural lesions of the organ of 
Corti. Damage is more severe after pneumococcal meningitis; 
Infection with pneumolysin-deficient pneumococci (PLN-A) causes significantly less 
hearing loss but does not reduce the meningeal inflammatory response. Ultrastructural 
damage is confined to nerve endings and supporting cells; sensory cells and hair bundles 
remain undamaged; 
The course of hearing loss and the meningeal inflammatory response after infection with 
neuraminidase-deficient pneumococci is indistinguishable from that due to wild- 
type S. pneumoniae; 
Hyaluronidase-deficient pneumococci survive poorly in the CSF and the 
bloodstream, but are still able to induce hearing loss during meningitis; 
Perfusion of viable pneumococci into the scala tympani of the cochlea leads after a short 
delay to hearing loss accompanied by ultrastructural damage to the organ of Corti. 
Antibiotic pretreatment partially protects the cochlea against the effects of 
pneumococcal perfusion. 
The following discussion will consider criticisms of the meningitis model and other studies 
of hearing loss in experimental meningitis; interpret data arising from infections with the 
defined pneumococcal mutants; examine the ultrastructural and electrophysiological findings 
in the light of other studies of cochlear pathology; and outline the clinical implications of the 
findings. 
5.1. Experimental meningitis model. 
5.1.1. Clinical relevance of this experimental meningitis model 
Extending conclusions from an animal experimental model to the clinical situation needs 
suitable caution. This issue was addressed in section 1.4. The main criticisms that can be 
levelled at the model used in this thesis are: 
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The route of administering the inoculum 
Administering organisms by intracranial injection bypasses the normal immunological events 
associated with establishing bacteraemia and invasion through the blood-brain barrier. 
However these events are unlikely to influence the development of cochlear pathology. 
Organisms must still penetrate the cochlear aqueduct, which forms an immunological barrier 
in the guinea pig (Blank et al 1994) (see section 1.3.2). The reasons for choosing 
intracranial inoculation are summarised in section 1.4.1. 
Species variation in the sensitivity of the cochlea to insults 
Most of the work establishing the normal physiology of the inner ear and the effects of 
ototoxic drugs has been conducted in guinea pigs. Thus data now obtained in experimental 
meningitis may be compared with existing data about cochlear structure and function. It is 
assumed that the basic physiology and structure of the mammalian cochlea is conserved 
across species, in spite of variations in size, peak frequency sensitivity and hearing 
threshold. There are subtle differences between the pattern of ultrastructural damage caused 
by meningitis in the rabbit and the guinea pig (see section 5.2.2.). Another example of 
species difference is that carboplatin preferentially attacks IHCs in chinchillas but OHCs in 
guinea pigs (Takeno et al 1994). Such differences are relatively minor. Should it be shown, 
for example, that the main afferent neurotransmitter differs in humans and guinea pigs, then 
much of our understanding of cochlear function would be overturned, and the clinical 
relevance of this study would be reduced. But at present it is likely that the mechanisms of 
damage advanced in section 5 . 5  would be applicable to the human cochlea. 
The patency of the cochlear aqueduct in the guinea pig and in humans has been fully 
discussed in section 1.2.3. Ample evidence of cochlear damage in cases of meningitis has 
been cited in section 1.5.2. 
5.1.2. Preparation and administration of the inoculum 
At least six reported techniques have been used to prepare S. pneumoniae for intrathecal 
inoculation. Differences between these techniques include: 
whether the inoculum is animal passaged; 
the phase of growth of organisms; 
whether organisms are grown in liquid or on solid media; 
whether organisms are cryopreserved prior to inoculation. 
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It is important to recognise these differences as they might influence the development of 
meningitis and the course of the inflammatory response. The constitution of bacterial cell 
walls (in Gram-positive organisms) and lipopolysaccharide (in Gram-negative organisms) 
changes according to the phase of growth (Cross et al 1993). Evidence has been presented 
in this thesis that passaging S. pneumoniae D39 through mice enhances the ability of the 
organisms to establish meningitis in guinea pigs, although the mechanism is unclear (section 
3.2.1). Contaminants from the culture medium including expressed bacterial products may 
be inadvertantly introduced unless the inoculum is washed and resuspended. Misleading 
results may arise from failure adequately to protect organisms from freeze-thaw damage 
(Nau et al 1994), or from using overnight cultures of S. pneumoniae where many organisms 
will have autolysed (Scheld and Brodeur, 1983; Dacey and Sande, 1974). Such inocula are 
likely to contain a large amount of bacterial debris, liberated pneumolysin and other 
expressed products as well as viable organisms. 
Late log phase organisms subcultured from an overnight broth culture were used for the 
experiments presented in this thesis, in common with most investigators (O'Donoghue et al 
1974; Tuomanen et al 1985b; McCracken, Jr. and Sakata, 1985). Replicate inocula were 
prepared by a modification of a technique described by Alwmark et al (1981), who 
demonstrated that pneumococci rapidly frozen in log phase in serum broth maintained 
viability for up to 6 months at -80°C. This approach underpinned the comparison between 
different isogenic derivatives, for which replicate experiments were essential. Pneumolysin 
within the cells also survives freeze-thawing (TJ Mitchell, personal communication). The 
reproducibility of such a technique is clearly shown by the extremely small variability 
between inocula in the comparative experiments (fig 3.30), and the astonishing similarity in 
terms of rate and degree of hearing loss between the group infected with wild-type D39 and 
the group infected with neuraminidase-deficient prepared in batches many months 
apart. 
The preliminary work with Escherichia coli was conducted with the relatively non- 
pathogenic laboratory strain K-12, which was rapidly cleared from the CSF. An inoculum of 
CFU was used in accordance with previous work by Levy (1978), who found that the 
inoculum required to induce meningitis in mice by intracranial injection was about 1 000-fold 
more for K-12 than for a known pathogenic strain of E. coli. As far as is known, K-12 does 
not express any cytolytic toxins. Therefore any hearing loss and pathological damage found 
was assumed to be due to an endotoxin-mediated host inflammatory response. 
In the experimental meningitis model presented in this thesis, a relatively large inoculum was 
used in order to generate hearing loss and cochlear damage within a reasonable time scale, 
given that recovery experiments were not permitted. The use of a large inoculum does 
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slightly complicate the interpretation of the findings. Cross (1993) has made the distinction 
between a true infection model, where few organisms are inoculated and then undergo 
replication in vivo, and a challenge/toxicity model where a large number of organisms or a 
high concentration of bacterial product is presented to the animal. In the former case, host- 
immune reactions more closely mimic those in clinical infection, responding to a gradually 
increasing stimulus. But if too few organisms are inoculated, many animals fail to develop a 
meningitis, so wasting resources. In one clinical study, children presenting with 
pneumococcal meningitis had CSF viable counts of between and CFU/ml, so an 
inoculum of CFU is not unrealistically high (Feldman, 1976). Depending on the 
intention of the study, other investigators have used intrathecal inocula varying from to 
CFU (Tauber and Zwahlen, 1994). 
5.1.3. Documenting the induction of meningitis 
A meningeal inflammatory response was clearly shown by CSF white cell counting and 
estimation of protein concentration according to standard techniques. Culture of CSF 
always yielded pure cultures of pneumococci with no contamination. Because the main 
focus of the study was to record hearing loss, changes in other CSF constituents such as 
lactate and glucose were not evaluated. In early experiments the meninges were also 
examined histologically to confirm the induction of an extensive leptomeningitis after 
subarachnoid inoculation of organisms. 
Two other key problems remain with the current guinea pig model: CSF and intravenous 
access. In the traditional Dacey and Sande rabbit model, adequate CSF is available to allow 
a small aliquot to be removed every few hours. Even with special adaptations, this approach 
was never very succesful in the guinea pig model, because of CSF leakage around the 
cisternal needle and trauma to the brain-stem. In one recent study of antibiotic 
pharmacokinetics in guinea pigs the external jugular vein was cannulated (Sun et al 1996). 
No similar attempt was made in the experiments reported in this thesis, although it is 
recognised that intraperitoneal injections can be unreliable due to inadvertent penetration of 
the gut. 
In conclusion, the model of experimental meningitis in the guinea pig presented in this thesis 
proved to be technically straightforward and reproducible, helped by careful attention to the 
preparation of the inoculum. The main disadvantages were the limited duration of infection, 
lack of an intravenous route to administer drugs and the small amount of CSF available 
which made repeated sampling difficult. 
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5.2. Cochlear damage in experimental meningitis and other conditions. 
5.2.1. Data from other experimental meningitis models. 
Five groups have published data on cochlear damage in experimental meningitis of which 
three have developed various techniques for measuring hearing loss. Their work was 
introduced in section 1.5.2. and is now discussed in more detail to highlight the differences 
between previous techniques and those presented in this thesis. 
Infant rat model of pneumococcal and H. influenzae meningitis (Kaplan) 
Wiedermann et al (1986) inoculated 150 5-day old infant rats with H. influenzae type B 
(1 -1 CFU) by intraperitoneal injection and sought the development of labyrinthitis for 
up to 6 days by light microscopy. All but one animal developed a positive CSF culture. 
Leukocytic infiltration was seen in the scala tympani and scala vestibuli but not in the scala 
media. In 26% of specimens there was a suggestion that inflammation was more severe in 
the basal turn of the scala tympani. Labyrinthitis peaked 48 h after inoculation. Bacteria 
detected by a fluorescent antibody technique were not seen in the inner ear until 48 h after 
inoculation, when organisms were distributed both in the perilymphatic space and the 
endolymphatic space. No changes in cellular morphology or cochlear architecture were 
observed. There were no inflammatory changes in other perineural or perivascular channels 
and animals did not develop retrograde middle ear disease. A further study found no 
difference in the ability of H. influenzae type B strains to invade the inner ear, whether or 
not they were strains derived from clinical cases who had become deaf (Kaplan et al 1989). 
Systemic induction of pneumococcal meningitis in infant rats proved to be more difficult, 
with only half of a group of 24 5-day old rats developing bacteraemia and meningitis after 
three intraperitoneal injections of S. pneumoniae type 6 (>1 CFU) (Rodriguez et al 199 1). 
Animals were examined 24 h after the final inoculation. Inflammation was found in the scala 
tympani (86%) and the scala vestibuli (55%) but not in the scala media. Bacteria were only 
found in the inner ear of 2 animals (18%) but examination by Gram stain is not as sensitive 
as using a fluorescent antibody stain. These studies in infant rats suggest that inflammation 
in the scala tympani extends from the subarachnoid space via the cochlear aqueduct and 
might precede bacterial invasion. It is not known how such suppurative labyrinthitis affected 
the inner ear as hearing was not measured nor the ultrastructure of the organ of Corti 
examined. 
Guinea pig model of Streptococcus suis meningitis (Kay) 
The technique for measuring brain stem responses in small animals by averaging far-field 
potentials in response to an auditory click was pioneered by Kay et al (1984). Stimulus 
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intensity was decreased in discrete steps of 5 dB and the hearing threshold was defined as 
the minimum stimulus level at which an obvious evoked response appeared. This technique 
was then applied to a study of experimental Streptococcus suis meningitis in guinea pigs 
(Kay, 1991). Hearing was assessed prior to inoculation and then re-assessed once signs of 
meningitis became evident. Animals were inoculated with a washed overnight culture of S. 
suis via three routes: intraperitoneal CFU; n=15); intracranial CFU; n=10) or 
intrabullar CFU; n=15). After the experiments the animals were perfused transcardially 
and the ears examined histologically. This study has a number of flaws: hearing was not 
assessed in many animals because they were found dead (indeed six of the ten animals 
inoculated intracranially died within 12 h); the hearing loss data are not presented 
numerically, preventing proper analysis; no controls were tested; and only click-evoked 
responses were evaluated giving a coarse assessment of hearing loss (see section 3.1.4). In 
spite of this, Kay presents the only published evidence that systemically-induced 
experimental meningitis (as opposed to intracranial inoculation) leads to hearing loss. Of the 
15 animals inoculated i.p., seven became unwell and four of five of these animals examined 
sustained a bilateral and severe hearing loss. In all, a total of seventeen animals were 
evaluated of which fifteen had hearing loss which was invariably associated with a 
suppurative labyrinthitis. Inflammation was limited mainly to the scala tympani with no 
evidence of inflammation in the scala media, just as found in the infant rat model. 
Rabbit model of pneumococcal meningitis (Tuomanen). 
The work with which the data presented in this thesis is most closely comparable is found in 
a series of three publications from Tuomanen's group at the Rockefeller Institute, New 
York. This group have investigated hearing loss in a modification of the Dacey and Sande 
rabbit model of experimental pneumococcal meningitis, using click- and tone-evoked brain 
stem response audiometry with an accuracy of no better than ±10 dB. In all the studies, 
rabbits were inoculated with CFU mid-log phase virulent type III S. pneumoniae by 
intracisternal injection. This inoculum is about 2 log units less than in the guinea pig model 
reported in this thesis. When infected in this way hearing loss occurred after a latent period 
of some 12 h, affecting all ears by 36 h after infection (Bhatt et al 1991). Histological 
examination demonstrated marked leukocytic infiltration of the scala tympani in all infected 
animals, with dilation of the cochlear vasculature and possible thrombosis in the stria 
vascularis. The cochlear aqueduct was patent but infiltrated with inflammatory cells. The 
organ of Corti appeared normal by light microscopy except in a few cases where 
degenerative changes in hair and supporting cells were invariably associated with leukocytic 
infiltration of the scala media. Interestingly, none of the infected animals became 
bacteraemic, in contrast with the experiments described in this thesis. 
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A subsequent study (Bhatt et al 1993) confirmed that hearing loss in experimental 
pneumococcal meningitis progressed with time and correlated with the development of a 
meningeal inflammatory response. Hearing was not affected until the CSF leukocyte count 
exceeded 2000 Regression analysis showed a similar rate of hearing loss of about 3 
dB/h for all stimuli (click, 1 kHz and 10 kHz tones). However, the onset of high frequency 
(10 kHz) loss occurred on average about 3 h earlier than low-frequency (1kHz) loss. A 
single rabbit underwent light-microscopic examination of the cochlea 19 h after inoculation 
when it had sustained a hearing loss of just 10 dB at 10 kHz. There was an inflammatory 
cell infiltrate in the scala tympani and the cochlear aqueduct, and the presence of 
pneumococci in the scala tympani was confirmed by immunohistochemical staining. It was 
suggested that there was a “base-to-apex” gradient of inflammation caused by inflammation 
spreading upwards from the cochlear aqueduct, and that this could explain the earlier onset 
of high-frequency loss. No damage to the organ of Corti was observed. Because this was a 
light microscopic study, it is certain that many subtle changes in the organ of Corti 
demonstrated in this thesis and by Osborne et al (1995) in experimental meningitis in the 
rabbit would have been missed (see below). 
The next study reported that ceftriaxone treatment with or without adjuvant dexamethasone 
could alter the course of hearing loss in an identical rabbit model (Bhatt et al 1995). 
Infected rabbits were allowed to recover and were examined up to two weeks after 
inoculation. This sort of work would have been impossible to conduct in Birmingham (for 
reasons outlined in the Methods) and so no attempt was made to duplicate these findings in 
the guinea pig model. Rabbits were divided into three groups of five subjects all of which 
were inoculated as above. Group I received sham injections, group II received ceftriaxone 
(75 mg/kg i.v.) at 12, 24 and 36 h post-inoculation while group III received in addition 
dexamethasone (0.5 mg/kg i.v.) 10 min prior to each of the three antibiotic doses. As 
expected all untreated animals sustained bilateral hearing loss of at least 40 dB by 30 h after 
inoculation. After five days, subjects treated with antibiotic alone had sustained a mean 
hearing loss (10 kHz) of 22 dB, while those who received adjuvant dexamethasone had lost 
just 18 dB. Two animals in each group went on to recover hearing by the time of the next 
hearing assessment two weeks after inoculation. Because of the small size of the groups and 
the coarse nature of the hearing measurements (with a minimum of 10 dB steps in stimulus 
interval) this study had far too little power to demonstrate clearly that adjuvant 
dexamethasone therapy was of greater benefit than antibiotic treatment alone. Reversible 
hearing loss has not previously been reported in experimental meningitis, simply because the 
long-term recovery experiments have not been performed. 
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Rabbit model of E. coli and H. influenzae meningitis (Osborne). 
Osborne et al (1 995) used high-resolution scanning and transmission electron microscopy to 
document ultrastructural damage to the organ of Corti during short-term experimental 
meningitis induced by Haemophilus influenzae CFU) or E. coli strain 2073 (a 
pathogenic strain isolated from a clinical case of meningitis; CFU) or E. coli strain K-12 
or CFU) in rabbits. Relatively large inocula were used in order to induce cochlear 
damage within a reasonable time limit. No particular endpoints were specified in the study 
and animals were sacrificed at a variety of times and degrees of hearing loss to see at what 
level of hearing loss damage to the organ of Corti could be detected. Hearing was 
monitored by click-evoked auditory brain-stem response testing, and ranged from 40 to 
>50 dB over 9 to 20 h during H. influenzae infection, and from 20 to >60 dB during E. coli 
infection. Bacteraemia was not sought, nor was the CSF examined quantitively. 
At low levels of hearing loss (<20 dB) very little structural damage to the organ of Corti 
was found. However, bacteria were found to have invaded the scala media. Analysis of 
transmission electron micrographs suggested that organisms penetrated the basilar 
membrane at the level of the spiral ligament and then migrated beneath the Claudius cells to 
reach the stria vascularis. Bacteria were also seen in the spaces between the OHCs. With 
greater hearing loss (>20 dB) pathological lesions were observed in patches of the organ of 
Corti. Damage affected hair cells, supporting cells and nerve endings. Hair cell bundles were 
distorted, stereocilia were fused, and the apical surfaces of the sensory cells were sometimes 
ballooned out or cratered. Mitochondria within hair cells were swollen and the cell 
cytoplasm vacuolated. Supporting cells sustained craters to the apical surface, particularly 
within the inner sulcus region. Nerve endings, particularly beneath OHCs, exhibited 
fragmentation of the plasma membrane and loss of intracellular organelles. 
The damage to the supporting cells (so breaching the reticular lamina) and lesions in the 
stria vascularis led the authors to propose that dissipation of the endocochlear potential 
could contribute to meningogenic hearing loss. 
Guinea pig model of pneumococcal meningitis (Blank) 
Blank et al (1994) conducted a histological study of acute meningogenic labyrinthitis in 
guinea pigs inoculated intracisternally with various amounts of S. pneumoniae type 3 (103 to 
CFU). The highest inoculum, which is approximately the same as the one used in the 
experiments reported in this thesis, proved fatal within 12 h. With lower inocula, animals 
survived for up to 15 days. Inflammation extended to the inner ear by extension along the 
cochlear aqueduct. However, infection then spread to the middle ear by destruction of the 
round window membrane to cause a retrograde otitis media. Reactive bone formation was 
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observed akin to the labyrinthine osteosclerosis sometimes observed in clinical cases of 
meningitis who have been deafened (Johnson et al 1995). This work therefore complements 
the study reported in this thesis by examining the development of histological changes in the 
inner ear after experimental pneumococcal meningitis over a longer time period. It also 
confirms the importance of the cochlear aqueduct as a means for the spread of infection 
from the subarachnoid space in guinea pigs. 
Improving these models of meningogenic hearing loss 
Two unresolved issues stand out from this work and were directly addressed when 
designing the experiments reported in this thesis: 
i) Is the hearing loss observed in experimental meningitis due to cochlear dysfunction, as 
suggested by the ultrastructural findings and evidence of labyrinthitis? 
ii) Does ultrastructural damage to the organ of Corti occur in pneumococcal meningitis? 
The data presented in this thesis constitute the first clear evidence that hearing loss in 
experimental pneumococcal meningitis is indeed due to cochlear dysfunction. This was 
achieved by modifying the technique of round-window recording of the auditory nerve 
compound action potential (CAP) to allow longer term recording. Cody et al (1980) have 
carefully validated CAP recording (or electrocochleography) in guinea pigs as an 
accurate measure of the functional state of the organ of Corti over the range 2 kHz to 30 
kHz. They found excellent agreement between the site of mechanically induced hair cell 
lesions and the frequency of maximum sensitivity change in the audiogram. They also 
found that recording the CAP from the round window membrane was rapid and 
reproducible to within 3 dB. The development of the technique was discussed in section 
3.2 .3 .  Further refinements would include the use of a silver ball electrode rather than a fine 
wire (this would reduce the chance of inadvertent puncture of the round window 
membrane) and the use of two electrodes placed on opposite sides of the cochlea to reduce 
interference from cochlear microphonics. As an alternative, the gate could be designed to 
deliver stimuli of alternating polarity, thereby cancelling out the cochlear microphonics. This 
would certainly improve precision at the lower frequencies where CM is prominent. In spite 
of these limitations, round window CAP recording offered greatly increased precision over 
recording far-field potentials and therefore improved the power of this study to detect a 
genuine difference between groups of subjects. 
Comparison with hearing loss data presented in this thesis 
With wild type pneumococcal meningitis in the guinea pig, hearing loss could be detected as 
early as 3 h after inoculation and was progressive. Indeed, hearing loss appeared to be 
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decline in linear fashion. This is in contrast to the lag reported by Bhatt et al in the rabbit 
model. This is almost certainly because a larger inoculum was used in the guinea pig model, 
containing more pneumolysin and inducing an earlier and probably more severe meningeal 
inflammatory response. In one experiment (D39(17)) a CSF leukocytosis was detected just 
3 h after inoculation. In addition, the cochlear aqueduct in the guinea pig is shorter than that 
in the rabbit, allowing earlier cochlear invasion. The rate of hearing loss (4 dBk) is a little 
more than that seen in the rabbit model, and again this may be explained by the higher 
inoculum. 
Data was obtained at many more frequencies than previously reported, allowing the 
construction of audiograms over the range 3 to 10 kHz. The shape of these was remarkably 
consistent, with a peak loss between 6 and 7 kHz, the peak sensitivity for the guinea pig 
cochlea. There was a trend to less hearing loss at the lower frequencies. However, no 
evidence was found to support the findings of Bhatt et al that high-frequency hearing loss 
precedes low-frequency loss. Again, this could be a result of the higher initial inoculum 
inducing a severe meningitis and an overwhelming suppurative labyrinthitis, whereas in their 
model a more progressive invasion of the scala tympani might occur. Certainly, on 
inspection of the scala tympani during dissection a gross inflammatory infiltrate could be 
seen filling the entire scala on several occasions. It is not necessary however to invoke a 
“base-to-apex” gradient of inflammation, as there are longitudinal gradations of hair cell 
structure and metabolism and endolymphatic potential (Slepecky, 1986) in the cochlea that 
might cause a greater susceptibility to high frequency loss. Many other non-inflammatory 
insults also cause more damage in the basal turn (see section 5.2.3). If anything, the data 
from the guinea pig model suggest that the most sensitive area of the cochlea is the most 
susceptible. 
No previous studies have reported changes in cochlear microphonics in experimental 
meningitis. Although there was great variability between animals, there was a clear trend 
towards loss of cochlear microphonics in animals infected with all the variants of S. 
pneumoniae D3 9. Cochlear microphonics predominantly reflect OHC function. Thus a fall 
in CM suggests significant cochlear pathology at the level of the hair cell, confirming that 
cochlear damage is at least partly responsible for meningogenic deafness. 
5.2.2. Ultrastructural lesions of the organ of Corti in experimental meningitis. 
The second major aim in this study was to document ultrastructural lesions that might 
correlate with hearing loss. The ultrastructure of the organ of Corti had not been examined 
in previous studies of experimental meningitis. This work developed in tandem with 
ultrastructural studies of the organ of Corti in meningitis in the rabbit (Osborne et al 1995) 
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so that parallels could be sought. Light microscopic analysis of the cochlea was not 
performed, except to examine guiding sections prior to cutting ultrathin sections for TEM 
analysis. Scanning electron microscopy was performed on a transmission electron 
microscope fitted with a scanning attachment, resulting in a very high resolution of the 
order of 3 nm. Because the detector is so close to the specimen, back-scattered electrons 
are less of a problem than in conventional SEMs, and higher accelerations (40 kV) can be 
used. However, the specimen size is greatly limited, with a maximum height of 4 mm. 
Where necessary the apices of the modioli were trimmed away so just the first two turns of 
the cochlea were routinely examined with SEM. 
Artefacts encountered included curling of the organ of Corti, so obscuring the surface, and 
cracking of supporting cells deep in the inner sulcus. With experience, these artefacts were 
easily distinguished from the more subtle craters in the apical surface of supporting cells, 
which were never seen in historical control specimens. Faults in the critical point dryer led 
to spoilage of several specimens (most notably the cochleas from animals challenged with 
pneumococcal cell wall). There is a large sampling error in TEM studies, since the ultrathin 
sections examined only represent a tiny fraction of the organ of Corti. 
Meningitis due to E. coli K-12 was not expected to cause much ultrastructural damage to 
the organ of Corti, according to our hypothesis that intracellular toxins were important in 
causing cochlear damage. A number of lesions were found, although damage was very 
patchy and some cochleas appeared to be intact even after several hours of meningitis. With 
pneumolysin-producing pneumococcal infection in the guinea pig there was a clear 
progression of damage: 6 h after inoculation, craters developed in the apical surface of 
border cells; by 9 h IHC and OHC hair bundles were deformed and between 9 and 12 h the 
apical surface of some OHCs was ballooned out. Pathological nerve endings were found 
particularly affecting neural elements associated with OHCs. In the absence of pneumolysin, 
the only convincing damage was to the nerve endings, with the apical surfaces of the hair 
cells and hair bundles remaining intact. The stria vascularis was not examined. These lesions 
will now be discussed in turn. 
Specific lesions of hair bundles 
In meningitis due to E. coli IHC hair bundles were damaged sporadically with uprooting, 
splaying and fusion of stereocilia. The appearance is similar to that following perfusion of 
endotoxin through the scala tympani, where individual stereocilia could be found attached 
to the undersurface of the tectorial membrane (Tarlow et al 1991). In pneumolysin- 
producing pneumococcal meningitis in the guinea pig the IHC hair bundles were also 
damaged. In pneumococcal meningitis in the rabbit there was striking injury to IHC hair 
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bundles with many stereocilia being completely absent, and those remaining being grossly 
shortened and deformed. 
Outer hair cell hair bundles were severely affected by wild type pneumococcal meningitis, 
with fusion of stereocilia and collapse of the hair bundle onto the surface of the sensory cell. 
This was not seen with infection with E. coli nor in the absence of pneumolysin. In the 
rabbit there was less evidence of damage to the OHC hair bundles but only a few specimens 
were examined. 
Given the absence of inflammation in the endolymphatic compartment, it is at first surprising 
that there should be so much damage to the endolymphatic surface of the organ of Corti. 
TEMs clearly show pathological damage of OHC hair bundle stereocilia, with loss of the 
plasma membrane, fusion and disintegration. This suggests that the stereocilial lesions are 
secondary to metabolic changes in the sensory cell. The interaction between stereocilia and 
the tectorial membrane may also be disrupted. Normally, the tips of the stereocilia of the 
hair bundles of IHCs and the first two rows of OHCs are not firmly embedded in the 
tectorial membrane (Lim, 1986). Disturbance of the tectorial membrane induced by 
endotoxin (Comis et al 1991) or by a change in the potassium concentration of the 
endolymph (Leng and Comis, 1979) might render the tectorial membrane more sticky or 
swollen, causing stereocilia to become detached during specimen processing. 
Specific lesions of hair cells 
The IHC bodies themselves were not greatly affected in any of the guinea pig experiments; 
no TEM studies were performed in the rabbit. This lack of damage is surprising given the 
defects in the nearby border cells. The intercellular junctions between the IHCs and the 
adjacent phalangeal processes appeared to be damaged (as judged by SEM) during infection 
with pneumolysin-producing S.pneumoniae (D39, 
In pneumolysin-producing pneumococcal infection, OHCs were severely affected. Infection 
with DNA1 appeared to cause the most damage as judged by TEM, but this again could 
reflect sampling error. Damage consisted of breakdown of the basolateral and apical plasma 
membrane especially at the site of the basal corpuscle, cell swelling, and vacuolation of the 
mitochondria. Cytoplasmic contents could be seen spewing out of the cell. The SEM 
appearances are striking, with severe deformation of the whole apical surface. Sometimes 
the cuticular plate appeared to be lifted clear of the surrounding phalangeal processes. 
Damage was almost completely confined to the first two rows of OHCs. In noise-induced 
damage, first row OHCs are in general more easily injured than third row OHCs (Slepecky, 
1986). However after mechanical trauma to Reissner's membrane it is third row OHCs 
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which bear the brunt of the damage (Cody et al 1980). It is not clear why first row cells are 
more susceptible to the damage induced by inflammation. 
Selective destruction of OHCs by kanamycin abolishes practically all of the CM and 
modifies the tuning curves of the IHC (Dallos et al 1972; Evans and Harrison, 1975). 
Zwislocki (1984) has even suggested that absence of OHCs would increase the shearing 
forces on most of the IHC stereocilia and cause hypersensitivity of the cochlea. Damage to 
OHCs will not therefore necessarily result in a fall in CAP. Inner hair cell tuning curves 
were not measured in the experiments presented in this thesis. In some of the meningitis 
experiments, the CAP thresholds improved over the first 3 h post inoculation. A similar rise 
in CAP threshold occurs initially when cytoplasmic fractions of H.influenzae type B are 
perfused into the inner ear (Dover et al, unpublished findings). If this is a genuine effect it 
may be due to an increase in synchronised firing of single units as seen when 
neurotransmitters such as noradrenaline are perfused into the cochlea (Comis and Leng, 
1979). It could also be due to failure to obtain the best recording conditions initially. 
Cochlear microphonic measurements from the round window during pneumococcal 
meningitis declined substantially, which correlates with significant damage to OHCs and 
OHC nerve endings. 
Supporting cell damage 
A consistent finding in all of the meningitis experiments was shallow cratering of the apical 
surface of the border cells and sometimes the adjacent inner sulcus cells. The importance of 
this region is that it forms part of the boundary between the endolymphatic and 
perilymphatic compartments; any damage here would allow intermixing of cochlear fluids. 
Where craters were observed, IHC hair bundles were usually disrupted, suggesting a link 
between IHC pathology and the supporting cell damage. At the point where craters were 
most frequently seen, the border cells are reduced to a thin rim of cytoplasm where they 
overlie the body of the IHC and its associated nerve endings (see plate 3.52). This may 
render them more susceptible to excitotoxic damage (see section 5.5.3). 
Cratering of the phalangeal cells between the inner and outer hair cells was prominent in 
rabbit pneumococcal meningitis. In the guinea pig, damage in this region appeared to be 
limited to fragmentation of the basolateral plasma membrane and vacuolation of the 
mitochondria. Surface craters could be explained by a preparation artefact at a site of pre- 
existing damage or, more likely, represent true loss of the apical cell membrane. 
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Nerve ending damage 
Another consistent finding unaffected by the absence of pneumolysin was vacuolation of 
mitochondria in nerve endings and fragmentation of the plasma membrane. Some of the 
nerve endings were severely damaged and swollen. Cochleas were fixed within two minutes 
of removal from the animal so it is difficult to invoke post-mortem deterioration as the 
reason for the observed damage. 
It is not possible to predict how this damage would affect neural transmission overall, given 
the large sampling error and the fact that single fibre recording was not performed in this 
study. Much of the damage in meningitis appeared to be localised to (presumably mostly 
efferent) nerve endings bordering OHCs, which may not therefore directly affect the CAP. 
However a strong clue that afferent neural transmission was affected is provided by the loss 
of uniformity of the CAP as pneumococcal meningitis proceeds. In addition, the presence of 
a large wave which is thought to reflect the summed excitatory post-synaptic potentials 
suggests that hair cell depolarisation and synaptic release is maintained even when there is a 
substantial hearing deficit (see section 1.3.5 and Eybalin, 1993 p. 323) 
Resistance of the scala media to invasion and inflammation 
The resistance of the scala media to inflammation was demonstrated in the experiments 
presented in this thesis and is a fairly consistent feature in all of the histopathological studies 
of experimental meningitis. If haematogenous dissemination were the main route of bacterial 
invasion into the cochlea, one would expect the highly vascular stria vascularis (and hence 
the scala media) to be a major site of bacterial ingress. Evidence however suggests that the 
main route of invasion of the cochlea is by extension via the cochlear aqueduct. In fact 
Osborne et al (1995) presented evidence that organisms infiltrate through the basilar 
membrane and penetrate between the hair cells and around the spiral ligament. Invasion of 
the scala media by H. influenzae type B was found by Osborne et al (1995) in rabbits and 
Wiedermann et al (1986) in infant rats, but even then there was little inflammatory reaction. 
In the rabbit, organisms were found emerging onto the surface of the organ of Corti. In the 
guinea pig experiments reported in this thesis, some organism-like structures were also 
observed on the surface of the organ of Corti with both wild-type and PLN-A infection. 
These structures were only ever seen above the junction between the IHC and its adjacent 
border cell. They were not solely seen in areas where the intercellular junctions appeared to 
be damaged. No organisms were seen in the intercellular spaces beneath the reticular 
lamina, probably due to sampling error. 
The resistance of the scala media to inflammation and bacterial invasion in the face of 
massive bacterial and leukocytic infiltration of the scala tympani is quite striking. It probably 
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reflects the nature of the boundaries of this compartment, designed to maintain extremely 
high electrochemical gradients. It is however insufficient to prevent serious damage to the 
organ of Corti as a whole. 
Comparison of findings in rabbit Hib and E. coli meningitis with data in this thesis 
There are many similarities between the damage identified in pneumococcal meningitis in 
the guinea pig and that induced by H. influenzae type B or E. coli meningitis in the rabbit 
(Osborne et al 1995); specifically, the appearance of the border cell craters, the ballooning 
of the apical surface of OHCs and the fragmentation of the plasma membrane of both the 
hair cells and the nerve endings. Animals were examined at about the same time intervals 
after induction of meningitis. Damage in the guinea pig seemed to be more widespread and 
in general more severe. Vacuolation of the hair cells was certainly more pronounced with 
infection, and many more OHCs appear to be damaged than in the rabbit as judged 
by SEM. However, this was not quantitatively assessed. The differences are probably 
because hearing loss was greater in pneumococcal meningitis in the guinea pig. Osborne et 
al recorded a hearing loss to click stimuli of less than 50 dB in eight of 10 animals whereas 
the mean loss in the guinea pig series was 50 dB at 10 kHz. These values are not strictly 
comparable, as the loss of sensitivity to click stimuli represents a more profound hearing 
loss than loss to a tone pip. Border cell craters occurred in a linear fashion in the rabbit that 
was not as apparent in the guinea pig. E. coli K-12 induced border cell craters in the guinea 
pig whereas it induced little damage to the supporting cells in the rabbit. 
In conclusion there is great similarity in the specific ultrastructural lesions observed in two 
different species resulting from infection with three different organisms. This suggests that 
the organ of Corti has a limited way of responding to inflammatory insults. It also gives 
more confidence that the ultrastructural lesions observed are genuinely a result of the 
meningitis. 
5.2.3. Cochlear lesions in other conditions 
It is clearly important to distinguish changes due to delayed or defective fixation from those 
due to genuine pathological damage. Osborne and Comis (1990) have carefully investigated 
the time-course of post-mortem changes in the guinea pig cochlea with high-resolution 
scanning electron microscopy. The basal turn is much more susceptible to post-mortem 
damage than the apical turn. The earliest changes observed just 15 minutes after death 
consist of separation of the hair bundle stereocilia (with loss of lateral links) and ballooning 
of the apical surface of the sensory cells. By 2 h after death fusion of stereocilia is common 
and there is severe disruption of the cuticular surfaces of the hair cells. By 4 h most of the 
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IHCs at the base have disintegrated. Many of these changes resemble those found after 
experimental pneumococcal meningitis. Cochleas included in the ultrastructural study were 
all fixed within two minutes of removal from animals which appeared to be well 
oxygenated. Thus post-mortem artefact is unlikely to explain the observed lesions. In any 
case, tearing and distortion of the cuticular surface of the hair cells and disruption of the 
tight junctions between the cells cannot be ascribed to post-mortem damage as these are 
late phenomena. 
Drug-induced ototoxicity due to aminoglycosides or platinum agents usually affects OHCs 
more than MCs. Defects range from mild disruption of the stereocilia to complete loss of 
the sensory cell. First row OHCs appear to be particularly susceptible to kanamycin which 
in a sufficient dose destroys all the OHCs in the first two turns of the guinea pig cochlea, 
resulting in a 90% fall in cochlear microphonics (Dallos et al 1972). Hair cells and their hair 
bundles rather than supporting cells bear the brunt of the damage. Whereas in meningitis 
stereocilia appear to become completely detached from the cuticular plate, after kanamycin 
treatment the roots remain (Osborne and Comis, 1990). This suggests a difference in the 
underlying mechanism, which is possibly due to the disruption of actin filaments as a result 
of raised intracellular calcium. The more severe damage such as formation of 
fusion/extrusion bodies on the surface of the sensory cells closely resembles the ballooning 
of the apical surface of the OHCs seen in pneumococcal meningitis. As in other conditions, 
drug-induced ototoxicity preferentially affects the basal turn of the cochlea before the apex 
(Osborne and Comis, 1990). 
5.3. The role of pneumococcal products in causing meningogenic 
deafness. 
5.3.1. Interpreting data in insertion-duplication mutagenesis studies: a caution. 
Investigating the pathogenesis of infection by omitting key virulence factors would appear 
to yield much useful data. But in spite of many refinements in the genetic techniques, 
interpreting such studies is not immediately straightforward. The problem may be illustrated 
thus: omitting a fuse in a circuit and finding that the power fails does not mean that the 
missing fuse is the source of the power. In the same way, omitting pneumolysin from the 
armoury of toxins produced by S. pneumoniae and finding a significant reduction in hearing 
loss does not necessarily mean that pneumolysin itself was responsible for all of the hearing 
loss. It is possible that pneumolysin could act as a co-factor by its actions on the immune 
system or by allowing another toxin access to structures it cannot normally reach. For 
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example, a study with the autolysin-deficient mutant AL- 1 showed reduced virulence for 
mouse bacteraemia. This was not because autolysin itself enhances virulence directly, but 
because without autolysin pneumococci fail to lyse so preventing the release of pneumolysin 
(Berry et al 1992). 
Then there is the possibility that the genetic manipulation alters the pathogenicity of the 
organism in some subtle way. One problem is that of a polar effect, where the gene 
manipulation inadvertently disrupts gene expression at a site downstream from the insertion 
site. Insertion-duplication mutagenesis causes more of a problem in this respect than the 
direct introduction of point mutations into the existing chromosomal gene. This so-called 
“polar effect” is a possible explanation for the poor in vivo growth of the mutant. 
One way of circumventing this would be to attempt to reconstitute full virulence by 
inserting a plasmid expressing hyaluronidase. If virulence is restored then it is clear that the 
absence of hyaluronidase itself is critical, as any downstream genes inadvertently disrupted 
by the original manipulation will remain inactivated. 
The stability of the mutant might be proven in one in vivo system but not be assured under 
the different, perhaps harsher, pressures of growth in another system. Again this is a 
problem with insertion-duplication mutagenesis where it might be imagined a large chunk of 
DNA could be shed from the chromosome with some advantage to the cell. Undetected 
reversion to wild-type phenotype would result in misleading findings, particularly when 
there is no apparent difference between the outcome of infection with the wild-type and 
with the mutant, as in the ANA1 study reported here. Thus in the experiments conducted in 
this thesis organisms recovered from the CSF were subjected to careful phenotypic analysis. 
As a further check, Southern blotting would have demonstrated preservation of the insert 
but this was not performed. Checks for antibiotic sensitivity were less helpful in this regard 
as there appeared to be some loss of antibiotic resistance with full preservation of the 
mutant phenotype in recovered organisms. This remains unexplained. 
Therefore conclusions from insertion-duplication mutagenesis studies should be consistent 
with expected biological activities of the products concerned. For PLN-A the findings are 
entirely consistent with the expected effects of omitting pneumolysin. The findings with 
and especially need much more cautious interpretation because much less data 
are available about the in vitro and in vivo effects of neuraminidase and hyaluronidase. 
5.3.2. Pneumolysin 
Microperfusion of purified recombinant pneumolysin (PLY; 0.5 to 10 total in 10 into 
scala tympani causes rapid devastation of the organ of Corti in a concentration-dependent 
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fashion (Comis et al 1993). Both the compound action potential and cochlear microphonics 
are reduced substantially. At lower doses the effect of PLY on CAP and CM is reversible. 
Ultrastructural damage consists of disruption and splaying of the hair bundle stereocilia, 
cratering of the apical surface of the hair cells and supporting cells and tearing away of the 
hair cells from the adjacent supporting cells. These changes are qualitatively identical but 
more severe and less patchy than those occurring after pneumococcal meningitis. The 
outermost row of OHCs is most susceptible to purified PLY, whereas in pneumococcal 
meningitis it is the innermost rows that sustain the most damage. The difference in the site 
of maximum damage is likely to be due to different localised concentrations of PLY when 
administered by cochlear perfusion compared to its natural release during meningitis. 
It is striking that the very ultrastructural changes induced by PLY are those that are 
abolished by infection with pneumolysin-deficient PLN-A. Compared to D3 9, infection with 
PLN-A caused an identical meningeal inflammatory response (as far as the power of the 
study allowed detection of these secondary differences), significantly less hearing loss at all 
frequencies tested (12 dB vs. 50 dB at 12 h at 10 kHz) and a slower rate of hearing loss (1 
dB/h vs. 4 dB/h). Damage to the reticular lamina and associated tight junctions, cratering of 
the apical surfaces of sensory cells and supporting cells, and significant damage to the hair 
bundles did not occur after PLN-A infection. 
The effect of pneumolysin expression on the toxicity of S. pneumoniae for respiratory 
mucosa has been studied by inoculating isolated human turbinate tissue maintained in an 
organ culture with an air interface with CFU/ml S. pneumoniae D39 or PLN-A (Rayner 
et al 1995). Wild-type infection causes a progressive fall in ciliary beat frequency over 48 h. 
Organisms particularly adhere to the mucus layer and damaged areas of mucosa. Damage to 
the mucosal surface consists of disorganisation of cilia, extrusion of ciliated cells, blebbing 
and cratering of the apical cell surfaces, and tearing of the tight junctions between unciliated 
epithelial cells. Organisms bind to the free edges of these cells. This damage very much 
resembles that seen in the organ of Corti as a result of pneumococcal meningitis, with the 
exception of bacterial adherence to damaged cells. When inoculated with PLN-A, ciliary 
beat frequency falls less quickly and a smaller area of the mucosa sustains significant 
damage. Cilia are unaffected and tight junctions between unciliated cells remain intact, so 
that far fewer organisms bind to normal mucosa. This is entirely consistent with the reduced 
effects of PLN-A on the guinea pig cochlea. Thus pneumolysin expression aids the 
adherence of S. pneumoniae to normal respiratory epithelium and causes additional 
ultrastructural pathology which is of a similar character to that observed in the organ of 
Corti after pneumococcal meningitis. 
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Pneumolysin expression appears not to affect the course of the acute meningeal 
inflammatory response in experimental pneumococcal meningitis, even though purified 
pneumolysin is capable of evoking an inflammatory response (see section 1.2.6). In rabbits 
Friedland et al (1995) found that inoculation with mid log-phase S. pneumoniae D39 or 
PLN-A CFU) yielded identical changes in CSF white cell count, protein and TNFa 
concentration. The in vivo growth curves were also identical and there was no evidence of a 
lag phase. In the guinea pig model reported here there was also no difference in the 
meningeal inflammatory response evoked by S. pneumoniae D39 or PLN-A. In spite of this 
there were striking differences in ultrastructural and electrophysiological damage sustained 
by the organ of Corti. This data together with the lack of cochlear damage induced by 
intracisternal injection of pneumococcal cell wall suggest that non-specific meningeal 
inflammation cannot of itself mediate hearing loss. 
Although pneumolysin expression may not influence the development of meningeal 
inflammation the evidence presented in this thesis and the toxicity shown in cochlear 
perfusion studies support a major role for pneumolysin in the pathogenesis of hearing loss in 
pneumococcal meningitis. 
5.3.3. Neuraminidase 
In this study, there were no distinguishable differences between the course of meningeal 
inflammation, in vivo growth, bacteraemia or cochlear damage induced by intracranial 
inoculation of wild-type S. pneumoniae D3 9 or its neuraminidase-deficient derivative 
The data in this thesis are among the first available on the behaviour of a 
neuraminidase-deficient pneumococcal mutant in vivo. In experimental mouse pneumonia, 
fails to replicate in the alveoli but can induce a bacteraemia (TJ Mitchell, unpublished 
observations). Identical strains made in the same laboratory were used in the mouse 
pneumonia study and the meningitis experiments reported here. The finding of widely 
different behaviour in vivo in these two different models therefore gives greater confidence 
to the results: a polar effect is less likely to explain the poor growth in the mouse alveoli 
given that the organisms grow well in guinea pig CSF and blood, and the strain used 
in the meningitis study is definitely less virulent in certain settings. 
It is possible that S. pneumoniae D39 only expresses a small amount of neuraminidase, 
which is critical for intra-alveolar replication but whose lack does not impair replication in 
the CSF or blood. In this regard, the neuraminidase production of S. pneumoniae D39 in 
vitro is around 7 mU/mg cell protein whereas in the type III strain GB05 it is about 1000 
mU/mg cell protein (TJ Mitchell, personal communication). Only in vivo expression 
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experiments would ascertain whether neuraminidase production between strains differed 
within the CSF space during infection. 
In conclusion the existing evidence that neuraminidase has an important role in the 
pathophysiology of pneumococcal meningitis is circumstantial (see section 1.2.7). This 
study does not support any role in pathogenesis once intracranial pneumococcal infection is 
established, although neuraminidase may well be important in earlier stages of 
pneumococcal infection. 
5.3.4. Hyaluronidase 
Preliminary data about the course of infection with a hyaluronidase-deficient strain of S. 
pneumoniae are presented. In spite of the poor survival of in vivo, the 
cochlea sustains almost as much electrophysiological and ultrastructural damage as in wild- 
type infection. Presumably, sufficient quantities of pneumococcal cell wall and pneumolysin 
were present in the initial inoculum to ensure the subsequent pathological effects. In 
preliminary experiments in the mouse pneumonia model, fails to replicate in the 
alveoli and animals do not become bacteraemic, results that are consistent with the 
meningitis data (TJ Mitchell et al unpublished data). It would be attractive to conclude that 
hyaluronidase has some hitherto unsuspected nutritional or anti-host defence action, but a 
polar effect of the mutation must first be excluded (see section 5.3.1). 
5.3.5. Pneumococcal cell wall 
The purpose of inducing meningitis with pneumococcal cell wall was to see if a sterile 
meningeal inflammatory response alone would cause cochlear pathology, and to better 
define the role of PCW (if any) in this process (see section 1.2.5). A small amount (1.6 mg) 
of PCW from strain R 3 6 4  the unencapsulated derivative of D39 used for the wild-type 
meningitis experiments, was kindly provided by Prof. A Tomasz, Rockefeller University, 
New York. Estimates in the literature of the amount of PCW per pneumococcus range from 
to organisms per mg cell wall (Tuomanen et al 1985b; Tuomanen et al 1985a; 
Prof Tomasz, personal communication). The estimate is imprecise because pneumococci 
tend to clump together so that optical density determinations have a substantial error, and 
an unknown amount of PCW is lost during purification. Thus a dose of 100 as used in 
this study represents somewhere between 5x106 and organisms, which is broadly 
similar to the number of viable organisms inoculated CFU). Once the suspension of 
PCW had been vigorously sonicated, a moderate meningeal inflammatory response could be 
evoked, although in only one of the three successful experiments was the CSF protein 
concentration elevated. Hearing loss was significantly less than after a similar duration of 
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meningitis induced by viable S. pneumoniae D39. Unfortunately, no histological specimens 
were preserved. This constitutes limited evidence that PCW is not critically involved in 
meningogenic deafness. It is possible that there is insufficient PCW in 3x10’ organisms to 
induce significant pathology (Prof Tomasz, personal communication). Challenge with 100 
of pneumococcal cell wall represents a large but transient pro-inflammatory stimulus 
which might evoke a different host inflammatory reaction to that induced by pneumococcal 
cell wall continuously released from organisms replicating in vivo. 
5.4. Cochlear perfusion. 
In order to model what happens when organisms invade the scala tympani via the cochlear 
aqueduct a suspension of viable organisms was perfused through the perilymphatic space. 
The time course of subsequent pathophysiological events was monitored. One key 
modification to the model previously in use in the laboratory (and used to investigate the 
effects of purified pneumolysin on the cochlea) was to reduce the CSF flow through the 
fistulised cochlea by opening the cisterna magna (Salt et al 1991). This was intended to 
prevent the inoculum from being washed away before a chain of pro-inflammatory events 
was established. 
5.4.1. 
Perfusion of viable pneumococci into the perilymphatic space damaged the organ of Corti of 
the guinea pig within three hours. By contrast, intracochlear perfusion of comparable 
inoculum of a relatively apathogenic strain of E. coli was well tolerated, at least in this acute 
setting, suggesting that bacterial growth in the scala tympani per se does not affect the 
organ of Corti. The results further suggest that if and when pneumococci reach the inner ear 
during meningitis serious and possibly irreversible damage to the organ of Corti may follow 
rapidly. 
The two main ultrastructural lesions detected (damage to stereocilia and cratering of the 
apical surface of border cells) are broadly similar to those induced by experimental H. 
influenzae type b and E. coli meningitis in rabbits and experimental pneumococcal and E. 
coli meningitis in guinea pigs (this thesis). Together, these data constitute good evidence 
that such lesions are almost certainly due to bacterial invasion of the cochlea. However, the 
preservation of the CM suggests that bacterial perfusion itself does not acutely impair OHC 
function or affect the endocochlear potential. In contrast to the findings in experimental 
meningitis and after cochlear perfusion of purified pneumolysin (Comis et al 1993), 
scanning electron microscopy revealed little damage to the OHCs after direct pneumococcal 
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perfusion of the cochlea. The ototoxic mechanisms in this hyperacute situation may 
therefore differ slightly from those acting during the longer time-course of meningitis, 
particularly in regard to OHC damage. 
The preservation of hearing during the first hour after perfusion of pneumococci could be 
explained in at least two ways. First, it could be due to a lag phase in bacterial growth 
and/or the delayed release of ototoxic host inflammatory mediators. Second, it is possible 
that organisms complete a few rounds of replication before autolysis, only then releasing 
intracellular pneumolysin and cell wall material. 
5.4.2. Antibiotic effects 
Does antibiotic reach the perilymph? 
One study has shown that cefotaxime (100 mg/kg) reliably penetrates the perilymphatic 
space of healthy (i.e. non-infected) guinea pigs when administered as an intravenous bolus 
(Sun et al 1996). The concentration of CTX and its metabolite desacetylcefotaxime was 
measured in the CSF and perilymph by high-performance liquid chromatography. The 
concentrations in the perilymph exceeded that in the CSF at all times. One hour after 
injection, the concentration of CTX in the perilymph was 5.5 mg/l compared to 2 mg/l in 
the CSF. The reported MICs for CTX for penicillin-resistant pneumococci are between 0.04 
and 1 mg/l. The data show that in the guinea pig, supra-MIC levels of CTX and its active 
metabolite are achieved in the perilymph for at least 6 h after a single bolus dose of 100 
mg/kg; they would be expected to be even higher during meningeal or perilymphatic 
inflammation. Filamentous forms, long chain formation and bacterial cell wall distortion 
characteristic of penicillin activity were observed 75 min after perfusion of viable 
pneumococci into the scala tympani of amoxycillin-pretreated guinea pigs. This suggests 
that a concentration of amoxycillin in excess of the MIC was achieved in the perilymphatic 
space when amoxycillin (1 00 mg/kg) was injected intraperitoneally 30 min pre-perfusion. 
The pro-inflammatory theory 
According to previous work, antibiotic pretreatment might be expected to exacerbate local 
inflammation and by implication hearing loss (Tuomanen et a l  1987; Pfister et al 1994). But 
in fact antibiotic pretreatment substantially protected the cochlea from the acute effects of 
pneumococcal perfusion This is consistent with a recent study of hearing loss in 
experimental pneumococcal meningitis in rabbits in which it was found that even without 
adjuvant dexamethasone, antibiotic treatment both reduced the chance of deafness and 
aided recovery of hearing if lost (Bhatt et al 1995) (see section 5.2.1). The timing of 
antibiotic administration is important. In experimental rabbit pneumococcal meningitis, the 
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magnitude of the antibiotic-induced inflammatory burst is highly dependent on the numbers 
of bacteria in the CSF. Inflammation is enhanced by administering an intravenous ampicillin 
bolus at the threshold of log-phase growth in vivo but is postponed when a bolus is given 
early in the course of infection (Pfister et al 1994). Furthermore, in experimental E. coli 
meningitis in the rabbit the mean concentration of free endotoxin in the CSF four hours after 
an antibiotic bolus is at least ten-fold lower than in untreated animals (Friedland et al 1993). 
These studies suggest that reducing the cumulative bacterial load outweighs any transient 
antibiotic-induced inflammatory burst. This would explain the data obtained. By inhibiting 
the initial period of bacterial replication, antibiotic pretreatment limits the amount of toxin 
and cell wall material to that contained in the initial inoculum, release of which is still 
sufficient to cause some hearing loss. With no antibiotic pretreatment, bacterial replication 
increases the total amount of toxin and cell wall material available for release, so increasing 
hearing loss. 
5.5. Mechanisms of cochlear damage and its prevention. 
Evidence has been presented for the role of pneumolysin in causing cochlear damage. It has 
been assumed (but not experimentally proven) that the pneumolysin-dependent 
ultrastructural lesions are responsible for the majority of hearing loss in this experimental 
meningitis model. It does not however follow that measures to block the action of 
pneumolysin would necessarily prevent deafness occurring. It could be that sufficient 
pneumolysin is released early in infection to cause profound cochlear damage. Also, other 
bacterial toxins such as the putative cytotoxic toxin produced by H. influenzae might trigger 
cochlear damage by similar mechanisms (Amaee, 1995; Dover et al unpublished findings). It 
is likely that cochlear damage has already begun by the time some patients present with 
bacterial meningitis. Therefore it is useful to try and identify the final common pathways of 
damage, as intervention at this level might be more successful in preventing meningogenic 
deafness. There are many similarities between the damage induced by pneumococcal 
meningitis and those which occur post-mortem or follow acoustic trauma or cochlear 
perfusion with ototoxic drugs or excitotoxic agonists. This suggests that these insults act 
via a shared final common pathway. Some new potential mechanisms of damage will now 
be discussed. 
5.5.1. Dissipation of the endocochlear potential and mixing of cochlear fluids 
Craters in supporting cells and tearing away of hair cells from supporting processes will 
disrupt the integrity of the reticular lamina. This will lead to mixing of cochlear fluids, 
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raising the potassium concentration in the perilymph and dissipating the endocochlear 
potential which is essential for mechanoelectrical transduction. A similar process probably 
occurs after auditory trauma, where hair cells can be ejected from the reticular lamina 
(Bohne and Rabbitt, 1983; Slepecky, 1986). The stria vascularis is damaged in H. 
influenzae and E. coli meningitis in the rabbit (Osborne et al 1995) and by perfusion of 
endotoxin through the scala tympani (Guo et al 1994), and such damage will further 
compromise the endocochlear potential. Holes in the reticular lamina are eventually sealed 
by phalangeal scarring and it is probable that the stria vascularis can recover, thus hearing 
loss resulting from dissipation of the endocochlear potential may be reversible. There is as 
yet no direct experimental evidence to support this theory because it is technically very 
difficult to measure the endocochlear potential over the prolonged time course of 
experimental meningitis. 
5.5.2. Loss of hair cells and damage to hair bundles: the putative role of nitric oxide. 
Many insults to the cochlea result in loss of sensory cells. Such cells are replaced by scar 
tissue so damage of this nature is irreversible. Ballooning of the apical surface of outer hair 
cells and disruption of OHC and IHC hair bundles is common after pneumococcal 
meningitis, perfusion of pneumolysin into the cochlea, and auditory trauma (Osborne and 
Comis, 1995; Comis et al 1993; Bohne and Rabbitt, 1983). Guinea pig outer hair cells in 
vitro are killed by a 60-minute exposure to endotoxin (Dulon et al 1990). The 
relationship between OHC damage and hearing loss is not clear cut (see section 5.2.2). 
Inner hair cells carry about 95% of the afferent innervation so damage to or loss of IHC hair 
bundles such as the fusion, uprooting and splaying of stereocilia seen in pneumococcal 
meningitis will clearly cause a fall in afferent nerve potential. Damage to stereocilia alone 
can account for a shift in threshold (Slepecky, 1986). 
The action of a common mediator might explain why hair cells and hair bundles sustain 
similar damage in response to a wide variety of insults. One likely candidate is nitric oxide 
(NO) which is implicated in many different pathologies including neural damage and 
microvascular changes in meningitis (Pfister et al 1994; Koedel et al 1995) (see section 
1.4.2). The pathological production of NO by an inducible NO synthase is a non-specific 
immunological defence. NO reacts with oxygen superoxide to form peroxynitrite anions 
which decompose to the potent oxidants OH. and NO,. (Moncada et al 1991). In the CNS, 
NO is released by microglia in response to pro-inflammatory cytokines (Boje and Arora, 
1992) and by neurons in response to glutamergic stimulation of N-methyl-D-aspartate 
(NMDA) receptors (Garthwaite et al 1988). NO synthase has been localised to the spiral 
ganglion cells of the rat cochlea (Zdanski et al 1994). Perfusion of the cochlea with sodium 
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nitroprusside, a nitric oxide donor, induces damage to OHCs, ballooning of the apical 
surface of supporting cells and swelling of nerve endings beneath the IHCs which closely 
resembles damage found in pneumococcal meningitis (Amaee, 1995). The severe damage 
which follows perfusion of 10 pneumolysin into the guinea pig cochlea is almost 
completely abolished by preperfusion with (50 mM), an inhibitor of 
NO synthase (Amaee et al 1995). Pneumolysin in the scala tympani probably punches 
transmembrane pores in hair and supporting cells. Intracellular calcium rises due to voltage- 
dependent or glutamate-dependent channels, and this induces dependent 
NO synthase. Pneumolysin is not the only pneumococcal product responsible for NO release 
since heat-killed pneumococci can induce NO production by cerebral endothelial cells 
(Haberl et al 1994). 
Damage may also be mediated by oxygen free radicals which are liberated by 
polymorphonuclear leukocytes and macrophages during inflammation. Guinea pig outer hair 
cells are highly susceptibIe to free-radical induced damage in vitro (Dulon et al 1990). Free 
radical scavengers reduce injury in experimental bacterial meningitis (Pfister et al 1992d; 
Koedel et al 1995) but their efficacy in preventing hearing loss has not been assessed. 
5.5.3. Excitotoxic and physical damage to the neural elements 
One consistent finding in all of the meningitis experiments was pathological damage to 
nerve endings. This damage was not related to the production or absence of pneumolysin. 
Because hearing loss in the absence of pneumolysin (and, as far as can be ascertained, in E. 
coli meningitis) was minimal, the importance of the ultrastructural changes observed is 
uncertain. Damage to nerve endings such as dendritic swelling beneath the IHCs is 
commonly seen in a wide variety of toxic insults to the cochlea, including acoustic 
overstimulation (Spoendlin, 197 1), ischaemia, hypoxia, post-mortem change and excitotoxic 
damage induced by perfusion of excitatory amino acid (EAA) agonists kainate, quisqualate 
or glutamate (Osborne et al unpublished findings). There is a great deal of experimental 
evidence that excessive release of glutamate has a major role in the onset and evolution of 
various neuropathologies and there is intense interest in the potential role for glutamate 
receptor antagonists as cytoprotective agents in ischaemic stroke, epilepsy and brain trauma 
(Meldrum, 1995; Lipton, 1993). Excitotoxic injury is probably mediated by ionic channel 
gated post-synaptic receptors which promote large cation fluxes and entry of Cl -  into the 
cell, causing osmotic swelling. processes then lead to the generation of NO 
(see above). Intervention against excitotoxic damage is therefore possible at three stages: 
prevention of excess glutamate release; blockade of glutamergic receptors and reduction of 
the post-receptor osmotic and mediated events. 
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Few studies of the role of EAA antagonists in the pathophysiology of bacterial meningitis 
have been published, although EAAs are detectable in the brain interstitial fluid during 
experimental E. coli meningitis (Guerra-Romero et al 1993; Perry et al 1993). Kynurenic 
acid, a nonselective excitatory amino acid (EAA) receptor antagonist, partially protects 
cortical and hippocampal neurons against injury in experimental streptococcal meningitis in 
rats (Leib et al 1996). HU-211, a novel non-competitive NMDA antagonist which also 
blocks uptake, reduces brain oedema in ceftriaxone-treated experimental 
pneumococcal meningitis in rats (Bass et al 1996). Neurotoxicity in the cochlea itself 
appears to be mediated by both NMDA and non-NMDA receptors (Eybalin, 1993, p348). 
NMDA antagonists such as D-2-amino-5-phosphovalerate (AP-5) only affect the CAP at 
high stimulus intensities (Puel et al 1991). AP-5 and another NMDA-receptor antagonist 
MK-801 (dizocilpine) possibly block the deleterious actions of pneumolysin (10 when 
preperfused into the guinea pig cochlea, but no details of the concentrations used were 
given (Amaee et al 1995). 
Spontaneous firing of single nerve units can be induced by raising the perilymph potassium 
concentration, which depolarises the afferent endings either directly or indirectly by 
releasing transmitter (probably glutamate) (Leng and Comis, 1979). In this way, breach of 
the reticular lamina may both reduce the endocochlear potential and cause a depolarisation 
nerve block. The accumulation of extracellular glutamate generated by spontaneous 
excitation or neuronal cell death could eventually overwhelm the putative glutamate- 
glutamine cycle and cause wider pathological effects as above. 
Sections proximal to the nerve endings were not examined in this study, but it would be 
reasonable to assume that inflammation and resulting swelling could compress dendrites 
where they pass through the narrow habenula perforata to leave the modiolus. Damage to 
the auditory nerve at the level of the internal auditory meatus would reduce brain-stem 
evoked potentials but would not affect the compound action potential recorded at the round 
window. 
5.5.4. Other factors 
Cochlear damage probably results from a combination of all of the factors above, many of 
which are interconnected. Other mechanisms that might contribute toward hearing loss in 
meningitis (septic embolism of the internal auditory artery, disturbance of the brain stem 
etc.) were discussed in section 1.5.2. 
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5.6. Conclusions 
What conclusions can be drawn from these experimental studies that might change clinical 
management of bacterial meningitis? 
Convincing evidence has been presented confirming the crucial role of pneumolysin in 
causing cochlear damage in pneumococcal meningitis. The electrophysiological data add to 
the evidence that cochlear damage is the chief cause of deafness in meningitis (see section 
1.5.2). In the meningitis model, a substantial hearing deficit developed in just a few hours, 
and under controlled conditions cochlear function was impaired just 90 minutes after 
exposure to viable pneumococci. The rapid onset of cochlear damage is consistent with two 
recent clinical studies showing that if deafness does occur in meningitis, it is usually present 
at the time of admission (Wald et al 1995; Richardson et al 1995). This emphasises the 
importance of immunisation as the chief tool in preventing meningitis and its neurological 
sequelae, since it may be too late to save hearing once the patient presents. 
The data obtained in these studies also emphasise the need to treat bacterial meningitis with 
appropriate antibiotics as urgently as possible to minimise the cumulative inflammatory 
stimulus and to reduce the probability of bacterial invasion of the inner ear with the 
potential ototoxic sequelae demonstrated here. 
Further evidence is needed of the importance of excitotoxic and NO-induced damage in the 
pathophysiology of meningitis. Adjuvant anti-inflammatory therapy to minimise the 
antibiotic-induced inflammatory burst has been promoted as a way of reducing the long- 
term neurological sequelae of bacterial meningitis (including deafness) but remains 
controversial (Schaad et al 1995). It would seem more sensible to focus attention on the 
final common pathways of damage, rather than on the inflammatory cascade. Intervention at 
this stage has the possibility of reversing damage already triggered by the pro-inflammatory 
cytokine cascade or the actions of bacterial toxins. Several cytoprotective agents are in 
clinical trials of efficacy in ischaemic stroke (Meldrum, 1995). It is unlikely that a 
pharmaceutical company will develop a drug specifically for use to prevent complications in 
meningitis. Future experimental meningitis studies should therefore evaluate cytoprotective 
agents that are likely to come on to the market in the near future licensed for other 
indications. 
Further specific experiments extending those presented in this thesis should include: 
Investigating if the haemolytic or complement-activating actions of pneumolysin are 
important in causing cochlear damage by inducing meningitis with the variants of D39 
containing defined point mutations in the PLY gene (Rubins et al 1996). A better 
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understanding of how pneumolysin damages the cochlea will help the search for 
efficacious adjuvant treatments. 
Investigating the efficacy of cytoprotective agents such as NMDA-antagonists in 
preventing cochlear damage in experimental meningitis. These agents could easily be 
assessed in the guinea pig model, which offers the great advantage that protection can 
be evaluated in terms of both hearing loss and ultrastructural damage 
Perfusing the cochlea with suspensions of PLN-A to see if pneumolysin is responsible 
for cochlear damage in that situation. 
Defining more clearly the putative role of hyaluronidase in pneumococcal replication in 
vivo. 
Finally, this study has demonstrated how a powerful molecular technique such as insertion- 
duplication mutagenesis can contribute to understanding the pathogenesis of infection when 
combined with careful physiological and microscopic techniques. It is only by such close co- 
operation across disciplines that we will better understand the incredible complexity of the 
interaction between microbe and host. Similar co-operation between the fields of infectious 
disease, clinical neurology, paediatrics and neuroscience may yet yield an effective adjuvant 
therapy that will prevent meningogenic deafness. 
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Appendix A: Composition of solutions used 
Phosphate buffer (0.2M) for fixative: Final 
0.2 M 
pH 7.2 
1.35g in 50 ml dH20+ 
0.3 1g NaOH in 39 ml 
Glutaraldehyde fixative: 
25 ml 0.2 M phosphate buffer 0.05 M 
10 ml 25% glutaraldehyde 2.5 % 
1.7 3 g sucrose 
to 100 ml with dH2O Osmolarity = 350 mmol/kg 
Osmium tetroxide 
2.5 ml 0.2 M phosphate buffer 
0.855 g sucrose 
to 10 ml with 
0.05 M 
0.1 g 0.1% 
Osmolarity = 350 mmol/kg 
10% buffered formalin for histological fixation 
100 ml 10x PBS (Gibco BRL, Ca/ Mg free, 042-0400) 
100 ml40% formaldehyde (BDH, Poole, UK) 
800 ml dH20 
Counting fluid (stains white cells in CSF): 
1 ml Glacial acetic acid 
2.5 ml Propan 1,2 diol 
1.5 ml Crystal violet 1 % in water 
Kept in the dark at 4°C 
to 100ml with dH20 
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TEM embedding resin 
After Mollenhaur 1964; all chemicals from Agar Scientific, Essex 
2.5 ml Agar 100 
3.3 ml Araldite Cy2 12 
4.2 ml Dodecenylsuccinic anhydride 
0.15 ml Dibutylphthalate 
0.25 ml 2,4,6-tri(dimethylaminomethyl) phenol 
Artificial perilymph. 
Batches of APL (100 ml) were filter-sterilized (0.2 and aliquots of 5 ml were stored at 
4°C. The composition is thus: 
mM g/l 
NaCl 137 8 
5 0.37 
2 2 ml of 1mM solution 
1 0.156 
O 1 0.202 
12 1.01 
Glucose 11 1.982 
Osmolarity = 300 ± 3 mmol/kg 
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Appendix B: Details of the construction of the isogenic mutants of S. pneumoniae D39 
deficient in pneumolysin, neuraminidase or hyaluronidase. 
All derivatives of D39 were kindly provided by Dr Tim Mitchell, Dept of Microbiology, 
University of Leicester. A brief description of their manufacture is given below. 
PLN-A: PLN-A deficient in pneumolysin was made by a two-stage process (see figure) 
because direct transformation of encapsulated D39 proved impossible. Plasmid pJCP20, a 
derivative of pBR322, carries the complete S. pneumoniae pneumolysin gene (pln) (Paton et 
al 1986). A 690 bp fragment of the pln gene was excised from pJCP20 and ligated into the 
vector pVA89 1 which carries a streptococcal gene (erm) encoding erythromycin resistance. 
pVA891 was transformed into E. coli K-12 DH1. The recombinant plasmid was purified 
and used to transform a non-encapsulated derivative of D39 (Rxl). By homologous 
recombination between the pneumolysin gene fragment in the plasmid and the S. 
pneumoniae chromosomal DNA the chromosomal coding sequence for pneumolysin was 
interrupted. This was confirmed with Southern blot hybridisation. DNA from this organism 
was finally transformed into encapsulated D39 and the failure to make a translated gene 
product confirmed with immunoblot analysis and a haemolytic assay(Berry et al 1989). 
PLN-A has been used in a number of studies of pneumococcal pathogenesis (Berry et al 
1989; Rayner et al 1995; Benton et al 1995; Friedland et al 1995; Canvin et al 1995). 
: deficient in hyaluronidase activity was also made by insertion-duplication 
mutagenesis, but this time by direct transformation of D39. The sequence of the 
hyaluronidase gene was established by Berry (1 994) (Adelaide) and Hill (1 995) (Leicester). 
A 1.3 kb fragment of the hyaluronidase gene was cloned into pG+host 5, a "suicide vector" 
which has a temperature-sensitive origin of replication. Transformation of D39 with the 
shuttle vector pVA838 (including the erythromycin resistance gene) was enhanced by 
adding competence factor from strain Rx1 and incubating at 22°C. A putative 
hyaluronidase-negative mutant was isolated and designated This failed to cleave 
hyaluronic acid in the agarose plate assay. Southern blot hybridisation confirmed 
incorporation of the inserted DNA into the chromosomal hyaluronidase gene. 
deficient in neuramindase activity was made by a similar process. The 
sequence of a neuramindase gene (nanA) had been previously established (Camara et al 
1991). A putative neuraminidase mutant was unable to cleave MUAN and 
Southern blot hybridisation again confirmed interruption of the chromosomal gene for 
neuraminidase. 
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Appendix C: Assays for pneumolysin, neuraminidase and hyaluronidase. 
I am grateful to Andrew Wallis and Dr Val Clarke, Department of Microbiology and 
Immunology, University of Leicester for performing the assays described below. 
Single colonies of either the inoculum under test or organisms recovered from the CSF were 
inoculated into 10 ml BHI with or without erythromycin ( 5  incubated overnight at 
37°C and then pelleted. Cell lysates were prepared by ultrasonication. Total cell protein was 
determined by a BioRad microassay. 
Pneumolysin activity was detected by a standard haemolytic assay. Twofold serial dilutions 
of the cell lysates were mixed with an equal volume of 2% sheep erythrocytes and incubated 
for 30 min at 37°C. Results were reported as either plus or minus. 
Neuraminidase activity was assayed fluorometrically by adding 20 of cell lysate to 200 
of 150 acid (MUAN) in a 100 mM 
citrate-phosphate buffer at pH 6.5 and incubating for 16 min at 37°C. Neuraminidase 
cleaves fluorescent 4-methylumbelliferone from MUAN. The reaction was stopped by 
adding 2 mi of 0.5 M Fluorescence was excited at a wavelength of 365 nm with an 
emission wavelength of 446 nm. The lower limit of detection of the assay was about 0.5-0.6 
mU/mg cell protein while the wildtype D39 expressed about 6.4 mU/mg cell protein. Assays 
were performed in duplicate on two separate occasions. 
Hyaluronidase activity was assessed in a qualitative agarose plate assay. Plates were 
prepared by adding 1 ml hyaluronic acid (2 mg/ml in PBS) and 1 ml bovine serum albumin 
(8 mg/ml in PBS) to 4 ml of 1.6% (wh) agarose in PBS and allowed to set for 1 h at 37°C. 
Cell lysate (10 was added to a well and incubated for 16 h at 37°C. The plate was 
overlaid with a 10% cetylpyridinium solution. Hyaluronidase activity was detected as a clear 
zone around the well. 
Appendix D: Raw data from meningitis experiments 
In the following pages the raw data from the comparative meningitis experiments are 
tabulated. Each column represents an individual cochlea. Figures given are the CAP loss 
(dB) at each of the eight frequencies measured at 3, 6,  9 and 12 h post inoculation. Blank 
cells represent failed recordings. 
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